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The aim of this research is to identify and analyse the process requirements for Health 
Information Systems (HIS).  It develops and evaluates a software innovation model for 
use in the development and deployment of HIS referred to as InnoDesignDeploy (IDD). 
A qualitative research approach is used. 
 
Information Systems are used in healthcare in various ways such as to make decisions 
on patient diagnosis, treatment, best practices, financial and administrative functions. 
Developing efficient and effective HIS is important for a number of reasons. Healthcare 
mistakes can have serious consequences that can affect patients’ lives and have a high 
financial cost. Technology is evolving quickly but is slow to be implemented in  
healthcare which is highly regulated. Technology needs to comply with relevant 
regulations. Regulations such as the IEC 62304 does not stipulate a specific process 
model for the software development process (for example, waterfall model, V-model 
or Agile practices) rather it states that one should be used (ANSI/AAMI/IEC 2006). In 
essence it states to use a model but it does not specify which one.  
 
There is no comprehensive methodology for developing and deploying HIS. IDD was 
developed through a series of research stages using sources in academia and industry. 
IDD focuses on essential processes, tasks and strategies used to develop and deploy 
HIS. This is an approach where innovation strategies and user involvement are key. 
The original contribution to knowledge is that IDD provides a structured approach 
which defines processes, strategies, roles, inputs and outputs of each step in a structured 




Chapter 1 Introduction 
In healthcare, software systems are prevalent and are increasingly used to collect, store 
and report data. Also, software has been deemed to be a medical device (MD) in its 
own right (European Union Council 2007). There is a lack of methods identifying 
where new innovations are needed and which offer concepts relevant to users (Lamé et 
al 2018). This thesis presents research that addresses the gap identified - lack of a 
comprehensive health information systems (HIS) model that addresses innovation, user 
involvement, and deployment strategies. The following research objectives are 
addressed: 
• To define a software innovation model for use in the successful design, 
development and implementation of health information systems; 
• To develop and evaluate this software innovation model. 
The software innovation model, InnoDesignDeploy (IDD), is proposed based on 
multiple sources of information including a literature review, a review of relevant 
standards such as the National Standards Authority of Ireland (NSAI), a study of 
existing practices in hospitals, and case studies in medical practice and a MD company. 
 
1.1 Problem Statement 
What makes healthcare different from other industries? Why is there a need for a spe-
cific model to address HIS development? Healthcare is different because: 
• In healthcare actions can directly affect patients’ lives, which makes it different 
from other industries (Kaissi 2012); 
• Healthcare innovation can be challenging as it is a regulated industry (Christen-
sen et al 2000); 
• Clinicians have individual autonomy, so it can be difficult in some cases to 
change their behaviours (Buttigieg 2015); 
• Managing software in hospitals has specific challenges such as size, complex 
practices, resistance to change and parallel practices (Shroff et al 2011); 
• Healthcare is fragmented with multi-faceted relationships between private and 
public stakeholders Geissbuhler (2013). 
 
2 
Kellermann and Jones (2013) point out that health IT can offer efficiencies such as 
reduced costs, but it has failed to reach this potential for a number of reasons: 
• Slow adoption of health IT systems; 
• Systems that are not interoperable; 
• Systems that are not easy to use; 
• Failure of health care providers to reengineer care processes to realise the full 
benefits of health IT. 
Barry et al (2018) point out that to achieve relevant and long-term change, an approach 
is needed that assists individuals, associations, culture, power, and dynamic interac-
tions. IDD provides processes and strategies that are user-centered, encourage innova-
tion, buy-in and guide the deployment of HIS. 
 
1.2 Research Design  
IDD was constructed using four research design development stages (Figure 1.1).  
 
Stage 1 defined the problem and involved identifying the research objectives, followed 
by a literature review. Findings of the literature review were then analysed to produce 
the research questions which informed the design of the initial IDD-Requirements. This 
enabled the development of the first version of IDD (IDD-V1). 
 
Stage 2 comprised case studies which were undertaken in medical practice and MD 
industry; these case studies facilitated a greater understanding of the problem and 
facilitated the gathering of further IDD-Requirements that were used as input into the 
second version of IDD (IDD-V2).  
 
Stage 3 comprised of another case study which was conducted in hospitals. The findings 
allowed IDD to be refined so that the third version of IDD (IDD-V3) could be proposed.  
 
Stage 4 involved external evaluation of IDD with health experts providing feedback on 
IDD-V3. IDD provides processes and strategies to projects developing and 




Figure 1.1: Research Design 
 
1.3 Research Contributions 
This research has resulted in a number of contributions. A literature review was 
presented that highlights the need for an model.  
 
A new model IDD was developed as part of the research. IDD was evaluated by external 
experts. IDD is different to existing models such as the V-model as it primarily puts the 
user central to the process, it acknowledges that the resultant change needs to be 
effectively managed and that multidisciplinary teams are crucial. The IDD model 
(Figure 1.2) is described in Chapter 7. 
 
This research also contributed to learning through the publication of papers (Travers 




1.4 Structure of Thesis 
This thesis has been structured in the following manner: 
 
Chapter 2 Literature Review. This chapter discusses HIS, regulation, organisation 
software management, people and innovation. Reasons for innovation successes and 
failures are also listed. Requirements were gathered to use as input into IDD-V1. 
 
Chapter 3: Research Methodology. This chapter discusses a number of research 
methodologies. The methodology chosen for this research is then discussed in detail. 
The research value and suitability of the chosen methodology is explored. The research 
design is then introduced. 
 
Chapter 4: Medical Practice and MD Industry Cases. This chapter details various 
data collection stages such as the medical practice and MD industry case studies. These 
case studies provided IDD-Requirements that were used to develop IDD-V2.  
 
Chapter 5: Hospital Case. This chapter discusses the hospital case study that was 
undertaken which produced IDD-V3.  
 
Chapter 6: Evaluation of IDD. This chapter discusses the external evaluation of IDD. 
The feedback was used to update and refine IDD. 
 
Chapter 7: Description of InnoDesignDeploy (IDD) model. This chapter provides a 
detailed description of IDD. 
 
Chapter 8: Conclusion. This chapter outlines how the research questions were 







Figure 1.2: Evaluated IDD Model 
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Chapter 2 Literature Review 
 
2.1 Introduction 
Heath Information Systems (HIS) are systems used in the healthcare industry and allow 
for the capture, manipulation, storage and transmission of data such as patient data or 
organisation data. HIS is a subset Health Information Technology (HIT). The objectives 
for this literature review are: 
• To review the history of HIS;  
• To discuss HIS, software process and Software Development Life-Cycle 
(SDLC) influences; 
• To assess innovation and change; 
• To compare reasons for innovation failures and successes; 
• To identify HIS requirements. 
 
Completing these objectives results in identifying factors that impede and promote HIS 
as well as the HIS requirements that should be considered in the development of 
InnoDesignDeploy (IDD). The scope of this literature review is a system-based 
perspective to software design and HIS. A systems-approach looks at understanding the 
interdependencies within a system and the changes that can be made for improvement 
(Johnson et al 2008). The aims are to identify and evaluate relevant research. In doing 
so the researcher explores the history of HIS and HIS software development. This leads 
to the discussion of topics such as change, innovation successes and innovation failures. 
During this literature review relevant models from this domain were identified, but no 
comprehensive model or set of guidelines were found to be available for HIS software 
development projects that addresses all of the common reasons for innovation successes 
and failures. The literature analysed allowed the researcher to gather an initial set of 
IDD-Requirements to address current gaps/deficiencies for a new proposed model 




2.2 Health Information Systems (HIS) 
HIS, in an Irish hospital context, are used in a number of different ways such as by the 
whole hospital, single departments and by clinicians in a personal context (Reid et al 
2012). There are a number of distinguishing features that make healthcare unique and 
unlike other industries. Geissbuhler (2013) and Sligo et al (2017) elaborate on the 
differences of healthcare to other industries by commenting that healthcare is 
fragmented with multifaceted relationships between private and public stakeholders. 
Healthcare is different from other industries for a number of reasons, such as being a 
complex and regulated environment and it provides services which can directly impact 
life and death (Kaissi 2012). Clinicians also have professional autonomy, which allows 
clinicians to be independent in their decision making. Managing software in hospitals 
has specific challenges such as size, complex practices, resistance to change and 
parallel practices (Shroff et al 2011). Changing behaviours can then be difficult in some 
cases (Buttigieg 2015). Software innovation allows projects to address user needs. 
Innovation can be challenging due to the uniqueness of the industry, while also having 
to adhere to regulations. The definition of innovation is “making changes to something 
established by introducing something new” (New Oxford Dictionary of English 1998). 
There are many types of innovation such as an innovation that is completely new, a 
process innovation or an innovation that is an improvement on an existing 
product/system. In process innovation, old technologies can be used in different 
processes, for example, having automated external defibrillators (AEDs) attached to 
drones. 
 
Information Systems (IS) use in other industries such as business and finance has shown 
benefits such as reduced costs and greater improvements for the customer (Harvard 
Business Review 2019). The same has yet to be fully seen in healthcare. Healthcare has 
traditionally lagged behind other industries where information systems have been used 
(Ireland, Department of Health 2013). The main reasons for implementations of 
information systems to lag behind are failures in communication, project scoping, and 
risk and stakeholder analysis (Abouzahra 2011; Sligo et al 2017). HIS is a crucial 
enabler in the transformation of healthcare delivery, the promotion of population health 
and wellbeing, and the creation of greater economic development potential (Ireland, 
Department of Health 2013). The World Health Organization (2019) state that systems 
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have been rolled out without an inspection of the evidence base on benefits and harms, 
which has led to a proliferation of short-lived implementations and a large amount of 
diversity of tools, with a poor understanding of their impact. With this in mind, a model 
that addresses these failures can aid in the successful implementation of HIS. As a result 
of this literature review, have specific implementation and change processes are iden-
tified as IDD-requirements (R2, R12 and R13) for inclusion in the IDD model. For 
example, when the text, change and results management required was analysed, it was 
coded under ‘change’. The code ‘change’ abstracted to theme - ‘change management’.  
This theme resulted in R2, R12 and R13. 
 
2.3 History of HIS  
Developing HIS is a complex task as healthcare mistakes can have serious 
consequences that can affect patients’ lives. Healthcare is a safety critical industry so 
quality of products such as software is a major concern. Challenges exist that can 
restrict the effective use of IT in healthcare (Geissbuhler 2013, Sligo et al 2017 and 
Wager et al 2013): 
• Healthcare is a fragmented industry with, for example, independent hospitals, 
MD companies where data sharing such as patient information is problematic; 
• Various stakeholders have different objectives such as charities being non-
profit, whereas private hospitals are for profit; 
• There are specific industry-focused regulations, such as the Health Information 
Portability and Accountability act (HIPAA) in America. HIPAA regulates 
health information (HI) for security and confidentiality. Data is complex as it 
can be in various forms such as text, images and graphics. Terminology can 
differ among clinicians. HI must be kept secure and confidential; Misalignment 
of incentive, for example, no fiscal reward for improved quality of care. 
 
The history of HIS dates back to the 1960s. Wager et al (2013) details the timeline of 
major events as well as advances in information technology (Appendix 1). This detailed 
history of HIS shows the vast change that has happened in the last number of decades. 




From the timeline (Wager et al 2013), it can be seen that the main influencer of change 
from the 1960s to the present has been advances in technology, which in turn enabled 
HIS to progress. The second influencer of change has been regulations and standards, 
which have changed as technology changed. The 1990s was a watershed for 
technological advances with the introduction of the Internet. The Internet allowed 
computers all over the world to be connected and radically changed how we 
communicated, for example, via email. The number of vendors in the hardware industry 
increased. In the 2000s, paper-based health records could be converted to electronic 
versions. This allowed for greater traceability and visibility of records and it enabled 
easier sharing of records. Internet speeds began to increase and access to the Internet 
grew. New portable devices became available. In the 2010s portable devices became 
more widely used and available in the form of smartphones. Cloud computing was 
developed and it facilitated the external storage of information. Home patient 
monitoring technology became more prevalent. The use of technological advances in 
healthcare has been slower than in other industries. Healthcare systems often consist of 
multiple software applications that have been developed in silos and have not been 
integrated with other applications. Multiple types of infrastructures, such as public 
hospitals, private hospitals, clinics and general practitioner practices, are not integrated 
enough to effectively communicate. For over two decades, technology has existed that 
facilitates the conversion of paper records to electronic ones, but countries like Ireland 
as yet do not have an entirely paperless system within healthcare.  
 
To address this, a model can provide a set of guidelines for different stakeholders to 
facilitate better communication and collaboration for HIS development. Software 
processes are activities used to aid in the development of software. Technology is 
advancing and healthcare is slowly moving in that direction (Tobey 2019). Therefore, 
there is an increased need for HIS to embrace technology and software to operate. For 
example, to reduce the rate of patients missing appointments, technology and software 
can be used to notify/remind patients of upcoming appointments. Patients can also use 
software to reschedule appointments or view their appointment history. This example 
of patients having the ability to manage their appointment history is useful as it reduces 
the healthcare resource’s time needed to manage appointments. Patients can also point 
out any potential errors in their appointments. Unfortunately having a new way of 
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working can have a negative instead of a positive impact. However, having a deep 
understanding of users’ needs can address and mitigate such negative impacts. 
 
Relevant research models were examined in terms of the areas they address and 
limitations (Table 2.1): 
• This research builds on the work of an number of the authors listed namely, 
MacNeil et al (2019), Ludwick and Doucette (2009), Coiera et al (2016), Turner 
et al (2016), Lo et al (2020) and Greenhalgh and Papoutsi (2018) as this research 
examines elements related to project failures and successes; 
• The works listed by Holden and Karsh (2010) and Kuziemsky (2015 and 2016) 
are out of the scope of this research. Holden and Karsh (2010) examines theories 
for prediction of IT acceptance. Kuziemsky (2015) examines the need for more 
studies of organisational and social issues at a micro level. Kuziemsky (2016) 
further examines organisational and social issues; 
• This research differentiates from the authors Greenhalgh et al (2017) who deal 


































Barriers and facilitators 
of technology innova-
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Provides a detailed summary of facil-
itators and barriers.  
 
Limitations of the 







HIS can aid in reducing 
gaps in 
healthcare supply and 
demand. 
 
HIS do not impact efficiency, quality 
of care, or patient safety. Processes 
around systems are the source of ad-
verse events.  
 
Examined the articles 
from 2000 to 2007. 
 






associated with the 
introduction of HIT 
into clinical settings. 
Identifies the major themes that have 
emerged.  
Further research on 
unintended conse-
quences needed to be 
able to manage them. 





impact challenges for 
human factors 
knowledge and HIT. 
Usability problems and unintended 
consequences from HIT. Provides a 
review the developments in human 
factors research. 
Selective review of re-
search from 2015 and 
2016. 





engaging with users in 
health informatics 
initiatives. 
A case study that applies a 
consensus-building technique in 
identifying approaches. 







Complexity in health 
services research. 
 
A ‘systems mindset’ is needed to 
acknowledge the changing 
interrelationships between parts of a 
system and adapts to unexpected 
changes. 






Health IT acceptance 
and use.  
Reviews the Technology Acceptance 
Model (TAM), to health care.  
 
Studies included in the 
review were from 
2008 or earlier. 
Greenhalgh 
et al (2017) 
 
 
A lot of promising 
technological health in-
novations are not 
adopted, abandoned or 
fail at the organization 
or system level.  
Provides and evidence-based, theory-
informed framework to aid in the pre-








Review of social and 
organisational HIT is-
sues. 
Five themes were identified and dis-
cussed.  
More 
research needed on 
bringing together mi-
cro and macro per-
spectives of 






No framework exists 
with a focus on social 
and organisational is-
sues in terms of unin-
tended consequences.  
Provides a framework of social and 
organizational issues for studying un-
intended consequences and HIT. Ex-
tends existing work as focused on or-
ganisational and social issues. 
 
Limited search terms. 




An approach is needed that is proactive for mitigating potential problems such as 
stakeholder engagement, communication and collaboration. Kaplan and Harris-
Salamone (2009) state that communication and workflow issues add to the complexity 
of projects. Collaboration is key to project success (Heath et al 2017). Collaboration 
can be difficult due to the various different types of stakeholders involved, which, can 
in turn lead to requirements gathering issues (Kaplan and Harris-Salamone 2009). 
Using a collaboration-intensive process can be successful in ascertaining stakeholder 
perspectives (Blake et al 2010). Potential negative impacts of new workflows can be 
reduced by project reviews (Magrabi et al 2016). Kuziemsky et al (2019) point out that 
health IT design should be flexible so as to evolve in parallel with the collaborative 
processes that it is automating. Kuziemsky et al (2016) also state that management is 
required in project design and evaluation as negative unintended consequences should 
be identified before implementation, thus being, proactive instead of reactive in terms 
of their management.  
 
2.3.1 Connected Health 
Connected Health is an example of a relatively new area of innovation in healthcare 
software (also sometimes called mHealth, eHealth or Digital Health), which is the 
transfer of data electronically. Connected health: 
encompasses terms such as wireless, digital, electronic, mobile, and tele-health and 
refers to a conceptual model for health management where devices, services or 
interventions are designed around the patient’s needs, and health related data is 
shared, in such a way that the patient can receive care in the most proactive and 
efficient manner possible. All stakeholders in the process are ‘connected’ by means of 
timely sharing and presentation of accurate and pertinent information regarding 
patient status through smarter use of data, devices, communication platforms and 
people. 
(Caulfield and Donnelly 2013) 
A further refinement of the definition states that:  
Connected Health is patient centred care resulting from process-driven health care 
delivery undertaken by healthcare professionals, patients and/or carers who are 




Many connected health technologies are not successful in fulfilling sustainable 
innovations in healthcare practices (Van Gemert-Pijnen et al 2011). They state that 
connected health technology development has to consider the complexity of healthcare 
and the rituals and habits of users. O’Sullivan and Dooley (2010) further identifies that 
in any organisation an understanding of root causes of failure leads to solutions for 
managing innovation that can be better deployed. 
 
2.4 Software Development Life-cycle (SDLC) Influences 
Software systems are often developed according to a Software Development Life-Cycle 
(SDLC) and there are software processes involved in such development. Cawley et al 
(2013) identifies four groups of influences to the software development life-cycle 
(SDLC) within the regulated industry of healthcare: 
• Regulation;  
• Software Management ; 
• People; 
• Organisation.  
These groups will be discussed next in terms of the influences on the SDLC specifically 
adherence to regulation; software management of tasks and resources; people involved 
in implementing a SDLC and defined roles, responsibilities, authority and tasks.  
 
2.4.1 Regulation 
When implementing software within healthcare the quality of the software is paramount 
and therefore regulations need to be understood and interpreted correctly. Software is 
used in medical devices (MDs) and in hospitals, and quality issues in some cases can 
ultimately affect patients’ lives. There is a need for such software to be safe and secure. 
Audits and traceability are some of the methods used to adhere to regulations (Cawley 
et al 2013). 
 
In the healthcare industry MDs and HIS are manufactured to aid patients. To safeguard 
patient safety and minimise risk such devices are regulated. Regulations are country 
specific. Companies that want to sell products such as MDs in more than one country, 
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have to adhere to the relevant regulations in more than one country. In America, the 
regulatory body is the Food and Drug Administration (FDA), whereas in Europe the 
regulatory body is the European Commission (EC) using the Medical Devices Directive 
(MDD) (EU Council 1993), (EU Commission 2007). Standards, such as the 
International Organisation for Standardization (ISO) standards, are also relevant. 
 
In terms of HIS regulations, legislation has been passed to further the adoption and 
meaningful use of health information technology in America. For example, in 2009, the 
HITECH Act requires organisations to become meaningful users of Electronic Health 
Records (EHR), to create the infrastructure for health information exchange (Wager et 
al 2013). In 2010 the Patient Protection and Affordable care Act was enacted with 
emphasis on evaluating new models of care delivery and payment reform. In Europe, 
the Medical Device Directive (MDD 2012) amended its definition of a MD to include 
software. Software can be embedded within a medical device or be used in the 
manufacturing of a device. Therefore, software could be in certain cases classed as a 
standalone MD. So standalone software can be a device in its own right.  
 
In Ireland, the National Standards Authority of Ireland (NSAI) is the national standards 
and measurement body. NSAI sets standards and issues certification in the quality and 
safety of goods and services. With existing standards, NSAI works with businesses to 
apply them. Where a standard is lacking, NSAI works with relevant parties to create 
and develop the appropriate standard, which can be national or international. In 2009 
NSAI published a guide entitled “Guide to Good Practice in Innovation and Product 
Development Processes” devised by NSAI, innovators, academics and industry experts. 
The guide discusses an innovation management process and the minimum requirements 
an organisation needs for successful innovation (NSAI 2009). In terms of innovation 
management it has specific innovation practices. Adding software specific processes 
will complement it as it is lacking specific software processes such as software testing 
and verification practices. Within healthcare the regulation of software can be discussed 




2.4.1.1 Software for medical devices (MDs) 
“The EU Directive 93/42/EEC states that a MD is any instrument, appliance, apparatus, 
material or other item, used alone or together, including the software required for its application 
intended by the manufacturer to be used for human beings for the purpose of diagnosis, 
prevention, monitoring, treatment or easing of disease, diagnosis, monitoring, treatment, easing 
of or compensation for an injury or handicap” (European Union Council 1993). 
 
Standards and guidelines have been developed to aid in achieving the safest possible 
product. For example, in America the U.S. code of federal regulations title 21 part 820 
governs the quality system regulations.  The international standard (ANSI/AAMI/IEC 
2006) governs MD software development life cycle (SDLC) processes. A set of 
processes, activities, and tasks that are needed within a MD SDLC process are defined 
by the International Electrotechnical Commission (IEC) 62304. Reading the standards 
can lead to incorrectly thinking that a waterfall-type software development 
process/methodology is the best model to use (Cawley et al 2011). This is because the 
ISO 62304 standard only states to use a methodology, but it does not recommend a 
specific one to use.  McCaffery et al (2012) point out that with regulatory compliance 
in mind MD companies usually use a SDLC such as the V-model. More recently Agile 
practices are becoming more popular in healthcare. Models such as the Waterfall, V-
model and Agile practices will be discussed later in Section 2.4.2. Another issue that 
arises is that there does not seem to be a method for quantifying just how much process 
is enough. In such a situation it is then left to the discretion of, for example, a project 
manager to decide, and two project managers could have different interpretations of 
how much process is sufficient. Companies attempting to improve their product also 
have to change their development processes to ensure high quality products (Hayes and 
Richardson 2008). If a change mindset is not in place or not managed then 
implementing any system or process will not be effective. Companies implementing 
process change can benefit from using a change management model but published 
models usually relate to organisation change as opposed to process changes (Hayes and 





Regulations are needed to ensure safety and performance but technology is moving 
faster than regulations (Vincent et al 2015). Edler et al (2016) point out that while 
regulation can be restrictive it can also create opportunities to create product or process 
innovations, that is, incremental and sometimes new solutions.  There is a requirement 
to balance the need for regulation with the need to innovate flexibly and efficiently 
(Vincent et al 2015). One way to achieve this is by having a process or a set of 
guidelines that facilitates software to be developed that is innovative while also 
adhering to relevant regulations. For example, having software tools/processes in place 
that provide regulatory compliance features can then free up staff to concentrate on 
creating innovate products for users and reduce costs in terms of time. In healthcare, 
because people’s lives depend on quality software, regulation is crucial to achieve this.  
 
Regulations are needed for safety. For MDs the regulations state to use a SDLC process 
and the V-model is the most commonly used methodology. Processes are needed to 
guide projects.  
 
2.4.1.2 Software for hospitals: Health Information Sys-
tems (HIS)  
As with MDs, HIS must protect patient safety and privacy, and in addition, there are 
clinical, technical and software regulations that need to be considered (e.g. EU 
directive: 2007/47/EC, European Union Council, 2007, EU Clinical Trials Directive 
(Directive 2001/20/EC)).  
 
The hospital setting is very different to the MD company setting. Reid et al (2012) note 
that MD software systems designed under tight regulatory controls might not be 
successful in the hospital setting. For implementation to be successful there is a need 
for co-operation between vendors, internal and external IT staff, and healthcare staff, 
and involves unique relationships among stakeholders with varying needs, interests, 
and objectives (Reid et al 2012).  
 
Organisations need to have appropriate information systems as Healthcare IT is a 
central component of a safe, good quality healthcare system. In healthcare most 
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organisations are using paper-based or unsatisfactory information systems this is in 
spite of the fact that it also is one of the most advanced technologically and the most 
information intensive (Wager et al 2013).  
 
Software use in healthcare has benefits such as quick accessibility, readability and 
visibility to data but healthcare has been slow to embrace software. Hospitals such as 
the Cleveland Clinic in America, have the ability to embrace the benefits of software 
use in the fact that this hospital is totally paperless and uses Electronic Health Records 
(EHR) (Cision 2013). Also, a number of countries such as Denmark and Sweden have 
prioritised availing of such benefits and extensively use EHR (Cajander et al 2019). In 
2014, Ireland started a national project tasked with moving from paper-based 
documentation to EHR (HSE 2014b). In 2020 this is still a work in progress.  
 
The healthcare sector as a whole represents many industries made up of diverse 
stakeholders representing a wide range of interests. Various stakeholders include 
patients, healthcare providers, regulators, payers and suppliers (including software 
providers). Thus, introducing a HIS innovation and managing the implementation 
change that ensues is a complex task. For a software system to be successful, user 
involvement and participation are essential in the software development (Abelein and 
Paech 2015; Sligo et al 2017).  
 
As a result of this literature review, have user-centred practices are identified as IDD-
requirements (R1, R6, R8 and R17) for inclusion in the IDD model. For example, when 
the text, user practices should be adaptive to the different types of users such as 
clinicians and patients and gathering support is needed was analysed, it was coded 
under ‘user types/buy-in’. The code ‘user types/buy-in’ abstracted to theme - ‘stake-
holder needs management’.  This theme resulted in R1, R6, R8 and R17. 
 
As with MDs, regulations are needed for safety of HIS. Take up of technology is slow. 
Stakeholders are important in the successful implementation of HIS, having a SDLC 




2.4.2 Software Development Process and Software Man-
agement 
Software management involves managing project tasks, resources and schedules as 
well as software practices which influence the Software Development Lifecycle 
(SDLC). Cawley et al (2013) give examples of project management tasks which include 
risk management and scheduling, whereas software practices include areas such as 
documentation and testing. Software practices also called processes includes activities, 
methods, practices and changes that are used to create and maintain software. To 
improve the quality of a product, organisations make changes or improvements to their 
software processes (Richardson et al 2010).  
 
Typically, software development is managed by having processes in place, for example, 
using a SDLC. MD companies typically use a SDLC model such as the V-model and 
previously the waterfall model. More recently Agile practices are becoming popular. 
The waterfall model is an older model that is linear in its execution. It is very rigid as 
each phase is sequential so any change during a project cannot be dealt with very easily 
and typically costs can spiral as feedback between phases is not accommodated 
McCaffery et al (2016b). For this reason, the waterfall model is not the most appropriate 
model to use.  
 
The V-model is not as rigid as the waterfall model as feedback during phases is 
accommodated McCaffery et al (2016b). Unfortunately, when a V-model project has 
already begun any new changes can create cost and budget increases over expected 
budgets (Munassar and Govardhan 2010).  
 
Some HIS such as mobile health/wellness applications do not have to adhere to 
regulations as the technology is developing faster than the regulations. Such HIS 
developers tend to use the more flexible model agile practices which is more adaptable 
to change. Which model is used depends on the needs of particular projects. Also in 
some cases there is unregulated health software used which is developed by people not 
trained in software engineering, having multidisciplinary teams which include software 




As technology advances and costs rise, healthcare organisations must deliver value by 
finding productive methods to embrace innovation by moving from rigid processes to 
more flexible ones (Crotty et al 2019). As a result of this literature review, cost 
management should be acknowledged is identified as an IDD-requirement (R22) for 
inclusion in the IDD model. For example, when the text, costs rise with technology 
advances was analysed, it was coded under ‘costs’. The code ‘costs’ abstracted to theme 
- ‘management of costs’. This theme resulted in R22. 
 
Agile practices are more flexible (Kannan et al 2017). Agile practices are becoming 
more popular in healthcare but showing effectiveness is challenging (Meyer and 
Eslambolchilar 2017). Agile practices follow an incremental and evolutionary lifecycle 
that frequently and rapidly delivers customer-valued software through collaboration 
from self-organising teams (Kannan et al 2017, McCaffery et al 2016a). In healthcare 
two limitations of Agile practices are, (1) how they function when involving many 
stakeholders, and (2), how they value workability and fast delivery over systematic 
precision (Flood et al 2016). The two main obstacles to faster adoption of Agile 
practices are organisational or team structures and cultural resistance to change (Unger 
and Celentano 2015). One challenge in healthcare innovation is achieving collaboration 
with stakeholders (Kannan et al 2017). Combining Agile practices with other SDLCs 
into a hybrid methodology can offer better quality software in a timely manner to end 
users (Goodison et al 2019). 
 
To design healthcare systems which are inherently complex brings with it challenges 
such as evolving dynamic processes and the possibility of trade-offs needed to address 
the different wishes of various stakeholders (Carroll et al 2018). To provide a quality 
system, management is needed in terms of planning and development which 
acknowledges the socio-technical elements with healthcare practice (Carroll et al 
2018). Baxter and Sommerville (2011) states that the reason that healthcare software 
applications fail to be used is that during development there is a lack of understanding 
with the underlying work structures that exist, which leads to conflicting new ways of 
working or changes to procedures that affect others. The waterfall model and the V-
model do not explicitly address these reasons for failure. Healthcare is also unique to 
other industries in terms of stakeholder’s behaviours (individual autonomy) and risk 
adverse and slow uptake of technology. While slower than other industries to embrace 
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software, healthcare is increasingly moving towards the use of more technology 
(Cresswell and Sheikh 2013). As a result of this literature review, plan for effective use 
of technology is identified as an IDD-requirement (R16) for inclusion in the IDD model. 
For example, when the text, technology use is rising in healthcare was analysed, it was 
coded under ‘technology’.  The code ‘technology’ abstracted to theme - ‘technology 
use’. This theme resulted in R16.  
 
Deployment of software is not acknowledged as a crucial phase in its own right and 
this is an area where user buy-in could be leveraged. Currently there is no SDLC, or set 
of guidelines available that provides guidance on end-to-end development such as user-
centred practices or change management. 
 
McHugh et al (2015) note that Agile practices have the advantage of improved 
development time, increased quality and reduced development costs. Agile practices 
are more flexible than the V-model and facilitate more user-centred involvement (albeit 
not extensively), but it does not have specific innovation practices. As no one agile 
method is comprehensive enough for use with safety critical software the authors 
proposed a model that integrates Agile practices with the V-model (McHugh et al 
2015). Combining an agile method with the V-Model does provide guidance for the 
development of software that has to be regulatory compliant but user-centred 
involvement is limited. The V-model and Agile practices can be incorporated as a 
hybrid with IDD. There are positive aspects such as having specific software strategies, 
while not being as restrictive as the waterfall model.  
 
2.4.3 People 
Cawley et al (2013) note that people influence the SDLC as they are involved with it 
daily, for example, in communication, programming, reviewing feedback and 
collaboration. Huckvale et al (2019) point out that the success of technology is linked 
to the extent to which human factors/usability engineering are considered in design, 
development and implementation. The key people in the innovation of HIS are, for 
example, the users and the team. The five main stakeholder (internal and external) 
groups in the innovation process are physicians, patients, organisations, innovator 
companies and regulatory agencies (Table 2.2). Each stakeholder has unique needs and 
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expectations. Sligo et al (2017) state that in healthcare there is often a dual hierarchical 
structure involving clinicians and managers. As clinicians both collectively and 
individually have professional autonomy, decentralised decision making is common. 
This structure must be considered when developing HIS. Encouraging a common goal 
can help create buy-in.  
 
 
Table 2.2: Key Stakeholders of the Healthcare Innovation Process (Omachonu and Einspruch 2010) 
 
Bath (2009) state that when developing plans for the implementation of technology in 
healthcare that user-centred design and opinions of such users is crucial. Human 
factors/usability engineering examines the interactions between people and devices. 
People enter control actions though an interface which takes the input processes and 
displays an output to the interface. People take this output from the interface, perceive 
this information and process it to make more controlled actions. These steps are very 
important and the decisions of the device are not subjective but the decisions of people 
are very subjective. The use could be any relevant stakeholder and HIS must ensure 
that all stakeholders needs and usage patterns are understood. For medical devices, the 
aim of the human factors/usability engineering process is to minimise use-related 
dangers and risks so that users can use the device safely and effectively (FDA 2013, 
Teixeira 2019). The advantages of applying human factors/usability engineering to 
medical devices (FDA 2013) include areas such as ease of use and training. These can 
also be applied for HIS for the very same reasons outlined for medical devices. The 
importance of ease of use and training for human factors/usability engineering 
application  in HIS was also found by Sligo et al (2017). As a result of this literature 
review, effective training, should be timely and appropriate is identified as an IDD-
requirement (R15) for inclusion in the IDD model. For example, when the text, training 
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is important for usability was analysed, it was coded under ‘user needs’.  The code ‘user 
needs’ abstracted to theme - ‘user training’.  This theme resulted in R15.  
 
Carayon et al (2018) point to the under realised potential of human factors/usability 
engineering to improve patient safety. Wager et al (2013) note that user-centred-design 
is one such way to develop safe HIS. Essential to this vision are health IT applications 
that support health management activities (Agarwal et al 2011). A responsive IT 
structure with a participatory and iterative design motivated by user need is more 
successful than an IT structure driven by technology (Lenz 2007). Two models that are 
more suited to participatory or iterative design are the V-model and Agile practices. 
Balas et al (2018) propose a model to aid in the adoption of an innovation by examining 
human factors and knowledge transformation in phases with different types of adopters: 
innovator, early adopter, late-majority adopters and lagging adopters. Balas et al (2018) 
recommend different strategies such as outcome assessment, training, guidelines and 
incentives for each adopter. People are very important when developing technology. 
 
People must be taken into account when developing HIS. There are a number of very 
diverse stakeholders who each have very different priorities and requirements. Multiple 
authors, for example, Omachonu and Einspruch 2010, Tohidi and Jabbari 2012 have 
identified the importance for innovation such as addressing all stakeholders needs. IDD 
should be cognisant of this. Human factors/usability engineering are crucial to MDs in 
the same way they are needed for HIS.  
 
2.4.4 Organisation  
An organisation influences the SDLC as it defines roles (for example, leadership), re-
sponsibilities, authority and tasks (Cawley 2013). The culture within an organisation 
impacts how people work together as it relates to values and ways of working. Al Rahbi 
et al (2017) reference the 1985 work of Schien for an explanation of culture as 
assumptions developed and uncovered by a group. Körner et al (2015) state that the 
culture of an organisation is an important feature for teamwork, treatment quality and 
success. Al Rahbi et al (2017) state that, in healthcare, leadership starts the process of 
culture generation.  
 
23 
Leadership and motivation are important to an organisation, as leaders are needed to 
drive the introduction or upgrade of a technology (Cawley 2013, Al Rahbi et al 2017). 
A leader must have the skills to motivate teams while also effectively planning and 
executing projects. Leaders must also positively manage the inevitable resulting change 
that occurs. Having a guiding culture with policies and structures in place can aid this 
as well as being useful to new team members. 
Hwang and Christensen (2007) point to challenges such as fragmentation of care, a lack 
of a retail market in which healthcare is costly and inconvenient, regulatory barriers 
such as the costs associated with regulatory compliance and a lowering of reimburse-
ment costs does not improve healthcare delivery. Any proposed model in this area must 
be cognizant of the uniqueness of healthcare. 
Leadership, teamwork and motivation are important. Within any organisation, the in-
troduction or upgrade of a HIS is an innovation that brings about a change that affects 
the entire organisation and influences the SDLC.  
 
2.5 Innovation and Change 
Introducing or upgrading a HIS is an innovation as software is created or updated. 
Advances in patient care bring change and often come by having a needs-based 
approach to innovation coupled with clinical insights that facilitate advances in patient 
care (Ray et al 2017). An innovation is the implementation of a new or improved 
invention, service, or process, a new marketing method, or a new organisational method 
in business practices, workplace organisation or external relations (UNESCO Institute 
for Statistics 2005). More specifically healthcare innovation is defined as: 
the introduction of a new concept, idea, service, process, or product aimed at 
improving treatment, diagnosis, education, outreach, prevention and research, and 
with the long term goals of improving quality, safety, outcomes, efficiency and costs. 
Omachonu and Einspruch (2010, p.5) 
 
A number of authors have proposed numerous different types of innovation. Four main 




• Product innovation: The introduction of a new or improved good or service; 
• Process innovation: The implementation of a new or improved production or 
delivery method; 
• Organisational/structural innovation: The implementation of a new organisa-
tional/business method; 
• Marketing innovation: The implementation of a new marketing method. 
 
Innovative activities in healthcare create value in areas such as quality, safety, 
efficiency and patient outcomes (MacNeil et al 2019). As a result of this literature re-
view, employ effective innovation practices are identified as IDD-requirements (R3 and 
R5) for inclusion in the IDD model. For example, when the text, keep to the main goals 
and objectives was analysed, it was coded under ‘goal’.  The code ‘goal’ abstracted to 
theme - ‘innovative practices’.  This theme resulted in R3 and R5. 
 
Innovation usually begins with an idea. Technical change usually requires 
organisational change (Sligo et al 2017). Buy-in is required for successful 
implementation. In this case, in hospitals, it can be difficult due to potential resistance 
(diverse stakeholders such as clinicians, administrators and managers), competing 
ideas, or failure to be sustained (Sligo et al 2017). Innovation is important to guide HIS 
development to be more innovative and provide better ways of delivering HIS. This 
research is focused specifically on process innovation as IDD is an aid to the delivery 
of innovative HIS. In healthcare, innovation can be either open or closed depending on 
the resources and choice of the organisation, for example, software can be developed 
in-house or outsourced to an external company.  
 
2.5.1 Change  
HIS bring significant change that needs to be planned and managed by relevant 
stakeholders such as clinicians and software engineers (Nelson and Staggers 2016). 
Developing and deploying an innovation in healthcare causes a change to existing work 
practices. Chaudhry et al (2006) outlines that organisational change, workflow 
redesign, human factors, and project management all impact IT adoption. Kijsanayotin 
et al (2009) state that the main reason for lack of adoption of healthcare IT is a lack of 
understanding of the socio-technical aspects of IT, particularly the understanding of 
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how people and organisations adopt IT. Noteboom (2012) point out that one of the main 
reasons for lack of adoption of healthcare IT is a perceived lack of benefit. This can 
lead to resistance to change. Resistance to change is also another major reason 
identified by Dzik (2006) who notes that staffing resources and appropriate and agile 
management need to be considered. Noteboom (2012) state that appropriate training 
and the time it takes to implement new technology along with resistance to change are 
important. Szydlowski and Smith (2009) examined change and found that change 
theory can be effective in implementing IT in hospitals.  
 
Most planning models assume that changes that occur in organisations are planned 
changes (Hayes and Richardson 2008). Healthcare is unique in that certain changes 
could potentially affect patients’ lives. That is one reason why it is a risk adverse 
industry which is slow to move with technology advances. Planning models exist such 
as the Waterfall model, the V-model and Agile practices. None of these models provide 
software development teams with complete guidance on end-to-end software 
development. For example, there is a lack of complete user-centred innovation and 
implementation practices. Burton (2008) proposes an alternative process improvement 
model called a Risk Management Capability Model (RMCM).  Burton states that even 
though there are standards and guidelines it not possible to guarantee complete 
regulatory compliance and existing process improvement models are not broad enough. 
In terms of this research it was found that numerous authors (Wager et al 2013, 
Kellermann and Jones 2013, Lorenzi and Riley 2010) have already found there are 
issues in the adoption of innovation such as user buy-in, resistance, resourcing of staff 
and training.  
 
The introduction or upgrade of a HIS brings about a change that affects the 
organisation. While healthcare service providers commit to improving a service and 
invest heavily in technological infrastructures to reach improved service levels, 
managing the change process of IT innovation is a complex task. The quality of the 
patient experience must improve while also supporting the clinician in their medical 
requirements. Leaders are needed to drive the introduction or upgrade of a technology. 
A leader must have the skills to effectively plan and execute a project. When deployed, 
new innovations inevitably create a change for an organisation in numerous different 
ways. For example, existing processes can be removed and people’s tasks can also 
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change or be removed. Baxter and Sommerville (2011) have pointed out that HIS 
innovations do impact the organisation and this impact is a change that has to be 
effectively managed.  
 
To explain how organisational change works in practice, Cameron and Green (2015) 
list four relevant change models: 
• Lewin’s Change Management Model. Lewin’s Change Management Model 
was developed in the 1950s and examines driving and resisting forces, and can 
be used in any change situation. For successful change the driving forces must 
outweigh the resisting forces. It is easy to use and timely to implement; 
• Bullock and Batten planned change model. Bullock and Batten model was de-
veloped in 1985 and it is a four-phase model that examines the methods applied 
to get an organisation to a desired state; 
• William Bridges, managing the transition. William Bridges, managing the tran-
sition model was developed in 1991 and examines transition and change. Tran-
sition is the ‘how’ and change is the ‘what’; 
• Kotter’s 8 Step Change Model. 
 
While these change models draw attention to important areas for change to be managed, 
they do not cover areas such as deployment of organisational goals to innovative 
actions. 
 
Kotter’s 8 Step Change Model was developed in 1990. The focus is on preparing for 
change instead of the actual change. For successful change, certain sequential steps 
need be executed. The 8 steps described by Kotter (2005) are: 
▪ Establish a Sense of Urgency;  
▪ Form a Powerful Guiding Coalition; 
▪ Create a Vision; 
▪ Communicate the Vision; 
▪ Empower Others to Act on the Vision;  
▪ Plan for and Create Short-Term Wins; 
▪ Consolidate Improvements and Produce Still More Change; 
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▪ Institutionalise New Approaches. 
 
In Ireland the Irish Health Service Executive (HSE) developed a change model based 
on a number of existing change models such as Kotter’s model. In 2018 after the 
commissioning of a literature review it found that to achieve meaningful and lasting 
change, a complexity-sensitive approach is needed which supports working with 
people, relationships, culture, power, and dynamic interactions (Barry et al 2018).  
 
Hughes et al (2015, 2017) state that project management and change management 
should not be treated separately as they are intertwined to deliver stakeholders’ 
requirements. The authors reference Leyland et al (2009) who point out that in 
healthcare projects key aspects of change management are ignored by traditional 
project management and propose integrating change management with project 
management. To implement change successfully in healthcare, skilled change leaders 
are required (Antwi and Kale 2014). When change is required, relevant stakeholders 
should be engaged with early and on an ongoing basis (Foley et al 2017). 
 
Existing literature on organisational change is vast and conflicting, however a 
consistent finding is that change is not only one action but a number of actions (Anyieni 
and Gidion 2016). To achieve success, project and operations management must work 
together (Cooke-Davies 2002; Hughes et al 2017). Project management and change 
management are disciplines that are complementary and mutually supportive which can 
contribute to the successful implementation of projects (Hornstein 2015; Hughes et al 
2017). Project managers should not only be trained in how to manage a project but also 
in how manage organisational change (Hornstein 2015). 
 
Software can provide opportunities for innovation and competitive differentiation. 
Cresswell and Sheikh (2013) state that the healthcare industry is complex and there are 
interrelated social and technical issues located within a wider organisational 
environment. Omachonu and Einspruch (2010) point out that innovations in healthcare 
are related to product, process or organisational. They further point to the fact that this 
is due in part to fears about infringements in security and patient privacy, and also 
because healthcare was traditionally a service performed locally and in person. Gottlieb 
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and Makower (2013) state that innovation in technology offers perhaps the best chance 
to tackle rising healthcare costs while maintaining high-quality care. Omachonu and 
Einspruch (2010) further confirm this, stating that IT remains a key driver of innovation 
in healthcare. 
 
Within any organisation, innovation is the process of creating change that adds value 
to customers (O’Sullivan and Dooley 2010). Healthcare systems are currently facing 
growing demand and expectations from traditional healthcare models. Healthcare 
organisations now realise that innovation is increasingly required to sustain a quality 
healthcare service system (Cazzaniga and Fischer 2015).  
 
To promote innovation within teams, a leader should develop teams in which there are 
a set of clear common objectives with high levels of participation, commitment to 
excellence and a support for innovation (West et al 2003). When selecting processes 
for innovation, an inspection must be carried out to identify potential processes that 
require improvement. This enables an organisation to focus, so as not to waste time and 
resources (Davenport 2013). Tohidi and Jabbari (2012) reviewed a number of 
innovation models and concluded that many of the models deemed customers’ need 
and the market demand as key to innovation. 
 
Flood et al (2013) state that involving the end user is critical for software systems to be 
successful. To successfully manage innovation the following areas, need to be 
addressed (NSAI 2013): 
• Context of the organisation needs to be understood; 
• Leadership and commitment required from senior management; 
• Planning; 
• Foster innovation drivers; 
• Develop a process for innovation; 
• Assess and increase performance; 




The development of in-house healthcare software is increasing. Hospitals must be 
cognisant some developed products might also have to be regulatory compliant 
(Buenafe 2013). 
 
2.5.2 Process Innovation  
There are different types of innovations. In this research project, innovation is relevant. 
When developing and deploying innovations a broad expertise is required in terms of 
project, people and change management. As change can have unplanned results, there 
needs to be an awareness of the potential effects on the different stakeholders. To do 
this, the leader should empower teams to spend the time required to understand and 
implement the change needed. 
 
Having a deep understanding of a user allows innovators to innovate what is needed as 
opposed to just putting technology in for the sake of it. A process or a set of guidelines 
is crucial to aiding successful implementation of an innovation but relevant SDLC only 
addresses the development of an innovation and not enough of the feasibility of 
innovation and the scoping of a project. Acknowledging the lack of a well-defined 
innovation development process, a guide was published by the NSAI (NSAI 2009). It 
was entitled “Guide to Good Practice in Innovation and Product Development 
Processes” and aims to address the lack of a comprehensive set of guidelines. It adds 
innovation practices to the development life-cycle. Although this guide was developed 
in 2009, it is still current and as it is the latest version. Figure 2.1 shows an overview 
of the NSAI innovation process, which has the following seven steps: 
1. Investigate potential opportunities. 
2. Choose the opportunity. 
3. Generate solutions with early prototyping where needed. 
4. Choose solution and develop full design specification to enable develop-
ment and stage reviews. 
5. Develop solution, with prototype to field test where needed. 
6. Produce, upscale and transfer to full production. 




These steps are similar to a method called Biodesign (Yock et al 2015) and also similar 
to another method called Design Thinking (Brown 2019). Design Thinking has been 
successfully used commercially for design consultancy firm IDEO. The NSAI 
innovation standard (2009) states that to lead innovation in an organisation a leader 
must:  
• Show complete commitment to all aspects at all times; 
• Focus on leading and let teams deliver; 
• Create a ways whereby the company can deliver. 
 
The steps have similarities with existing SDLC models (V-model and Agile practices) 
such as design, develop and test practices but there are differences in specific 
innovation practices recommended that don’t exist in the SDLC models discussed.  
 
In terms of innovation practices, the NSAI innovation process has the advantage of 






Figure 2.1: Innovation Process (NSAI 2009) 
 
Figure 2.1 shows innovation practices which involve diverging and converging to 
facilitate the scoping of a project by investigating and choosing the opportunity with 
which to progress. The disadvantage is that it is designed to be product specific, not 
software specific. Also, it recommends user interaction but does not specify specific 
user-centred practices.  
 
Guidelines are needed for successful implementation of an innovation which include 
innovation strategies. The next section will discuss the reasons identified in literature 
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for software failures and successes so as to gain an understanding of the common 
guidelines/requirements needed for IDD. 
 
2.5.3 Software Innovation Failures and Successes 
Software needs to be managed effectively to reduce the risk of failure. For hospitals 
requiring HIS, the acquisition of a HIS can be done either by developing it internally 
or by purchasing it from an external source such as a software vendor. Wager et al 
(2013) state that the acquisition and implementation process demand strong and 
effective leadership, planning, organisational, and communication skills to be 
successful. The authors further note the common reasons for HIS failures during 
acquisition are (Wager et al 2013): 
• Failure to manage communication; 
• Failure to keep the main objective; 
• Giving too little or too much information; 
• Failing to involve the leadership team and users extensively; 
• Unfair negotiations. 
 
As well as during the acquisition phase, Kellermann and Jones (2013) note that in 
general HIS failures are due to several factors such as:  
• Slow adoption of health IT systems; 
• Systems that are not interoperable; 
• Systems that are not easy to use; 
• Failure of health care providers to reengineer care processes to realise the full 
benefits of health IT. 
 
As a result of this literature review, systems need to be interoperable is identified as an 
IDD-requirement (R19) for inclusion in the IDD model. For example, when the text, 
systems that are not interoperable can lead to HIS failures was analysed, it was coded 
under ‘systems’. The code ‘systems’ abstracted to theme - ‘interoperable system needs’.  
This theme resulted in R19.  
 
Lorenzi and Riley (2000) examined software implementation and listed 8 reasons why 
IT fails to be implemented successfully (Table 2.3), such as communication, culture, 
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and leadership. As a result of this literature review, foster good communication is iden-
tified as IDD-requirements (R4 and R9) for inclusion in the IDD model. For example, 
when the text, act on feedback from users was analysed, it was coded under ‘feedback’.  
The code ‘feedback’ abstracted to theme – ‘foster communication’.  This theme resulted 
in R4 and R9. Encourage good leadership and planning is also identified as IDD-re-
quirements (R7 and R10) for inclusion in the IDD model. For example, when the text,  
review team knowledge and skills was analysed, it was coded under ‘teams’. The code 
‘teams’ abstracted to theme - ‘empower teams’. This theme resulted in R7 and R10. 
 
 
Table 2.3: Reasons for Failures in Implementing Major Information Systems (Lorenzi and Riley 2000) 
 
There are numerous HIS projects that fail during implementation for reasons such as 
systems built on incorrect assumptions or poor requirements gathering from users 
(Kuziemsky and Lau 2010). Users need systems that integrate well with other existing 
systems. Users will not use a system if it is not easy to use. Implementing HIS is 
complex and to mitigate failure organisational, structural, technological, and human 
factors need to be addressed to be successful (Hughes et al 2017; Sligo et al 2017). 
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These authors state that HIS is complex. It requires the following during 
implementation: 
• Good leadership which provides guidance, support and effective communica-
tion across all areas of a project. Having a ‘champion’ of the HIS is a useful aid 
to communication by keeping end users informed of progress; 
• End user buy-in is encouraged by involving end users throughout;  
• To increase the likelihood of the technology being used it must be high quality, 
easy to use and improve the way end users deliver healthcare; 
• Training needs sufficient time and adequate resourcing; 
• To evaluate the HIS implementation ongoing feedback is needed at all stages. 
 
O’Sullivan and Dooley (2010) examined failures across multiple IT organisations. 
Specific causes for the failures of innovations are specific to an organisation, but there 
are a number of causes, which are common across organisations, these include 
(O’Sullivan and Dooley 2010): 
• Inadequate definition of organisational direction; 
• Ineffective mechanisms for the deployment of organisational goals to innova-
tive actions; 
• Poor leadership of the systems innovation process; 
• Poor planning in the generation of innovations; 
• Poor implementation of innovations; 
• Low employee participation in the innovation process; 
• Ineffective results management. 
 
 
As a result of this literature review, plan effective mechanisms for the deployment of 
goals to innovative actions are identified as IDD-requirements (R20 and R21) for in-
clusion in the IDD model. For example, when the text, and acknowledge that 
implementation of innovation is as important as the development was analysed, it was 
coded under ‘implementation’. The code ‘implementation’ abstracted to theme – ‘de-
ployment plan’. This theme resulted in R20 and R21.  
 
Ray et al (2019) state that new systems that fail tend to disrupt patient-clinician 
communication, fail to record all of the information detail, and increase workloads. The 
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main challenges in the adoption of healthcare innovations such as software are 
(Omachonu and Einspruch 2010): 
• Healthcare is regulated, which can make changes more difficult; 
• The usual starting point of a healthcare innovation process can affect patients’ 
lives and clinicians tend to protect their individual autonomy and reputation;  
• Behaviour of organisations, clinicians and current practices is hard to change; 
• The key stakeholders must be taken into account.  
 
2.5.4 Analysis of Project Failure and Success  
When looking at these various reasons for failures from multiple authors in literature 
there are common reasons/themes that begin to emerge and these can be used as areas 
to be addressed/requirements in the proposed IDD model (Table 2.4).  
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Lack of leadership      X  X X X 
Lack of communication  X   X   X X 
Lack of clear objectives and scoping  X   X  X X X 
Lack of training  X   X  X X  
Mismanagement of technology    X  X X  X  
Lack of recognition of the various stakeholders  X X   X  X X 
Acquisition, and Implementation phases lack 
effective management 
X  X X X  X X X 
Table 2.4: Emerging Common Failure Themes and Related Authors 
 
When examining software project successes there are also a number of reasons 
identified. Buntin et al (2011) state that, in health IT implementation, people are crucial 
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and that robust leadership and buy-in is needed. This was also confirmed by Sligo et al 
(2017). The Agency for Healthcare Research and Quality (AHRQ) is an American 
government agency that works to improve the safety and quality of America's health 
care system. AHRQ noted that technology adaption in healthcare is slower than in other 
industries. To investigate this AHRQ (2012) published a report which examined 
industries other than health, that design and develop successful consumer IT products. 
They then made the following 10 recommendations for healthcare: 
1. Have appropriate knowledge and skills for all phases of development. 
2. Understand customer needs within the environments that the product will 
be used. 
3. Use a diverse set of customers for generating ideas and evaluating product 
iterations. 
4. Use established design methods as well as intuition or use innovation-driven 
approaches to design. 
5. Learn about customers and the market early on. 
6. Design decisions and alterations should be based on feedback from proto-
typing and pilot testing. 
7. Success metrics should be based on the needs of customers. 
8. Balance customer needs with product safety and privacy. 
9. Build products based on existing standards. 
10. Use marketing strategies in promotion of the product and when the product 
is deployed be responsive to customers. 
As a result of this literature review, have knowledge of the market and relevant 
regulations and have knowledge of relevant standards are identified as IDD-require-
ments (R11 and R18) for inclusion in the IDD model. For example, when the text, build 
to relevant market and standards was analysed, it was coded under ‘standards’. The 
code ‘standards’ abstracted to theme – ‘regulatory compliance’.  This theme resulted in 
R11 and R18. 
 
In terms of successful implementation of software such as major health information 
technology, Cresswell et al (2013) identified the following:  
• Careful planning; 




As a result of this literature review, have ongoing evaluation of processes is identified 
as an IDD-requirement (R14) for inclusion in the IDD model. For example, when the 
text, planning and evaluation of processes was analysed, it was coded under ‘process’. 
The code ‘process’ abstracted to theme – ‘defined process’. This theme resulted in R14.  
 
For HIS and HIT in general to be used effectively it must be easy to use and improve 
job performance. For successful implementation of HIT a number of variables have 
been identified such as change, ease of use and usefulness (Table 2.5) (Karsh 2004). 
These variables, for example, ease of use, have also been regularly identified in the 
literature (Sligo et al (2017), Kellermann and Jones (2013)).  
 
 
Table 2.5: Implementation Design Principles and Predictors of Technology Acceptance (Karsh 2004). 
 
After reviewing fifty systematic reviews Lau et al (2010) identified factors that 
influence HIS success: 
• Having systems in-house where developers are users;  
• Having integrated decision support and practices that are benchmarked;  
• Having an awareness of a provider’s knowledge and perception;  
• Having incentives for reimbursement;  
• Having an awareness of legislation and policies.  
Carroll (2016) further identified common factors for success such as clear definitions 
of success and user centred practices. When comparing the different 
recommendations/variables/factors for successful HIS from the various authors listed 
there are common areas that begin to emerge frequently. They can be used as areas to 
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Buy-in 
 
 X        X  
Communication 
 
      X   X X 
Training X  X    X  X X  
User-centred practices 
 
X  X  X X  X  X X 
Market Knowledge 
 
X  X         
Build products based on standards 
 
X  X   X  X    
Planning   X X      X  
Evaluation of Progress X   X      X  
Table 2.6: Emerging Common Success Themes and Related Authors 
 
2.6 Review of Learnings 
Innovation can be a long and complex process involving many stages and with many 
stakeholders. The literature review presented in this thesis is not scoped around being 
longitudinal. 
 
HIS innovation is currently fragmented with numerous stakeholders with differing 
objectives and through this review it is evident that there is a need for a model/set of 
guidelines to support the successful development and deployment of HIS innovation in 
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healthcare. This literature review uncovered issues in the healthcare industry. 
Developing innovative software in healthcare must adhere to regulations and standards. 
These regulations change depending on the type of innovation and on the country the 
software is to be used. The regulations state that software should be developed using a 
process but do not name a process to use. This can be viewed in two ways. It is a positive 
in terms of experienced teams who can have the freedom to decide what model is most 
suitable for them. It is a negative for novice teams who need guidance on how to 
proceed.  
 
Within the literature review, a number of gaps emerged: 
• No appropriate model addresses the need for specific user-centred process. For 
example, stakeholders are not routinely engaged with early and on an on-going 
basis throughout projects which can be addressed with strategies to encourage 
stakeholder buy-in in projects. Additionally, leaders and teams need expertise 
in effective and relevant communication strategies; 
• No appropriate model acknowledges the importance of change management on 
par with project management. For example, during the implementation phase 
having a change champion to be a flag bearer for a new innovation, and a facil-
itator with whom users can address concerns; 
• No appropriate model has specific innovation strategies. Having innovation 
strategies such as multidisciplinary teams to allow different viewpoints to be 
included for potential innovations using tools to foster creativity;  
• No appropriate model acknowledges the need for specific deployment/imple-
mentation strategies, such as personalised timely training. Training should be 
timely and specific for each relevant stakeholder. It also needs to be in a format 
that is useful.  
 
Incorporating strategies to address these gaps in the form of guidelines within IDD 
allows leaders to better manage and implement innovative HIS that are of benefit to 
stakeholders. This research project is concerned with the following objectives: 
• To define a software innovation model for use in the design, development and 
implementation of HIS; 
• To develop and evaluate this software innovation model.  
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To address these the following research questions are derived: 
• RQ1: How is process used in health innovation? 
• RQ2: How should healthcare software innovations be developed and deployed? 
These lead to sub-questions 
RQ2a: How does a medical device company manage software development?  
• Medical device companies are not as slow as hospitals to innovate. Medical 
device companies develop and deploy software that is always regulatory com-
pliant. How do MD companies develop software? 
RQ2b: How do clinical departments within a publicly funded hospital setting deploy 
software? 
• Hospitals have to innovate to address the needs of its stakeholders. While slower 
than MD companies to innovate due to its risk adverse environment how do 
hospitals implement HIS? 
There is a gap where a model/set of guidelines could build on and complement 
innovation, stakeholder and change management to aid in the successful deployment of 
HIS innovations.  
 
2.7 IDD-V1 
By examining the literature to uncover common themes, a number of IDD-
Requirements (Table 2.7) emerged which were then included in IDD. A number of the 
IDD-requirements were related and classed as sub-requirements (Table 2.7). This 













Table 2.7: Initial IDD-Requirements for IDD-V1
Requirement 
Number 
IDD- Requirement and Sub IDD-Requirement 
R1 Have user-centred practices  
 Sub Requirement R6: Manage information effectively 
Sub Requirement R8: Involve users/customers extensively 
Sub Requirement R17: User buy-in is important 
R2 Have specific implementation and change processes 
 Sub Requirement R12: Change management process needed 
Sub Requirement R13: Results management needs to be addressed 
R3 Employ effective innovation practices 
 Sub Requirement R5: Keep to the main goals and objectives 
R4 Foster good communication 
 Sub Requirement R9: Act on feedback from users 
R7 Encourage good leadership and planning/use of defined processes 
 Sub Requirement R10: Review team knowledge and skills 
R11 Have knowledge of the market and relevant regulations 
 Sub Requirement R18: Have knowledge of relevant standards 
R14 Have ongoing evaluation of processes.  
R15 Effective training, should be timely and appropriate 
R16 Plan for effective use of technology 
R19 Systems need to be interoperable 
R20 Plan effective mechanisms for the deployment of goals to innovative actions 
 Sub Requirement R21: Acknowledge that implementation of innovation is as 
important as the development 








Three main themes then emerged which were relevant areas that these IDD-





Each IDD-Requirement in turn facilitates or enables these areas. These areas match to 
phases used in existing software development models such as the V-model and will be 
progressed further as part of the data collection methods employed to define, develop 
and evaluate IDD.  
 
2.8 Conclusion 
To remain competitive, the healthcare software industry must reduce costs, streamline 
research and development, increase accountability, and accelerate time to market while 
also adhering to regulations and ensuring patient safety and quality. The Healthcare 
industry as a whole faces constant challenges such as government regulations, 
complexity, productivity, competitors and quality issues. Requirements were identified 
in the literature review (IDD-Requirements) as a necessary element in the development 
of a health software. To aid the successful implementation of innovative software health 
projects, having a model or set of guidelines can assist software teams and users 
considering the implementation of HIS.  
 
Technology is evolving quickly. Currently there is no complete integrated model for 
developing HIS that explicitly addresses user-centred practices, innovation and 
implementation (change management/process change). Stakeholders are important in 
the successful implementation of HIS, having a SDLC that has additional user-centred 
practices would be useful. Software development models such as the waterfall or V-
model are not comprehensive enough as seen by the number of software innovation 
failures. Relevant regulations state that a model should be used but does not stipulate 
which to use. Having a process or a set of guidelines that facilitates software to be 
developed that is innovative while also adhering to relevant regulations. For example, 
having software tools/processes in place that provide regulatory compliance features 
 
44 
can then free up staff to concentrate on creating innovate products for users and reduce 
costs in terms of time. A number of IDD-Requirements emerged (Table 2.7) from the 
































Chapter 3 Research Methods  
 
3.1 Introduction 
This chapter discusses the research approach chosen which is a qualitative research 
approach. Qualitative research is commonly used in the area of health research to ex-
amine structural processes using techniques such as observation, interviewing and anal-
ysis of documents (Grbich 1999; Kitto et al 2008; Eckerdal 2016; Hammarberg et al 
2016). Observation and interviewing are two of the main ways to collect data in the 
field (Jamshed 2014) which are used in this research. This chapter highlights the objec-
tives of this research and describes the various research paradigms and methods ap-
plied. The research value and the design of this research are also discussed. 
 
3.2 Research Objectives 
The objective of this research is to define, develop and evaluate a software innovation 
model (IDD) which, was completed over four stages.  In Stage 1, information was gath-
ered from a literature review, which included a discussion on HIS, software develop-
ment, change and innovation in healthcare. This facilitated the initial model develop-
ment by gathering a set of IDD-Requirements for IDD-V1. In Stages 2 and 3, IDD was 
then developed further by collecting and analysing data from case studies in medical 
practice, MD industry and hospitals. In Stage 4, IDD was further refined after evalua-
tion by external experts.  
 
3.3 Research Paradigms 
Qualitative data is usually in the form of non-numeric data whereas quantitative data is 
usually in the form of numeric data (Miles and Huberman 1994; Grbich 1999; Seers 
2012; Hammarberg et al 2016). The qualitative paradigm is used in areas such as 
healthcare, business studies, educational research and public administration (Miles and 
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Huberman 1994; Merriam and Grenier 2019) so it is a suitable paradigm for this re-
search. Qualitative research involves a researcher gathering a holistic view of the area 
being researched, by interacting with individuals or groups (Gray 2014; Eckerdal 
2016). The researcher can then make conclusions using various methods of analysis. 
In research there are two general patterns of enquiry that exist, which are inductive and 
deductive reasoning (Seers 2012; Kalpokaite and Radivojevic 2019). Inductive 
reasoning (a bottom up approach) starts with data collection that is then analysed, 
whereas deductive reasoning (a top down approach) starts with the expansion of a set 
of principles that are then tested through empirical observation or experimentation 
(Gray 2014). Deductive reasoning begins with a theory, whereas with inductive 
reasoning a theory is the result of research (Dewey 1933; Miles et al 2014). The 
research questions for this PhD are answered using inductive reasoning as IDD is 
developed as a result of this research. 
 
There are different types of studies such as exploratory, descriptive, explanatory and 
interpretive studies. Exploratory studies aim to find out what is happening and to ask 
questions about it (Miles and Huberman 1994). Descriptive studies aim to describe a 
situation (Gray 2014). Explanatory studies aim to go further than descriptive studies by 
also explaining descriptive information (Gray 2014). Interpretive studies aim to inves-
tigate peoples’ experiences and their perspectives of those experiences (Gray 2014). 
This research is a combination of interpretive and exploratory. Myers (1997) argues 
that qualitative research can be grouped into positivist, interpretive or critical.  
 
3.3.1 Positivist  
Positivism states that the social world is external to the research and therefore can be 
measured by observation (Gray 2014; Malterud 2019). Positivist research is used to test 
a predefined theory so it is concerned with control, prediction, reduction and explana-
tion. Research is performed in a laboratory setting where the researcher is an observer 
of events (Evered and Louis 1981). As much as possible external interaction is limited 
and any interaction required is performed in a controlled manner. This research is not 





Interpretive research is based on obtaining an understanding of the research output 
through the meanings that people give to them (Malterud 2019). A person’s interaction 
with the world is associated unintentionally with his or her own subjective meanings to 
situations (Orlikowski and Baroudi 1991; Merriam and Grenier 2019). Interpretive re-
search is a good fit for this research as it attempts is to understand the domain before 
proposing IDD.  
 
3.3.3 Critical  
Critical researchers investigate socially accepted norms with the aim of critically chal-
lenging and evaluating them (Orlikowski and Baroudi 1991; Merriam and Grenier 
2019). Critical research is similar to interpretive research but it goes further by chal-
lenging the norm. This is not suitable to this research; the objectives of this research 
are to define, develop and evaluate a software innovation model. This proposed soft-
ware innovation model IDD is an improvement building on existing models and prac-
tices.  
 
3.3.4 Relevance to this Research 
This research is qualitative in nature. It is based in healthcare, dealing with behaviours 
and decision-making. Qualitative data is collected and analysed to enable a holistic un-
derstanding of the area of research. The data is analysed with a bottom up, interpretive 
approach. The results of the case studies are observed and interpreted in this setting. 
The findings are useful in healthcare in general and for other similar situations such as 
other health related software projects.  
 
3.4 Research Methods 
There are a number of research methods that can be utilised in qualitative research using 
interpretive paradigms such as: 
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• Field experiment; 
• Quasi experiment; 
• Action case;  
• Action research; 
• Case study; 
• Mixed methods. 
 
3.4.1 Field and Quasi experiments 
Field experiments take place in the real world but lack control of the environment 
(Queirós et al 2017). Quasi experiments compare groups with the aim of discovering 
variance (Jopling 2019). Quasi experiments address the lack of control of a field exper-
iment by recognising the struggle in control. Field experiments and quasi experiments 
need to be set up in the correct environment, which was not feasible in this research.  
 
3.4.2 Action Case and Action Research 
Action case is aimed at gaining an understanding, but within a small to medium inter-
vention. Action research is where researchers and practitioners work in collaboration, 
with an emphasis on supporting change with organisations (such as hospitals and 
schools) (Grbich 1999; Gray 2014; Merriam and Grenier 2019). Due to the lack of field 
and implementation/intervention opportunities action case and action research were 
also not suitable methods for this research. 
 
3.4.3 Case Study 
A case study can be either a single or multiple study. It aims to gain an understanding 
in a real-world context through investigation and observation. A case study typically 
addresses how and why research questions (Gray 2014; Green and Thorogood 2018). 
One criticism is that it is not always easy to generalise from a specific case, but the 
same can be said for most scientific inquiries. Case studies are a useful form of inquiry 
in complex situations such as health, especially when human behaviour and social 
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interactions are key to understanding an area of interest (Harrison et al 2017). Before 
starting a case study, the objectives are defined. The results are then measured against 
the objectives.  
The case study method was chosen for this research. After completing a literature re-
view, the researcher needed to understand innovation and how software process im-
provements within medical practice and in industry are carried out and how hospitals 
deal with software projects and software models.   
 
3.4.4 Mixed Methods 
In practice, a number of mixed methods, such as case studies and action research, tend 
to be used for the following reasons (Gray 2014):  
• Research normally has more than one research question, and one research 
method might not be suitable for each research question. 
• Data triangulation (collection of data from different sources at different times) 
is facilitated when mixed methods are used.  
• Each method has advantages and disadvantages so the use of more than one can 
create a balance of the disadvantages of each method. 
 
A mixed methods approach was not utilised in this research as case studies were suita-
ble to the research questions. Instead the data sources were mixed. 
 
3.5 Research Value 
Research needs to be of value (Hammarberg et al 2016). Miles and Huberman (1994) 
propose five questions that can aid a researcher in judging the quality of conclusions 
made: 
1. Objectivity: Is there freedom from unacknowledged researcher bias and is there 
relative neutrality? 
2. Reliability: Is the process that was followed in the research consistent and rea-
sonably stable across researchers, methods and over time? 
3. Internal Validity: Do the study findings make sense? 
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4. External Validity: Does the study findings have any larger significance? 
5. Utilisation: Is the study useful to others? 
Robson (2002) states that reliable and valid research is the mode of operation in quan-
titative research so the problem is to find ways to do the same in qualitative research 
while taking into account that the environment and contexts are different and more 
flexible.  
 
3.5.1 Objectivity (Confirmability)   
Grbich (1999) states that objectivity is the separation of the researcher emotionally from 
the data. It is achieved by giving a thoughtful account of how the research was done 
and can involve triangulation exercises (Seal 2000; Saks and Allsop 2019). This re-
search implements data source triangulation through the collection of data and analysis 
from several different sources also. The methods used include interviews, observation 
and documentation reviews. With respect to refutability, some of the research findings, 
namely the MD company case study and the hospital interviews, have been published. 
Triangulation was used in this research to identify themes from the data collected. 
 
3.5.2 Reliability (Dependability/Auditability) 
Miles and Huberman (1994) state the following guiding enquiry: 
• Have things been done with reasonable care?  
Reliability is the capacity to provide outcomes that are acceptable (Grbich 1999; Ham-
marberg et al 2016). Auditing can be used to check dependability. Using a single re-
search method does not guarantee reliability, but using a number of research methods 
can mitigate this. For this research a number of data sources were used such as obser-




3.5.3 Internal Validity (Credibility/Authenticity) 
Participants are the only people who can judge this, as they know the area being re-
searched (Miles and Huberman 1994). Validity is the capability to verify data (Grbich 
1999; Hammarberg et al 2016). It is achieved through observation, lengthy engagement 
in the field and triangulation exercises (Lincoln and Guba 1985; Saks and Allsop 2019). 
This research uses data source triangulation. Initially, multiple sources of literature 
were used. Data from medical practice, industry and hospitals were integrated through 
case study research involving observations and interviews. Method triangulation was 
used to strengthen findings where possible. The methods used include interviews, ob-
servation and documentation analysis. The analysis of documents involved coding the 
content into themes. Lastly IDD was evaluated by experts. 
 
3.5.4 External Validity (Transferability/Fittingness) 
External validity can be answered by checking if the research has relevance to other 
similar areas (Hammarberg et al 2016). Miles and Huberman (1994) list the following 
guiding enquiries: 
• Are the conclusions transferable to other settings? 
• Is the original sample of people and variables described enough to allow for 
comparisons? 
IDD proposed in this research was evaluated with a diverse group of health experts 
(clinicians and engineers) in the healthcare domain. These health experts provided feed-
back to further refine IDD. 
 
3.5.5 Utilisation (Application/Action Orientation) 
The utilisation requirement can be answered by checking if there any benefit from car-
rying out this research. As IDD was developed and refined using various inputs from 
relevant health experts it can be used as guidance to software teams on design, devel-
opment and implementation of HIS.  
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3.6 Data Collection  
Data was collected to gain an understanding of how medical practice; MD industry and 
hospitals develop software.  
Ethics approval was received from the University of Limerick ethics committee (Ap-
pendices 2-3). Approval was also received from the HSE ethics committee. All of the 
data gathered was anonymised so as not to contain any participants names.  
Data collected for the literature review was gathered from primary and secondary 
sources such as academic journals, official reports, textbook and newspapers. Guide-
lines from Runeson and Höst (2009) were used for planning the case studies. 
Within the case studies, experts were utilised in the data collection and the evaluation 
of IDD. The criteria for inclusion of experts in this research were people that are im-
pacted by software in healthcare such as clinicians, software engineers, hospital man-
agers, patients and general healthcare staff such as administrators. While experts were 
used throughout this research, experts in healthcare can be difficult to access (Grbich 
1999; Bogner and Menz 2002). For example, a focus group may be difficult to organise 
with such a group as their timetables can be hard to work with if you need to accom-
modate a number of experts at the same time. “Experts have technical process oriented and 
interpretive knowledge referring to their specific professional sphere of activity” (Bogner and 
Menz 2002). However, getting the viewpoint of experts was important to help the re-
searcher gain an understanding of the research area, and evaluate IDD. It is unlikely 
that a sample of experts can be taken from a population target of all of the experts listed, 
but the opinions expressed should reflect the population target (Richardson 1999). To 
address this, various techniques were used to gain access to relevant experts such as 
snowballing, networking and travelling to meet with experts in their own environments.  
Observation involves observing situations as well as listening to the person being ob-
served in their own situations (Holloway and Galvin 2016). To get as close to an event 
or activity as they are happening, the technique to use is participant observation (Grbich 
1999; Yock et al 2015). Participant observation is where data is gathered directly from 
naturally occurring situations, so that behaviour and responses are seen in situ (Green 
and Thorogood 2018). To conduct observations the researcher must immerse them-
selves in the area of interest as immersion enables the collection of more accurate and 
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complete information from observations (Yock et al 2015). In the healthcare environ-
ment direct observation ensures that researchers can identify clinically significant prob-
lems (Yock et al 2015; Green and Thorogood 2018). As it can be hard for non-
healthcare professionals to perform observations, to address this Yock et al (2015) rec-
ommend utilising personal networks such as friends, networking and introductions. In 
comparison to interviewing, observation is less disruptive, more unobtrusive but also 
more time consuming (Holloway and Galvin 2016). One disadvantage of observation 
can be the “observer effect”. This is where there are changes in the phenomenon being 
observed that are caused as a result of the act of observation. This can be minimised if 
the observer becomes fully immersed and part of the team (Yock et al 2015).  The 
Biodesign process for performing observations was followed (Yock et al 2015). The 
observation process involved the team each individually observing real situations. This 
was done at different times of the day and night and, if needed, multiple times to con-
firm observations. The team members maintained enough distance so as to not be in the 
way but close enough to observe. Over time the team members’ presence became more 
routine to the participants being observed. Therefore, participants followed the 
observed process in a natural manner.  
Interviews are used to get an understanding of the world from the perspective of the 
participants (Glassner and Loughlin 1987; Eckerdal 2016). In this research the inter-
views conducted were with experts. Dexter (2006/1969) and Grbich (1999) point out 
that when interviewing elite groups, it is usually time limited. This was the case in this 
research. As time was limited with participants/interviewees, the interview questions 
were short and concise (Appendix 2, Interview Questions). The interviews were not 
recorded as the researcher was advised by health experts that recording causes distrac-
tion and stifles observations and discussion. To overcome the potential to miss infor-
mation the researcher took extensive interview notes. The interviews were transcribed 
manually using shorthand and then afterwards they were typed into a word processor. 
The interviewee should be well prepared and knowledgeable of the subject area in ques-
tion (Grbich 1999; Dexter 2006; Eckerdal 2016). The main advantage of interviews in 
general is that they can offer flexibility. Information can be clarified at the time if needs 
be but this can result in interviews becoming time consuming to carry out (Holloway 
and Galvin 2016). Structured interviews involve a researcher asking predefined ques-
tions in a particular order. Through a structured interview technique, this can provide a 
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more balanced insight and ensure consistency. Structured interviews were used in this 
research to allow for data comparison with other sections of this research (such as the 
MD company and the hospital case studies).  
 
3.7 Data Analysis 































Observations were documented for analysis. 
Guidelines from Runeson and Höst (2009) were 
used in planning how to administer the case 
studies: Design of the case study (defining the 
objectives and planning the case study); Prepa-
ration for data collection (defining procedures 
and protocols for the collection of the data);Col-
lecting the data; Analysing the data; Reporting. 
Structured interviews were carried out as recom-















The Biodesign process for conducting observa-
tions (Yock et al 2015) was followed: 
- Set up observations 
- Prepare for observations 
- Conduct observations 
- Document observations 
- Name the problem 







Case study - 
Hospitals 
Interview Guidelines from Runeson and Höst (2009) were 
used in planning how to administer the case 
studies. 
Structured interviews were carried out as recom-







Table 3.1: Research Methods Used 
 
The analysis of observations from the Medical Practice case study followed the Bi-
odesign process. The researcher was part of a four-person inter-disciplinary team who 
carried out the observations. The team split up to carry out observations individually 
and then met afterwards to analyse the data. The researcher spent time before each ob-
servation session gathering background information, for example, looking up relevant 
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medical terms. The researcher’s own background was in software engineering. The ob-
servation process for coding involved all four team members. This group effort required 
the naming of problems observed and devising statements of the problems (needs state-
ments). The advantage of using this process was that it was an existing form of data 
collection that had been used in gathering requirements for innovations that were com-
mercially successful. Observations were collected by each team member. The team 
worked to equally divide out the observations to facilitate further analysis. The obser-
vations were collated and categorised to uncover themes and crossover. Some observa-
tions were removed initially on review, as there were merely statements of fact. Others 
were duplicated as more than one team member made the same observation. After this 
initial review of the observations they were then grouped by subject area. The observa-
tions were distilled down to a manageable number of needs. Preliminary filtering re-
duced the number of needs. These needs were then refined and progressed to areas 
where innovations could be implemented. Preliminary filtering reduced the number 
down by using criteria devised within the Biodesign process such as market size, patient 
impact, stakeholder analysis, cost reduction, market dynamics (growth prospects), ma-
jor competition. A needs statement was then written to identify unmet clinical needs 
that could be addressed with innovations. External mentors were available to validate 
the needs statements. The aim of a needs statements is to frame the problem in one 
sentence. Potential concepts were proposed.  
After screening the concepts to a manageable number of proposed solutions, a review 
of relevant areas such as intellectual property (IP), regulatory environment, reimburse-
ment, business modelling and prototyping was undertaken. There are different types of 
intellectual property such as patents, trademarks, copyrights, and trade secrets. The in-
tellectual property landscape was explored, for example, does prior art exist. An intel-
lectual property approach to the solution was developed, for example, steps needed to 
patent the solution. The regulatory environment relevant to the proposed solution was 
explored. For example, where will the solution be sold? What regulations are applicable 
to the solution? The reimbursement of the proposed solution was reviewed (will health 
insurance companies pay for it?). The relevant type of business model for the solution 
was selected. To find out if the proposed solution can be technically feasible, prototyp-
ing was used. Prototyping involved creating a physical interpretation of the abstract 
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solution proposed. After reviewing the areas of intellectual property, regulatory envi-
ronment, reimbursement, business modelling and prototyping this enabled final concept 
selection to be completed.  
Observations from the MD industry case study were documented and analysed using 
thematic analysis by the researcher. This was an individual effort. To analyse the data 
gathered by the researcher from interviews and literature, thematic analysis was also 
used. Thematic analysis involves examining emerging themes from data (Kalpokaite 
and Radivojevic 2019). Firstly, all the data was examined to look for patterns. The pat-
terns that emerged then became potential codes (a label on data). Sections of data with 
similar information were given the same label. This allowed for further sorting of the 
data and to search for themes. Themes are broader than codes as they are summarised 
categories. The themes were then reviewed so that all the data was examined and that 
all the themes were relevant.  
More specifically, content thematic analysis was used to analyse the interviews and 
literature data. A number of emerging themes were identified using open coding to 
categorise the text, thus allowing a story to be built around specific events, facts, and 
interpretations. For example, a paragraph talking about training could be two codes 
such as ‘lack of training’ and ‘fear of change’. Themes emerged after reflection to then 
look for patterns in the data to form categories as recommended by multiple authors 
such as Seers (2012), Miles et al (2014) and Kalpokaite and Radivojevic (2019). 
Analysis involves choices that are subjective so it is important to document the process 
followed (Seers 2012). To make sense of these themes they were synthesised further as 
IDD-Requirements which formed processes that contain strategies. Strategies are the 
instantiation of processes or the tasks needed to complete a process.  
 
3.8 Research Design  
The intended use of IDD is to support software teams on design, development and im-
plementation of HIS. MD companies are adept at using robust processes to innovate. 
Consequently, innovation projects, hospitals and MD industry were identified as re-
search subjects. To address the objectives of this research a four-stage research ap-
proach (Figure 3.1) was used:  
• Stage 1: Problem Definition;  
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• Stage 2: Medical Practice and MD Industry Case Studies; 
• Stage 3: Hospital Case Study;  
• Stage 4: External Evaluation.  
 
Figure 3.1: Research Design 
 
In Stage 1, the problem was defined by developing a research objective. A literature 
review was carried out and an initial version of IDD-V1 was proposed. 
In Stage 2, case studies in medical practice and MD industry were carried out by ob-
serving tasks, interviewing people and reviewing documentation. The data gathered and 
analysed in this stage was used as input in the development of IDD-V2. 
In Stage 3, a hospital case study was carried out by conducting interviews. Using the 
data gathered and analysed in this stage as an input in the development of IDD-V3.  
In Stage 4, external evaluation of IDD was undertaken by getting feedback on IDD-V3 
from external experts. The expert’s feedback was analysed and used to update IDD to 
a final version. 




Figure 3.2: Research in Chronological Order  
 
3.8.1 Stage 1: Problem Definition 
Stage 1 of this research design began with defining the problem, followed by a literature 
review. The literature review (Chapter 2) involved an analysis of the academic litera-
ture, and further accumulating documentation on the research subject, such as grey lit-
erature and regulatory literature. This was analysed to get a greater understanding of 
the research area and to gather initial IDD-Requirements for the first version of the 
proposed IDD model (IDD-V1). In IDD-V1 the input IDD-Requirements were grouped 
in terms of relevant areas within software projects such as planning, development and 
implementation. The literature review provided a better understanding of the problem 
and identified IDD-Requirements for input into the development of IDD-V1.  
The literature review highlighted the lack of a suitable defined methodological process 
for innovation, development and deployment of useful software in the HIS domain. The 
method used here was to collect different forms of information and to analyse and re-
view this information using thematic analysis. This facilitated the gathering of an initial 




3.8.2 Stage 2: Medical Practice and MD Industry Case 
Studies 
In stage 2, medical practice and MD industry case studies where undertaken. When 
devising IDD-V2 the IDD-Requirements that emerged from the analysis were added to 
the existing IDD-V1. This facilitated the refinement of IDD-V1 to be developed into 
IDD-V2. As part of the medical practice case study the researcher took part in a medical 
practice innovation programme, BioInnovate, in public and private hospitals. For the 
MD industry case study, a placement within a MD company was undertaken. The re-
searcher was allowed to observe and interview the MD software project and staff. The 
researcher documented the data collected and uncovered themes using thematic analy-
sis.  
 
3.8.2.1 Medical Practice Case Study: BioInnovate 
For the medical practice case study, the researcher spent ten months taking part in an 
innovation programme. The innovation programme examined the process of innova-
tion. This includes the user from the outset by engaging health experts and with poten-
tial users. The medical practice innovation programme was team based and followed a 
three-step innovation process as follows: 
• Step1: Identify 
o Needs finding  
o Needs filtering and specification 
• Step 2: Invent  
o Concepts  
o Concept selection  
• Step 3: Implement 
o Development strategy 
o Development plan 
The first two steps identify and invent are iterative. The team were tasked with observ-
ing the process and learning about innovation. Patients, nurses, paramedics and clini-
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cians were observed through their journey/interaction with healthcare, such as in hos-
pitals or ambulances. This then resulted in the identification of a need (potential area 
for innovation) and the validation of said need.  
The first step to identify needs involved using observations to find needs. The Biodesign 
process for performing observations was followed. The process starts with the set up 
for observation, this involves facilitating observations to be carried out. Researchers 
must then prepare to observe, for example, knowing what kind of participants will be 
observed. The observations are then conducted. The researcher documents the obser-
vations. Observations on clinical immersion were carried out in a number of hospitals 
with the aim of observing clinical problems. Participant observation was used as the 
researcher was immersed in hospitals for the medical practice innovation programme. 
For example, when observing ambulance personnel, the researcher worked the same 
night shift hours and took the same break times so as to fully immerse in the situation 
to be observed. This ensured the researcher could get as close as possible to events as 
and when they happened, and allowed the researcher to gain the relevant insight to 
problems. The observer effect was minimised as the researcher became fully integrated 
and staff observed were comfortable with the researcher’s presence.  
The second step invent involved brainstorming the needs statements to develop poten-
tial concepts. Brainstorming is aided greatly by teams with diverse backgrounds, points 
of view, and expertise (Yock et al 2015). The concepts were then selected by screening. 
Screening involved grouping and organising the concepts into areas such as feasibility 
of concept. Mind maps were useful in organising the concepts. If gaps emerged in con-
cepts then more brainstorming was undertaken. Proposed solutions could then be com-
pared to the relevant need.  
The third step implement was where the solution was implemented. This involved de-
velopment strategy and planning. The Intellectual Property (IP), regulatory environ-
ment, reimbursement, business modelling reviewed in the invent step were then imple-
mented in this step with a development strategy and plan. 
At the end of the medical practice case study, the data gathered was analysed. The 
themes that emerged were used as input IDD-Requirements for the IDD-V2. When de-
vising IDD-V2, the IDD-Requirements that emerged from the analysis were grouped 
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by the area they addressed.  
 
3.8.2.2 MD industry Case Study 
For the MD industry case study, the researcher spent three months at a MD company. 
The researcher was on-site during a software project to improve software process and 
manage the resulting change. This project was set up to support the company in moving 
from a document-centric approach to more integrated, artefact-centric approach for 
managing their product development processes. The document-centric approach in-
volved manual management of documents whereas the artefact-centric approach pro-
vided a software information system with process management to aid in the organisa-
tion of MD product development. The company viewed this proposed process improve-
ment as a change management issue. The company were particularly concerned with 
how this change could be managed effectively while also remaining compliant to the 
relevant regulations. In the MD industry regulation compliance is important, as without 
relevant compliance MDs cannot be sold.  
During the three months of the case study the researcher had the opportunity not only 
to interview key staff but to also observe how the project progressed. The researcher 
observed a project team dealing with the introduction of a new software system and the 
resulting process change. This allowed the researcher to observe all areas of the project 
such as staff training, documentation requirements and change management. The re-
searcher was able to get a better understanding of problems encountered when imple-
menting new software and processes. The observations took place two days a week 
over the three months. Additionally, structured one-to-one interviews with software 
development team members was undertaken with interview questions devised based on 
the approach of Grbich (1999), Gill et al (2008) and Green and Thorogood (2018). The 
questions were short, simple, clear and open ended. To relax the interviewee at the start 
of the interview, the initial questions were descriptive moving to more probing ones:  
• What are the current IT systems in place in your department?  




The seven interviewees were all experienced in product development processes (Table 
3.2). The interviewees’ work experience spanned from 5 to 20 years. The interviews 
were carried out on-site at the MD company. 
Interviewee Department Experience 
(Years) Specialty 
1 Quality 20 Software Engineer 
2 Quality 5 Administration with focus on quality 
3 Regulation 19 Manager 
4 Design 16 Project Manager/Software Engineer 
5 Design 5 Software Engineer 
6 Test 8 Software Engineer 
7 Test 12 Software Engineer 
Table 3.2: Summary of Interviewee Profiles. 
 
Triangulation (applying a combination of research methods/data) was used to facilitate 
the validation of information and to remove bias (Miles and Huberman 1994; 
Kalpokaite and Radivojevic 2019). Artefacts were collected on site, such as policy doc-
uments, presentations, for example, training, organisational charts, relevant standards 
and email correspondence. This provided the researcher with a rich collection of project 
data. Participant observations, interview data, and artefacts were analysed. As change 
management was of particular concern within this project, the researcher reviewed the 
data within the structure of Kotter’s Change model (Kotter 2005). This also allowed 
the researcher to understand how change had been made within the organisation (Hayes 
and Richardson 2008), whilst still maintaining the regulatory requirements, which are 
so important from its sales’ perspective. This facilitated the gaining of a holistic view 
of the working environment. Emerging themes taken from the data during thematic 
analysis were used as input IDD-Requirements for IDD-V2. 
When devising IDD-V2 the IDD-Requirements that emerged from the analysis fell into 
a number of main groups or areas. These groups each then contained relevant require-




3.8.3 Stage 3: Hospital Case Study 
For the hospital case study structured interviews were carried out. The interview ques-
tions devised by the researcher were again based on the approach of Grbich (1999), Gill 
et al (2008) and Green and Thorogood (2018). To facilitate data comparison with the 
MD industry case study the same questions were used (Appendix 2, Interview ques-
tions).  
Questions focused on understanding how software and software models are used in 
their daily work. The hospital interviews were held with twelve key staff members who 
were all involved with IT to various degrees (Table 3.3). The interviewees were iden-
tified using the snowballing technique. The snowballing technique involved asking the 
first relevant expert to identify another potential expert then asking the same of that 
expert. This was used to identify other experts in a field of expertise within a sample 
population. This facilitated access to experts, from other experts, that the researcher 
would not normally have had access to. 
Interviewee Department Experience  
(Years) 
Specialty 
1 Quality 23 Nurse and Risk Manager with focus on use of IT systems 
2 Radiology 29 Administration with focus on quality 
3 Physiotherapy 17 General Administration 
4 HR  28 Project Manager 
5 Dermatology 4 Clinician 
6 Radiology 25 Clinician/Project Manager 
7 IT 30 Manager with focus on hardware and software deploy-
ment 
8 Quality 19 Manager with focus on rick management 
9 Laboratory 28 Manager with focus on deployment 
10 Radiology 28 Clinician/Project Manager 
11 IT 20 Project Manager 
12 Quality 10 System user 




The interviewees’ work experience spanned from 4 to 30 years. The interviewees’ an-
swers were reliably aggregated and comparisons were made between the different in-
terviewees. Participant’s interview data was analysed to understand the processes 
within the case study. Saturation was reached when no new information emerged from 
the analysis. The data collected allowed the researcher to understand how change had 
been made and to facilitate a comparison with the MD company case study. 
Analysis of the data provided a further set of grouping of IDD-Requirements into the 
relevant areas they address such as project management and change management. This 
facilitated the researcher creating IDD-V3. When devising IDD-V3 the IDD-Require-
ments that emerged from the analysis were added to the existing IDD-V2. The output 
from Stage 3 is presented in Chapter 5. 
 
3.8.4 Stage 4: External Evaluation 
Stage 4 of this research involved the researcher gathering feedback on IDD-V3 to eval-
uate it, refining it to the final model. Fourteen experts with 5 to 30 years’ experience 
each were identified and again the snowballing technique was used. The experts were 
interviewed face to face, over the phone or via email. For face to face and phone 
interviews shorthand writing was used instead of audio recording. The rationale for this 
was that the experts tended to be more at ease when not recorded. This is a method that 
is acknowledged in literature (Holloway 2005). The experts were all involved in IT to 
various degrees such as management, design and use (Table 3.4). IDD was explained 









Participant Specialty Experience (Years) Department  
1 Physiotherapist and Lecturer 12 Clinical Therapies 
2 Lecturer Clinical Therapies 15 Clinical Therapies 
3 Physiotherapist and Lecturer 10 Clinical Therapies 
4 General Practitioner and Professor 30 General Practice  
5 Lecturer Clinical Therapies 13 Clinical Therapies 
6 Nurse 2 Clinical Therapies 
7 Nurse 30 Clinical Therapies 
8 Software Engineering Manager 15 IT 
9 Software Engineering Manager 10+ IT 
10 Software Architect 7 IT 
11 Software Engineer 5+ IT 
12 Software Engineer 6 IT 
13 Software Engineer  11 IT 
14 Software Architect 11 IT 
Table 3.4: Summary of Interviewee Profiles. 
 
The interview questions devised by the researcher were again based on the approach of 
Grbich (1999), Gill et al (2008) and Green and Thorogood (2018). The questions were 
about the proposed model developed by the researcher namely IDD-V3 (Appendix 3, 
Interview questions). The aim was to ask questions that gave long answers. A number 
of types of question were devised such as direct and follow-up. The health experts’ 
responses and feedback were analysed using thematic analysis. Emerging themes were 
used to create updated IDD-Requirements to be included in the final version of IDD. 
Chapter 7 presents results from Stage 4. 
 
3.9 Conclusion 
The research objectives of this research were discussed, as they are determinants of the 
applicable research method. The various research methods were then listed. The re-
search design was discussed. Case studies were used in the data collection stage of this 
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research. Qualitative research was used to examine structural processes using tech-
niques such as observation, interviewing and analysis of documents. Data analysis fa-
cilitated the development of various versions of IDD. This research was designed to 




































Chapter 4 Medical Practice and MD Industry Cases  
 
4.1 Introduction  
Stage 1 of this research involved defining the problem by developing research objec-
tives and carrying out a literature review. This facilitated the gathering of an initial set 
of IDD-Requirements, thus developing IDD-V1. This chapter discusses Stage 2 in 
which two case studies were undertaken. The first case study was in medical practice 
(the BioInnovate case) and the second case study was in industry (the MD industry 
case).  
The medical practice case study and the MD industry case study were quite different 
types of studies. The medical practice case study involved the researcher working as 
part of a team and individually carrying out observations on a number of medical pro-
cesses across different sites to develop potential innovations. The researcher was im-
mersed within a medical practice innovation programme. The MD industry case study 
involved the researcher working individually on one site to analyse how software pro-
cesses improvement is implemented. The researcher spent three months within a MD 
company, MedIn, as part of a project team and was allowed to observe and interview 
staff as they developed and implemented a software project.  
Research carried out during the MD industry case study has been published and pre-
sented at the HEALTHINF conference (Appendix 8). The published paper discussed 
process followed and change management employed within MedIn. 
Output from analysis of these case studies were then used as input IDD-Requirements 
to further refine IDD-V1 to produce IDD-V2.  
 
4.2 Use of Innovation Processes in Health – The Medical Practice 
Case  
The aim of the medical practice case study was to understand how process is used in 
health and how innovations are developed.  
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The BioInnovate programme is modelled on the Biodesign programme offered at 
Stanford University, America. Biodesign works to help accelerate the delivery of new 
technologies into patient care (Biodesign 2012). Delivering quality healthcare has 
become more and more difficult and expensive due to various factors such as growing 
populations and people living longer (National Research Council 2001, Carroll 2016). 
A collaborative approach is used that focuses on the needs of patients, clinicians and 
the healthcare industry as a whole (Biodesign 2012). The researcher’s role in 
BioInnovate was as a participant observer. This provided a unique first hand insight 
into health innovation in a real-world project. She was part of a multi-disciplinary team 
with each member having a different core competency: business, medicine, mechanical 
engineering and software engineering (researcher). A mission statement was devised 
and used to guide to activities of the 10-month programme. 
 
Team mission statement: 
To innovate a cost effective, gold-standard solution to a significant unmet clinical need 
that can be brought to market within 5 years 
 
The team developed a set of acceptance criteria. Acceptance criteria devised by teams 
are pre-requisite requirements merged with project mission, strengths and weaknesses 
that have to be met (Biodesign 2012). The acceptance criteria were of use in guiding 
activities during the 10 months. For example, the potential innovation must address a 
sizeable market. 
 
In developing an innovation, the team then followed a three-phase process to 
innovation: Identify (uncover valid needs), Invent (refine needs to invent solutions) and 
Implement (strategy for deployment). The following sections describes the output from 
each of these phases. 
 
4.2.1 Uncover Valid Needs 
The Identify Phase started with an introduction to the innovation process during a boot 
camp. The boot camp ran for two weeks. The team were then immersed in diverse 
clinical environments. This involved observing users (patients and healthcare 
professionals) in a range of clinical settings including: specialist diagnostic clinics, 
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surgical and interventional procedures, post-operative care and rehabilitation. During 
this Phase, observations were made on how a variety of healthcare professionals 
interacted with patients. This was an opportunity to identify and document the technical 
challenges that are encountered every day in the patient’s journey. Over a hundred 
observations were made. Two observations were:  
• Embolisation procedures are lengthy and, in some cases, need more than one 
procedure;  
• Valve replacement surgery is an invasive procedure.  
In terms of software development, this equates to requirements elicitation. Before an 
observation session the researcher spent time preparing for the session such as 
ascertaining the relevant procedure duration. Each team member gathered observations 
individually and documented them by writing each one down. Directly after the 
observation sessions the observations encountered were typed up. Time was then spent 
gathering relevant information around each observation and if needed clarification was 
sought from the participants or a designated mentor. The team then met to create needs 
statements from the observations gathered. The researcher and the team first had to 
reduce the number of observations by removing observations that were for example, 
duplicates or statements of fact. The remaining observations were converted to needs 
statements.  
 
The Biodesign method for performing and analysing observations was followed (Yock 
et al 2015). This resulted in the creation of needs statements for a number of the 
observations. The needs statements were divided between the team members. Each 
team member preformed an in-depth analysis on a number of needs, spending time 
understanding the need. Again if needed the researcher could seek clarification from 
the participants or a designated mentor. This allowed the researcher to determine if a 
needs statement actually was valid and viable for a solution. A deep understanding of 
a need is required to allow teams to filter out unnecessary needs (Yock et al 2015).  
This allowed the team to identify unmet clinical needs. Needs filtering involved the 
comparison of one needs statement against another with the aim of uncovering areas to 
progress. An example of two needs statements identified from the observations were:  
• A more reliable and cost-effective way to embolise of a blood vessel;  
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• A need for a less invasive alternative to aortic valve surgery.  
Embolisation was observed to be costly and existing methods did not always work fully. 
Aortic valve surgery was observed to be an invasive procedure. 
 
In terms of learnings from this Phase, the team were given access to patients and 
healthcare professionals in diverse places, such as in clinical and home settings. As the 
researcher’s background was software based, shadowing users in healthcare was a 
unique opportunity. For various reasons, such as time and cost limitations, it is not 
always possible to access to users. The advantages of such access were (a) to facilitate 
getting first-hand knowledge of the problems that exist, (b) to learn that not all problems 
need a solution and (c) to complement requirements gathering.  
 
4.2.2 Refine Needs to Invent Solutions 
The team were intensively mentored and advised by a range of experienced and 
committed clinical, academic and entrepreneurial mentors. Its aim was to invent 
solutions by refining the needs. During the Invent Phase, the unmet clinical needs which 
were uncovered during the Identify Phase were processed. A number progressed 
through to develop a range of potential concepts. Then, the concepts were screened. 
The researcher and the team spent time screening the concepts. The researcher and the 
team devised criteria for consideration of concepts. One such example was, interest in 
the topic. As well as adhering to the vision and mission the team members had to have 
an interest in a concept to progress it. The team were given classes and mentorship in 
the following areas to aid in progressing concepts to the next Phase: 
• Intellectual Property Basics; 
• Regulatory Basics; 
• Reimbursement Basics; 
• Business Models;  
• Prototyping; 
• Final Concept Selection.  
Finally, potential concepts were selected to be progressed to the Implement Phase. One 
concept that was not chosen to progress was: 
• A MD to treat heart failure. 
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o Typically, the uptake of such innovations is slow. This was not deemed 
viable as it did not match the mission statement (bring to market within 
5 years) or the criteria of addressing a personal interest of the team. The 
burden of proof for such a device and the time to market proved too 
costly to proceed.  
Two concepts that were chosen to progress were:  
• A one-shot MD for embolisation of a blood vessel;  
• A MD to aid in Transcatheter Aortic Valve Implantation procedures.  
The embolisation of blood vessel required a MD device solution that could provide 
accurate embolisation first time. This would in turn reduce the number of follow on 
procedures that could be needed for existing innovations. For the Transcatheter Aortic 
Valve Implantation procedures, again a more accurate MD was required as a number 
of the patients for this procedure were elderly. Both concepts were identified as viable 
for commercialisation. In terms of software development, the BioInnovate programme 
was very useful as typically there is normally no mentorship or multidisciplinary teams. 
Mentorship can guide and educate teams; multidisciplinary teams can give more 
perspectives on an area within which to innovate. 
 
In terms of learnings from this Phase, having multidisciplinary teams developing 
potential concepts was complemented and enhanced as each team member had vastly 
different viewpoints. This made the teams more creative in developing the potential 
concepts. Mentorship was useful as teams have access to experienced people for 
guidance. 
 
4.2.3 Strategy for Deployment 
During the Implement Phase the team considered their strategy for implementation, 
which involved prototyping, regulatory affairs and reimbursement strategies. Refined 
concepts were brought forward to the business planning stage. The concepts were 
mature enough to be pitched to external experts. The two final concepts discussed in 
Section 4.2.2 were pitched, and ultimately the embolization concept was chosen. The 
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Identify, Invent and Implement Phases collectively were ultimately effective as an 
innovation was progressed. 
 
In terms of learnings, an innovation was chosen that had potential to challenge existing 
innovations. Challenging accepted norms was aided by the different Phases the teams 
followed, the mentorship, the different perspectives to which the team had access (team 
members and users) and the creative ways of working, such as pitching ideas. 
 
4.2.4 Case Study Analysis and Implications for IDD  
Within the BioInnovate programme, MD innovation is covered, but it does not 
specifically cover non-hardware software systems (BioInnovate 2012). The 
TechInnovate (2017) innovation training group aims to address this by covering general 
software innovation practices, but not specifically HIS. IDD addresses this gap by 
merging innovation processes with software practices aimed at HIS. 
 
The diverse backgrounds of the team members encouraged creativity, as each member 
had diverse viewpoints to bring to the project. This is not common in software design 
projects. The access that the programme had to facilitate the team in observing various 
healthcare situations from operations, outpatient clinics, ward rounds and ambulance 
calls was unique. This allowed the team to obtain a deep understanding of the needs of 
the relevant users.  
 
During the Identify Phase the team initially experienced some resistance. The team 
found that buy-in is useful to manage the change. The team noted that clinicians and 
health staff (such as nurses) had early morning meetings at 7.30am. The team requested 
a slot to present at this meeting. This allowed the members to provide an introduction 
of the work planned and allowed for questions to be asked. After this meeting there was 
greater buy-in from staff, as the reason for being there was explained, which was to 
provide potential innovations for the benefit of staff and patients.  
 
During the Invent Phase, mentorship was very informative as the network of mentors 
were all serial entrepreneurs located from around the world and the team were 




During the Implement Phase, the commercialisation strategies which the programme 
offered proved to be very informative. The team was able to meet with and pitch to 
venture capitalists and angel investors. Having such access allowed the team to learn 
the basic pitfalls which start-up companies make when trying to get funding.  
 
Involvement by the researcher in this case study resulted in four more IDD-
Requirements to be gathered. It also confirmed a number of the IDD-Requirements 
uncovered in the literature review. The literature review uncovered twenty-two IDD-
Requirements (R1 to R22). This case study identified four more (R23 to R26): 
• R23 Use of three phases/steps can support innovation; 
• R24 Mentorship can guide and educate teams; 
• R25 Multidisciplinary teams give more perspectives on an area to innovate; 
• R26 Pitching encourages teams to be concise and lean in their ways of working. 
 
R23 Use of three phases/steps can support innovation; 
The use of three Phases such as Identify, Invent and Implement have similarities 
to existing software development steps (planning/identification, 
development/ideation and implementation/strategy). Requirements are 
evaluated and some are progressed. This was included as R23 in IDD [as the 
processes within each Phase can lend themselves to software development]. 
These three Phases were found to be successful in uncovering problems, 
verifying that the problems could be addressed with an innovation and 
developing a relevant innovative solution. Teams can spend time observing and 
trying to understand the complexities of healthcare workers daily jobs. 
Observation would work well in software development as usually a lack of 
understanding of problems leads to innovation failures. For example, 
organisations such as AHRQ (2012) have recommendations for successful 
healthcare consumer IT products and one of the recommendations is to 
understand customer needs within the relevant environments that products are 
used. Having such innovation practices also address IDD-Requirement R3 
(Employ effective innovation practices), R6 (Manage information effectively) 
and R8 (Involve users/customers extensively) identified in the literature review. 
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One possible constraint would be that it takes time and resources to commit. 
Such constraints are easy to overcome with long-term strategic planning. In the 
long term, this can save time and money, as requirements would not need to be 
re-evaluated later due to such problems as incorrect requirements gathered. 
Phases can be an aid to staff to provide structure. Use of phases (R23) was added 
as a requirement to aid in innovation development. 
 
R24 Mentorship can guide and educate teams; 
Mentorship was found to be very useful as experts such as entrepreneurs were 
available to guide and educate teams. Having a mentor is especially useful for 
novice team members who are beginning to understand how to engage and work 
as part of a multidisciplinary team. For example, mentors can guide teams on 
important areas to focus on due to their knowledge. Mentorship (R24) was 
added as a requirement to guide and educate teams.  
 
R25 Multidisciplinary teams give more perspectives on an area to innovate; 
The use of multidisciplinary teams fostered innovation by facilitating multiple 
perspectives on problems. The user is central in the innovative process, by, for 
example, immersing teams in problem areas observing users (Yock et al 2015). 
Having user-centred practices (Abelein and Paech 2015) was also a 
Requirement (R1) identified the literature review (Chapter 2).  
Multidisciplinary teams was found to be very successful. Diverse teams can 
give more perspectives on an area to innovate (Yock et al 2015).  Borrill et al 
(2000) found higher levels of innovation in patient care when groups of diverse 
ranges worked together. For IDD this would be very useful as requirements can 
then be evaluated from multiple perspectives. For example, having a team 
member that is a patient advocate can provide another viewpoint on a project. 
Multidisciplinary teams (R25) was added as a requirement to facilitate different 
perspectives. 
 
R26 Pitching encourages teams to be concise and lean in their ways of working; 
Pitching to other team members, mentors and external experts was used to 
articulate the most important areas of an innovation. This is of use for IDD as it 
encourages teams to work more concisely to articulate what the unique selling 
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point is. For example, teams to become clear on what is the ultimate project 
goal. For IDD this would be very useful to support decisions about what areas 
to progress. Pitching (R26) was added as a requirement to aid in decision 
support. 
 
When comparing the IDD-Requirements elicited in this case study with the literature 
review it was found that of the 22 IDD-Requirements uncovered in the literature review 
a number of them also came up in this case study such as: 
• R11: Have knowledge of the market and relevant regulations (AHRQ 2012), 
o BioInnovate encourages teams to become experts in the relevant areas 
for innovation and provide mentors to guide teams; 
• R4: Foster good communication (Wager et al 2013), 
o BioInnovate uses diverse teams who need to effectively communicate 
as they progress through the programme; 
• R15: Effective training (Noteboom 2012), 
o BioInnovate teams are encouraged to use available tools to train where 
needed; 
• R5: Keep to main goals and objectives (Wager et al 2013), 
o BioInnovate recommends having goals and objectives by using mission 
statements to guide teams; 
• R9: Act on feedback from users (AHRQ 2012), 
o BioInnovate uses observation and interaction with users. 
 
This supported the relevancy of these IDD-Requirements as they have been identified 
both in literature and in practice during this research.  
 
4.3 Software Process Improvement – The MD Industry Case 
The researcher spent three months on site with a MD company. The IDD-Requirements 
gathered facilitated the further development of IDD. In the healthcare industry, MDs 
are manufactured to aid patients. To safeguard patient safety and minimise risk such 
devices are regulated. The regulatory body in America is the Food and Drug 
Administration (FDA) whereas in Europe the regulatory body is the European 
Commission (EC), using the Medical Devices Directive (MDD) (EU Council 1993), 
(EU Commission 2007). Regulators can also approve standards such as the 
 
77 
International Organisation for Standardization (ISO) standards. The MDD (2012) 
amended its definition of a medical device to include software.  Therefore, software is 
in many cases classed as a standalone MD. In addition, MD software embedded within 
a MD or used in the manufacturing of a device is also subject to regulation.  
International medical device standard IEC 82304‐1 addresses standalone software as a 
medical device (IEC 2016). Cawley et al (2011, 2013) identified that many MD 
companies are pre-occupied with complying with regulations and that MD companies 
are looking at how to manage process improvement while not affecting regulatory 
compliance. 
 
To project the privacy of the MD company an alias name of MedIn was assigned. 
MedIn is a MD company with branches located internationally. Within MedIn, 
Research and development (R&D) is performed along with the manufacturing of 
commercial MDs. The MDs contain embedded software. The researcher had access to 
the software development process within MedIn to understand their development and 
implementation process. IT projects within MedIn were collectively managed by a 
senior executive, the Chief Technology Officer (CTO), who in turn managed project 
managers who were in charge of individual projects. Further to understanding the 
software development process, the researcher analysed the implementation of a new 
software system and the change which resulted.  
 
The MD industry faces persistent challenges, including competitors, government 
regulations, and productivity and quality issues. To remain competitive, they must 
reduce costs, streamline R&D, increase accountability, incorporate traceability and 
accelerate time to market. Standards and guidelines have been developed to aid in 
achieving the safest possible product. For example, in America the U.S. code of federal 
regulations title 21 part 820 governs the quality system regulations. The international 
standard (ANSI/AAMI/IEC 2006) governs MD software development life cycle 
(SDLC) processes. When developing a product, MedIn start with identifying the 
intended use, as this will establish the device class, which in turn identifies the 
regulations and standards to which the MD must comply. Their risk analysis process 
helps to determine the class of device. Previously, each of these product development 
processes was documented and reviewed at every phase in a manual paper-based 
document-centric approach. The company decided to move to an artefact-centric 
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(electronic documents) approach for managing their product development processes. 
To facilitate this, MedIn selected a software product from a leading software provider. 
This software provider offered artefact-centric product development solutions. For 
MedIn, this software provider had the main advantage of providing for regulatory 
compliance such as electronic signatures and adherence to relevant FDA regulations 
(for example, FDA standard 21 CFR part 11). 
 
Using electronic documents for managing their product development processes also 
reduced the time-to-market and the software provided better visibility into the progress 
of product development, thus reducing the work needed to maintain traceability and to 
respond to change. MedIn were applying software process improvement in a safety 
critical environment while minimising risk and adhering to regulations. The primary or 
core regulations applicable to MedIn are IEC 62304 Software Development Lifecycle 
and FDA guidance on Off The Shelf (OTS) software. 
 
The risk management regulation applicable was ISO 14971. The guidance document 
on how to apply ISO 14971 was found in 80002-1. Finally, the following regulations 
that influence the product were: 
▪ GAMP 5 V-model; 
▪ ISO 13485 Quality Management System (QMS) for use in Europe; 
▪ FDA 21 CFR 820 Quality Management System (QMS) for use in America; 
▪ MDDS (Medical Device Data Systems); 
▪ Usability standards; 
▪ If a networked device then, 
o FDA Cyber Security Guidance; 
o IEC 80001-1; 
▪ If device used in clinical trials then, 
o Digital Signatures 21 CFR part 11. 
 
Each of the regulations listed are all substantial in terms of the work needed for 
compliance. Staff have to be aware of them and also be aware of any updates or changes 
to relevant regulations. Regulations must be adhered to by MedIn to remain regulatory 
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compliant. Any changes in processes must be evaluated by external regulators to check 
if regulations are impacted. Training on the new software product was given by the 
software provider to key personnel identified such as the quality team and the software 
development team. A sample project was chosen to demonstrate and test the use of this 
new approach. When complete the plan was to test and use this new approach with a 
live project.  
 
4.3.1 Software Process and Change in MedIn 
Software process and change have to be managed. Regardless of any changes to the 
software process, it was important that the Software Development Lifecycle (SDLC) 
continued to adhere to the relevant regulations. In MedIn, processes are described and 
documented. These, in turn, are mapped to a relevant standard. Standards have 
accompanying guidance documents to aid interpretation.  Usually MD software 
developers develop software with a plan driven sequential SDLC, such as the V-Model 
(McCaffery et al 2012). In the future, MedIn planned to further improve their process, 
by moving from their current SDLC process of a V-model to an Agile software 
development process. To implement this, they identified that this may have to be 
achieved in the short term with smaller deliveries. Using smaller deliveries reduces the 
amount of software features thus reducing the complexity of each delivery. This is not 
agile but in fact smaller V-model deliveries. So, the move to agile in this way will take 
longer but the project will have time then to adjust to a new way of working. Agile 
practices will not remove the need for documentation, as this is necessary for regulatory 
compliance. Overall MedIn want to become more iterative and get more feedback 
during their process. In recognition of the need for more agile practices McHugh et al 
(2013) propose a hybrid model called the AV model, which, integrates agile practices 





Figure 4.1 The AV model (McHugh et al 2013) 
 
Hayes and Richardson (2008) agree that, prior to any change, the need for such a change 
must be communicated to everyone in the organisation. They further state that 
management should be behind the change and that the development team must be 
motivated to realise the change. A lack of urgency is a common reason why many 
organisations fail when implementing a change. MedIn’s process was a manual paper-
based approach where for regulatory compliance all documents had be reviewed, 
manually signed by the quality control department and stored in an easily accessible 
place if requested to view by a regulatory auditor to check for regulatory compliance. 
In MedIn, this process was no longer useful as it was taking too much time for 
employees, adding unnecessary complexity to projects and clouding visibility on 
project status. This document-centric approach involved members of staff having to 
process and file each document. This had been recognised by management and 
employees and was the driving force behind the change that was being undertaken. 
Further disadvantages of the document-centric approach that impact MedIn’s Quality 
Management Processes were:  
▪ Quality: Accountability was hindered; 
▪ Traceability: Using documents to manage the product development process 
clouded visibility into project status; 
▪ Risk: Design transfers between teams were complicated by using documents; 
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▪ Configuration Management: Creating and managing documents were the most 
time-consuming tasks. 
 
Management and staff recognised there was a need for change as the paper system was 
cumbersome and not cost-effective in a competitive market.  A sense of urgency came 
from various levels in the company, from the CTO to the software developers. 
 
4.3.2 Artefact-Centric Approach 
MedIn investigated moving away from a document-centric approach to another 
approach, the artefact-centric approach. This approach was selected as they were 
restricted to choose an approach which maintained regulatory compliance. An artefact-
centric approach relies not on documents but on commercial software to create, track, 
and trace individual artefacts and work items. The advantages in moving to an artefact-
centric approach, that MedIn identified, were: 
▪ Quality, Traceability, Risk and Configuration management: The software can 
provide better visibility into the progress of product development, and reduce 
the work needed to maintain traceability and version control that can respond to 
change; 
▪ Time-to-market improved as removing the old system and moving to the 
artefact system reduced time. 
 
In reviewing the potential of the new artefact-centric approach, the advantages 
identified address the disadvantages of the old system. MedIn began with the CTO of 
the company getting support from other senior management. The CTO reviewed and 
identified a suitable software product to facilitate the planned change in process, while 
still adhering to relevant regulatory constraints. Key staff members were also identified 
and chosen to be trained initially on how this new process could work. Time was 
allocated for the members to implement a pilot project with the new process. The 
guiding coalition was driven by the CTO. However, as other key staff members were 




To aid the management of regulatory compliance, MedIn implemented the software 
package to track product development artefacts, verification and validation artefacts, 
internal IT systems, and other activities. Management within MedIn identified the need 
to develop an implementation plan which stated the objectives of the change.  This was 
used as the basis to identify the vision of the project. From this, management were 
enabled to plan the training needs, staff and the scope of the pilot project. The need to 
have a vision/mission for a project was also identified in the medical practice case 
study. 
 
Communication of the vision came from senior management. Once the implementation 
and training plans were identified, management had a vehicle by which they could carry 
out this communication effectively.  They were able to discuss implementation with all 
employees who subsequently undertook the relevant training. Therefore, employees 
became aware of relevant tasks to be completed in the project and of their roles within 
the project.  
 
At MedIn the project began with staff training, followed by a pilot implementation, 
before a planned rollout of the new artefact-centric approach to all projects. The 
importance of the vision was evident to the team members, as the actions that were put 
in place (such as the pilot project) demonstrated that, from a senior management point 
of view, this was an important project which needed to be worked on by everyone.  The 
team members were keenly aware that the existing process was very time consuming 
and burdensome and that the proposed vision was a more time efficient process.  
 
Within MedIn, the change was planned and had clear goals and objectives by allocating 
relevant team members to carry out a pilot project. It allowed the team members to 
become acquainted and familiar with how the new process should work. At the end of 
the three-month case study the change implemented was working well and to an 
organised plan going forward.  
 
4.3.3 Implementation of Full Project 
After three months as the project was still on-going a further follow-up visit was 
planned to understand how the process was working after implementation of the full 
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project in the long term. This facilitated the confirming or removing of the IDD-
Requirements gathered in this case study through interviews. Seven key staff members 








1 Quality 20 Software Engineer 
2 Quality 5 Administration with focus on quality 
3 Regulation 19 Manager 
4 Design 16 Project Manager/Software Engineer 
5 Design 5 Software Engineer 
6 Test 8 Software Engineer 
7 Test 12 Software Engineer 
Table 4.1: Summary of Interviewee Profiles. 
 
The new process was working well and had progressed to live projects. 
“This new process took an adjustment in the way I worked, but now I can’t imagine 
going back to the paper-based system. Printing, getting documents signed manually 
was now looking back a lot more work”. 
(Interviewee 2 Role: Quality Administrator) 
Three unanticipated issues were identified that were limiting for staff: (i) early 
termination of pilot project; (ii) loss of key staff; (iii) new software resulted in 
unanticipated changes in some work practices. 
 
The pilot project chosen turned out to be a larger project than projected. This resulted 
in more time required than was allocated, which in turn impacted resources. 
Compounding this situation even further, senior management wanted to see results 
quickly and market demands also pushed the decision even further to remove resources 
from the pilot project.  
“We successfully finished the overall project but we couldn’t keep going with the pilot. 
I would have preferred to have that time to learn but that is the nature of the work”. 
(Interviewee 1 Role: Software Engineer) 
This effectively ended the pilot project before its planned completion date and the 
resources such as staff were moved to another project. This created some apprehension 




There was a loss of some staff who were early champions for the new process. This 
loss required further training for remaining staff. “Losing a key member of staff who was 
a champion for the software was a loss”. (Interviewee 6 Role: Software Engineer) 
The software that was purchased for the new process was problematic for some staff as 
they could not carry out some functions as effectively as before. This was not an 
anticipated issue but staff found ways of working around this.  
“I was used to my way of generating relevant reports and getting them signed off. It 
took me longer initially with the process but now I am more proficient with it I can 
now access my reports more quickly”. 
       (Interviewee 1 Role: Software Engineer) 
 
4.3.4 Case Study Analysis and Implications for IDD  
This case study with MedIn allowed the researcher confirm some of the IDD-
Requirements already uncovered (such as communication and mission) as well as 
gathering further relevant IDD-Requirements (R27 to R32) for IDD: 
• R27 Instil a sense of urgency;  
• R28 Use of a pilot project; 
• R29 Use quality management processes; 
• R30 Develop a guiding mission;  
• R31 Empowerment of staff;  
• R32 Employ effective planning. 
 
R27 Instil a sense of urgency; 
It was a surprise that in an era of software systems that a paper-based system 
would still be in use in an innovative MD company. However, it was a system 
that worked well at smaller scales, and became unworkable as the project grew 
in size. Existing processes in MedIn were well documented, so that new team 
members were able to assimilate quickly, for example, having a sense of 
urgency provided focus to team members. Change management was very 
important to MedIn, as much as project management. This was found to be 
important also in the literature review. Instil a sense of urgency (R27) was very 
apparent as staff could no longer work with the paper-based system that became 
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so large that it was timely to implement and lacked visibility on information 
gathered. Therefore, change needs to be managed. Change management was a 
key process that impacts the SDLC for MDs. The literature review also 
uncovered the importance of change (R12, change management process 
needed). 
 
R28 Use of a pilot project; 
The use of a pilot project was deemed an important necessary requirement 
(R28). For example, breaking a complex project into smaller more management 
parts allows teams to work on smaller parts first to become more familiar with 
new ways of working. The pilot project worked well as it helped to eliminate 
stress and anxiety for staff. This was actually discounted as a requirement earlier 
in the medical practice case study. In the medical practice case study, it was 
called boot camp and not considered a paramount requirement.  
 
R29 Use quality management processes; 
The use of quality management processes (R29) at MedIn were effective in 
dealing with the change brought about by altering the exiting document process. 
Regulations still had to be adhered to and the new way of working had to be 
regulatory compliant. The team members were given the time to use the new 
artefact-centric approach. For example, having quality processes, such as 
regulatory needs tasks, keeps projects compliant. 
 
R30 Develop a guiding mission; 
The team developed a guiding mission (R30) to work towards which 
acknowledged the need to have a better way or working, as the current one was 
becoming unworkable. The need to keep to the main goals and objectives 
(mission statement) to work towards was also identified in the literature review 
(R5) and the medical practice case study. For example, developing a guiding 
mission will aid teams to keep focus, in much the same way that a researcher 
develops research questions. 
 
R31 Empowerment of staff;  
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Empowerment of staff (R31) was identified as important to the potential success 
of the project. To facilitate this, the CTO identified key staff members and 
facilitated them to champion the new way of working to all staff. For example, 
teams that are empowered recognise that their inputs are meaningful. 
 
R32 Employ effective planning; 
Employ effective planning (R32) was facilitated by having clear goals and 
objectives which focused the project. The need for keeping to main goals and 
objectives was also identified in the literature review (R5) and in the medical 
practice case study. For example, planning is important as an aid to providing 
proactive structures for teams. 
 
This case study also identified a number of the IDD-Requirements uncovered 
previously in the literature review and the medical practice case study such as R4 
(Foster good communication (Wager et al 2013)) and R15 (Effective training 
(Noteboom 2012)).  
 
Due to regulation restrictions and business concerns such as time to market, MD 
companies have to implement change in an organised and planned fashion. When 
manufacturing MDs there are many constraints that have to be taken into account such 
as safety, regulatory compliance and traceability. To do this, well-defined processes are 
used. Overall, staff reported that the new process was working well, compliant to 
relevant regulations. After some setbacks staff were enabled to measure their work and 
collect metrics that gave greater visibility on the project, which was not possible 
previously.  
 
The IDD-Requirements identified during the case study remain, but planning is needed 
for unavoidable events. The pilot project was restricted by market demands, a key staff 
member was no longer on the project and the new software resulted in unanticipated 
changes in some work practices. This cannot be avoided but was mitigated with training 
documentation and knowledge transfer processes so as not to lose vital knowledge if 




At this point in the research a significant amount of data collection was complete and 
it facilitated the identification of more IDD-Requirements (R23 to R32) from the two 
case studies, allowing for the refinement of IDD. The case studies also confirmed IDD-
Requirements already identified in the literature review. The extra IDD-Requirements 
elicited (R23 to R32) were predominately in the areas of process and change 
management. 
 
4.4 IDD-V2  
The IDD-Requirements identified in the medical practice and the MD industry case 
studies were used as inputs into the creation of IDD-V2 (Figure 4.2). As there is a lot 
of content in Figure 4.2 and to aid in the readability of IDD-V2 it is broken down into 
sections (Figures 4.2a, 4.2b and 4.2c). Arrows in the figures connect relevant sections 
as sometimes sections need to be revisited depending on project outcomes. To make 
sense of the IDD-Requirements thematic analysis was used to group and visualise the 
information. The information was then synthesised further to form processes which 

























Figure 4.2c: IDD-V2 Section 3 
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IDD-V2 takes the form of three steps (renamed from IDD-V1 planning, development 
and implementation to more innovation centric descriptions), Identification, Ideation 
and Strategy. The three areas can be implemented in sequence but as reviews and 
feedback are part of each area then the order of progression through IDD can change. 
Within each process are a number of strategies to complete. The strategies implement 
relevant IDD-Requirements gathered such as R32 (Employ effective planning). IDD 
can be used with an existing SDLC such as the V-model. IDD attempts to address this 
gap by utilising requirements identified for innovation. 
 
The objective of undertaking the case studies was to understand and gather IDD-
Requirements to aid in the development of IDD. 
  
 This serves the purpose of addressing the first objective of this research, namely:  
• To define a software innovation model for use in the design, development and 
implementation of health information systems; 
 
4.4.1 IDD-V2 Identification Process 
The Identification Process deals with identifying areas for innovation. Project 
managers/leaders identify the market and the potential rewards. As in the literature 
review, medical practice and MD industry cases, planning is important. Planning is 
used to allocate the resources and capabilities needed as well as identifying potential 
constraints, define outcomes and risks. The project manager sets out the vision for the 
project and encourages teams to take appropriate positive risks to create innovative 
solutions. Communication is bidirectional and open to feedback.  
As seen in the medical practice case, using multidisciplinary teams aid the creative 
process and facilitate innovation. For multidisciplinary teams to work, collaboration 
and coalition is needed from team members and from users. As in the case studies a 
common goal encourages coalition. As seen in the literature review and the case studies, 
training is needed. This process begins with a training strategy which involves initial 
training of multidisciplinary teams. Intensive training is followed to inform the team 
members of the process of innovation. If feasible a pilot project is useful as seen in the 
case studies. Software development projects can have constraints such as budgets. 
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Teams are mentored by relevant experts so that any questions can be readily answered. 
Empowerment of teams is encouraged by allowing teams input into decision making, 
this also encourages team buy-in. 
 
As in the medical practice case, teams decide on a mission statement that is a goal for 
the project and this will guide the team through the project. The team members then 
become immersed in diverse clinical environments. This puts the potential users at the 
centre of the innovation process, this was seen in the literature review and the medical 
practice case. Coalition is needed here between healthcare workers and teams. A sense 
of urgency is also needed as immersion is timely but cannot impose too much on 
healthcare workers or patients. There is a fine balance between getting enough exposure 
to the problem and being in the way of the people being observed. Teams should be 
cognisant of time allocated to immersion so as to be prepared and efficient in gathering 
observations. Planning must be proactive and include risk management so as to be 
prepared for unexpected events.  
 
4.4.2 IDD-V2 Ideation Process 
The Ideation Process consists of refining areas to invent quality solutions in a timely 
manner. As in the medical practice case, teams are immersed in problem areas to 
identify potential areas for innovations, which are then screened to choose valid ones. 
This involves going back to try and observe the area again or discussing it with a 
mentor. A mentor is an expert in the area of potential innovation that is available to 
teams during the project. Screening of areas for innovation is used as not every potential 
innovation can be progressed due to limitations, such as time, money and resources. 
Planning is used to decide how to progress with specific areas of innovation, for 
example, by ranking.  
Concepts are then developed. Team members brainstorm to develop a range of potential 
solutions. Within this process there are specific strategies to be followed. The team 
develop a number of potential concepts and screens/ranks them. The team then begins 
to brainstorm these chosen concepts. As in the medical practice case, to encourage 
creativity tools can be used, such as the Osborn Parnes Creative Problem-
Solving Process (CPS) (Noller et al 1976). This was introduced during the medical 
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practice case mentorship process. The CPS (Noller et al 1976) involves converging on 
an area, then diverging to get a clearer picture (Figure 4.3). Converging on an area 
involves looking at the detail or specifics of the area, whilst diverging from an area 
involves looking at an area more generally. Converging and diverging was also seen in 
the literature review as part of the NSAI innovation standard (2009). This gives multiple 
perspectives of the chosen area. The CPS process can be used multiple times throughout 




Figure 4.3: The Osborn-Parnes Creative Problem-Solving Process (Noller et al 1976). 
 
Brainstorming is a group problem-solving technique where ideas are contributed 
(Besant 2016). It involves the team choosing a place to work together. Every brainstorm 
session should have a set of rules which the team adhere to. One such set of rules for 
brainstorming are (Henningsen and Henningsen 2018):  
• Withhold judgment of ideas; 
• Encourage wild and exaggerated ideas; 
• Quantity counts, not quality; 
• Build on the ideas put forward by others; 
• Every person and every idea has equal worth. 
 
Proposed concepts can be further developed by grouping, and again as earlier ranking 
them in terms of appropriateness and viability. For example, some proposed concepts 
are not practical to develop for various reasons such as cost. A number of screening 
headings can be used such as what is the unique selling point of this potential 
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innovation. The innovation features can be divided into what was crucial and what was 
nice to have. This allows teams to concentrate on the important aspects only to begin 
with. As in the literature review and the case studies, the importance of stakeholders 
cannot be ignored. Stakeholder analysis is a very detailed assessment of the needs of 
relevant stakeholders. As healthcare deals with people’s lives there are a lot of different 
types of stakeholders that must be acknowledged and understood. The existing market 
and the IP landscape must be analysed. Any relevant regulations must be identified. 
 
An initial prototype can be produced. A simple low fidelity prototype is quick to 
produce and low cost as materials such as paper can be used. Feedback from users is 
used to refine and develop a working innovation that can be released to relevant 
stakeholders to gather feedback and these actions can go through a number of iterations 
as needed. These actions can be tracked and reported. Testing is carried out to verify 
and validate the potential innovation. 
 
4.4.3 IDD-V2 Strategy Process 
The Strategy Process consists of business-related strategies to bring the innovation to 
market. Market research carried out initially in the identification process is continued. 
The team need to research the market in more detail to refine a business plan.  
 
The innovation can be trialled with relevant stakeholders. As stakeholders have been 
part of the earlier processes they are engaged, familiar and invested in it (buy-in). As 
seen in the literature review and the medical practice case, having stakeholder buy-in 
is important as there needs to be a sense of urgency to consolidate and institutionalise 
the innovation.  
 
As part of the market research and the business plan a route to market is devised. 
Finance is needed to bring an innovation to market and if the team is part of a small 
company pitching for finance may be the only route to market. Effective planning of 
the route to market is needed in this process. Relevant questions in this process are: 
• Market research, 
o What is the route to market? 
• Business planning, 
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o What is the potential market? 
o Regulatory landscape. Are there regulations this innovation must adhere 
to? If so, what are they and if not is there potential for regulations in the 
future? For example, some health software does not need to adhere to 
regulations but this can change as regulations evolve. Changes must be 
managed effectively quickly such as having a sense of urgency to suc-
cessfully manage the change; 
• Pitching, 
o Pitching the innovation/product to potential financial backers. Who 
might pay for this innovation? This was found to be very important in 
the medical practice case study. Can teams concisely present the 
potential innovation to attract financial backing? 
 
4.5 Conclusion  
In Stage 2 of this research a medical practice case study and a MD industry case study 
were undertaken and this facilitated gathering additional IDD-Requirements. In Section 
4.2.4 of this chapter a number of requirements were identified such as R23 (using a 
three-Phase approach to developing innovations resulted in successful innovations), 
R24 (mentorship), R25 (using multidisciplinary teams to engage with users) and R26 
(pitching). In Section 4.3.4 of this chapter a number of further requirements were 
identified such as R27 (instil a sense of urgency), R28 (use of a pilot project), R29 
(quality management processes), R30 (a guiding mission), R31 (empowerment of staff) 
and R32 (effective planning). These IDD-Requirements were used as input to IDD-V2. 
Both case studies also confirmed a number of the existing IDD-Requirements found in 











Chapter 5 Hospital Case  
 
5.1 Introduction 
In Stage 3, a hospital case study was carried out. Structured interviews were undertaken 
to understand how software and software models are used by staff in their daily work.  
This case study is discussed in terms of the change and quality management processes 
followed within the hospitals.  
 
Research carried out during the hospital case study has been published and presented 
at the HEALTHINF conference (Appendix 9). The published paper discussed process 
and change management within the hospitals where interviews were undertaken. 
 
The output from this case study along with IDD-V2 were used to inform the next stage 
of development to IDD-V3. IDD is comprised of three development areas: Identifica-
tion, Ideation and Strategy. These development areas are each comprised of processes, 
which, are then made up of strategies to aid in the completion of the processes. 
 
5.2 Software Process – The Hospital Case (Analysis of HSE in-
novations) 
The objective of undertaking this case study was to understand and gather IDD-
Requirements to aid in the development of the IDD-V3. In recent years, much has been 
documented about the crisis which healthcare systems currently face due to growing 
demand and expectations from traditional healthcare models. Healthcare organisations 
now realise that innovation is increasingly required to sustain a quality healthcare 
service system (Cazzaniga and Fischer 2015). To be successful, innovations through 
the implementation and upgrading of Information Technology (IT) systems are needed 
to align with practice to support the evolution of healthcare processes to manage 
change. Interviews were carried out in publicly funded Irish hospitals. 
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Healthcare service providers commit to improving a service and invest heavily in 
technological infrastructures to reach improved service levels. However, managing the 
change process of HIS innovation is complex. Furthermore, healthcare service 
providers are required to improve the quality of the patient experience while also 
supporting the clinician in their medical requirements. Healthcare IT must also protect 
patient safety and privacy, and in addition, there are clinical, technical and software 
regulations and standards that need to be considered (e.g. EU directive: 2007/47/EC, 
European Union Council, 2007, EU Clinical Trials Directive (Directive 2001/20/EC 
and ISO standards). Change management requires a specific approach to transition an 
organisation to a desired future state (Benjamin and Levinson 1993, Hayes 2018). 
Within a hospital context, the various steps required to achieve a desired future state is 
of importance to ensure that patient safety is a priority and quality is not jeopardised 
(Cazzaniga and Fischer 2015). Change management is useful in this situation as it aims 
to provide a structured approach to implement change in a controlled manner through 
various deliverables or milestones while, adhering to specific requirements on 
functionality, budget and time. One-to-one interviews were carried with twelve key 
staff from three publicly funded hospitals that were all involved in IT change to various 
degrees (Table 5.1).  
Interviewee Department Years’ 
Experience 
Specialty 
1 Quality 23 Nurse and Risk Manager with focus on use of IT systems 
2 Radiology 29 Administration with focus on quality 
3 Physiotherapy 17 General Administration 
4 HR  28 Project Manager 
5 Dermatology 4 Clinician 
6 Radiology 25 Clinician/Project Manager 
7 IT 30 Manager with focus on hardware and software deployment 
8 Quality 19 Manager with focus on risk management 
9 Laboratory 28 Manager with focus on deployment 
10 Radiology 28 Clinician/Project Manager 
11 IT 20 Project Manager 
12 Quality 10 System user 
Table 5.1: Summary of Interviewee Profiles 
 
All of the staff interviewed use HIS extensively. Clinicians can have management roles 
as well as treating patients. Project managers deal with developing HIS and rolling out 
the implementation of HIS. System users use HIS daily. 
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The interview findings identified how change management can be viewed as a product 
of change leadership.  During the analysis, a key theme identified was change manage-
ment and quality management. Both of which were also themes in the literature review 
and the case studies. 
 
5.2.1 Change Management and Quality Management 
The need for change was clearly highlighted from the interviews.  
“Change is overdue as every evening each patient and the interventions delivered to 
them have to be input. This is very time consuming. Also, a big change that is needed 
is with the problem of patients not having a unique identifier.”  
(Interviewee 3 Role: Administrator)  
The findings indicate that, in the hospital, change is a forward planning process which 
is well documented and audited through various stages. Change required a cultural 
commitment from the organisation as a whole to accommodate a new set of procedures, 
one of which is the use of auditing. For example, Interviewee 1 (Role: Risk Manager) 
categorised the change process as a set of procedures, structure, process and outcome. 
Structure is forward planning policy to indicate change requirements, e.g. equipment. 
Process is a set of guidelines to ensure that change is implemented correctly. Outcome 
is used to assess the success of the change policy. The categories identified by 
Interviewee 1 (Role: Risk Manager) are actually from Donabedian's model (1980 and 
2005). Donabedian's model (2005) provides a process to analyse quality, which, is 
comprised of three factors: structure, process, and outcome.  
 
This suggests that preparing for the change process needs to be considered as well as 
executing the change. For example, Interviewee 5 (Role: Clinician) provided an 
example of how a new IT system or process was implemented and explained that they  
“Developed a patient registry and we spent two years in feasibility with one year 
developing. We identified stakeholders and their concerns so we focused on care not 
disease. Delphi studies gains consensus and e-Delphi validates the model. (Delphi 
method for gaining expert opinion). This worked well for us.”  
(Interviewee 5 Role: Clinician) 
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Interviewee 5 (Role: Clinician) raised concerns around the use of software in some 
cases and explained that  
“There is an ad hoc manner in the use of software. There is no awareness of data 
protection such as emailing and document sharing”  
       (Interviewee 5 Role: Clinician) 
Interviewee 6 (Role: Clinician/Project Manager) also highlighted some concerns with 
the overall HIS, namely that a lack of a unique patient identifier impacts IT projects 
and a lack of out-of-hours IT support from the IT department located in the hospital. 
There were mixed views on change linked to the introduction of new IT systems and 
processes. While some users seemed relatively pleased “overall it is an improvement as 
images can be view from multiple locations” (Interviewee 4 Role: Project Manager). Others 
reported to be disappointed with the overall change and “the manner in which the change 
process occurred” (Interviewee 4 Role: General Administration). 
For HIS projects to be used nationwide, the procurement is carried out nationally and 
the implementation is achieved locally. “Involvement of staff is crucial for buy-in” 
(Interviewee 4 Role: Project Manager), which suggests that change management is a 
much wider collaborative effort within a department. Interviewee 5 (Role: Clinician) 
highlights this and explains that the implementation of some new IT systems represents 
“silo thinking as lack of understanding of standards, networking, eco-system and health 
informatics” (Interviewee 5 Role: Clinician). In addition, to accommodate a smooth 
change transition, training on a new system is vital. Also sharing similar concerns and 
highlighting that “buy-in crucial to generate enthusiasm” (Interviewee 7 Role: Manager) 
regarding a change in service systems. In addition, they suggest that “training should be 
relevant and timely” (Interviewee 7 Role: Manager) without which user acceptance of 
IT-enabled innovation may be hampered. With regards to some projects, there were 
“too long a time delay from training to using the system” (Interviewee 4 Role: Project 
Manager) which can hamper the initial success of an IT programme.  Interviewee 4 
(Role: Project Manager) explains that it 
“removed the need for staff to type up clinicians’ recordings for reports but it has 
actually created more jobs as cancellation lists need managing also the DNA (Did not 
attend) list has to be done twice daily.”      
     (Interviewee 4 Role: Project Manager) 
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Interviewee 6 (Role: Clinician/Project Manager) shares similar concerns regarding 
training and suggested that  
“more frequent staff sessions needed. Overall staff felt that training was not sufficient 
and more difficult for older people. Staged training sessions would have helped such 
as introduction, advanced, super user training.”  
(Interviewee 6 Role: Clinician/Project Manager) 
While some projects provide standard operating procedures the inclusion of other 
software companies for supporting services may cause concerns for some users, for 
example, subcontracting support services (Interviewee 6 Role: Clinician/Project 
Manager). The findings also suggest that communication regarding the objective of 
implementing change is critical. For example, Interviewee 7 (Role: Manager) raises the 
question regarding: “What are the objectives?” (Interviewee 7 Role: Manager) and goes 
on to explain that  
“there is no point in implementing centrally and then letting people do what they want 
locally. You might as well have two systems.” 
(Interviewee 7 Role: Manager) 
This suggests that implementing change requires improved quality, planning and 
communication strategies which have already been identified in the literature review 
and the case studies.  
Interviewees were provided with the opportunity to explain what they might do 
differently if they were to undertake a similar change management task.  Interviewee 1 
(Role: Risk Manager) explained that they would like to have more control of the chosen 
software vendors and suggested that not all users were happy with the software.  
Interviewee 2 (Role: Administrator) raised more concerns with the overall change 
process. For example, they had concerns around the need to rebuild a service network, 
the need to fill out medical records (time-consuming) and the threat of personnel 
moving department or institution and in so doing, taking competence out of the 
department. Therefore, more engagement of all parties and external expertise is a 
critical element of the success in change management. Interviewee 5 (Role: Clinician) 
explained that they could have “engaged with research centre…to get more visibility” 
(Interviewee 5 Role: Clinician). Building on this comment, the interviewee suggested 
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that it should be a national competence approach to similar projects and explained that 
“we need a centre such as a medical software institute with wide stakeholder representation to 
oversee projects” (Interviewee 5 Role: Clinician).  
 
IDD addresses the gap by having a number of IDD-Requirements that addresses 
stakeholders such as R8 (Involve users/customers extensively) and R9 (Act on feedback 
from users).  
 
Change can be effectively managed using a change model such as Kotter’s. This was 
highlighted by Interviewee 2 (Role: Administrator) who also indicated that the eight 
steps is “what should be done…but plans can change due to unexpected problems” 
(Interviewee 2 Role: Administrator). This suggests that there may be a need to offer 
greater flexibility or agility to change management models such as Kotter’s. 
Interviewee 5 (Role: Clinician) also suggests that models such as Kotter offer a good 
basis to manage change.  
“For our system we were mobile and patient centric. We understood the people and 
their motivations. That is a platform for engagement and multi-disciplinary teams”.    
(Interviewee 5 Role: Clinician) 
Adopting an improved structured approach was discussed. Users need to be supported 
if they are to successfully use a HIS. 
“Well-structured maintenance service agreements especially out of hours service, for 
example, the previous system came from [Global Tech Company] and they had a 
person onsite to deal with issues”.  
(Interviewee 6 Role: Clinician/Project Manager) 
To successfully implement change requires an ability to understand user’s requirements 
and foster a relationship to ensure buy-in from the beginning of the project.  
“To implement change, you have to talk to the end user and get buy-in. Start with what 
you want and work back. Successful projects always had buy-in”. 
       (Interviewee 7 Role: Manager) 
However, to facilitate an improved structured process, Interviewee 2 (Role: 
Administrator) indicated the need to “encourage more trust” and avail of additional onsite 
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support from the technology providers. One of the issues associated with the lack of 
support was the different time-zones (i.e. Ireland and America) requiring out of office 
phone calls for long durations. The level of support provided was often unsatisfactory, 
for example, “they sometimes say the problem is our network when the network is working” 
(Interviewee 2 Role: Administrator). Interviewee 4 (Role: Project Manager) also shared 
these concerns and explained that if they underwent a similar project they would have 
“someone on hand instead of having to ring with issues. This would make a big difference” 
(Interviewee 4 Role: Project Manager). In addition, considering that one of the core 
objectives was to streamline healthcare processes, Interviewee 4 (Role: Project 
Manager) highlights their disappointment in that the project “is supposed to be paperless 
but it is not. Actually, we are using more paper and ink now”. Interviewee 6 (Role: 
Clinician/Project Manager) explained that going live presented some unexpected 
issues:  
“The initial go live took longer and also the bedding in period took longer than expected 
and more patient lists should have been cancelled beforehand. So, what happened were 
lots of people waiting two weeks so it was not patient load effective at the beginning.”  
(Interviewee 6 Role: Clinician/Project Manager) 
Planning and vision can be problematic: 
“We plan things and it takes so long that by the time it’s implemented the projects are 
too old.”        
    (Interviewee 6 Role: Clinician/Project Manager)  
One way to address this is by planning. Interviewee 7 (Role: Manager) suggests that 
“better long term and short-term planning needed”. Thus, there is a clear indication that 
implementing change requires a structured approach which communicates both the 
need and benefits of supporting change.  
IDD addresses the identified gaps by having four IDD-Requirements entitled change 
management needed (R12), foster good communication (R4), effective training (R15) 
and employ effective planning (R32). 
The key learnings are:  
• Change management is crucial and needs to be planned;  
• Training needs to be planned and appropriate; 
• Effective communication and getting buy-in is needed for change; 
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• Change requires improved quality, planning and communication strategies. 
 
5.2.2 Case Study Analysis and Implications for IDD  
This case allowed relevant IDD-Requirements to be gathered within a hospital 
situation. This further confirmed a number of the IDD-Requirements uncovered 
previously and another requirement was identified. 
 
It was found that communication differed in the hospitals from the medical practice and 
the MD industry case studies. There were various degrees of awareness of change 
models. Due to the different management structures some information was not 
effectively transferred to all relevant teams. For example, in the hospital there was a 
change model chosen to be used (incidentally it was based on Kotter’s model (2005) 
discussed previously) but not all of the staff were aware it. In the medical practice and 
the MD industry case studies there were centralised repositories for information such 
as training manuals. In the hospitals there were centralised repositories setup but in 
some cases the information was not kept up-to-date, so users did not see the benefit of 
using them. This could not happen in the MD industry case as regulators require access 
to repositories. Therefore, if the repositories are not current or complete regulatory 
compliance can be revoked. This would result in MD companies losing the ability to 
sell products.  IDD gives awareness to processes overall. There are relevant processes 
and each process is supported by strategies. This allows users to get a broad overview 
of project processes with the ability to drill down into the relevant information. 
Planning is proactive through the use of risk assessments, audits and reviews. 
Communication is a complex task. Therefore, to aid in having effective dialogue it is 
encouraged to be bi-direction, to listen and to be open to criticism. 
 
It was found that training is provided in projects but it is not always relevant. For 
example, the same training for novice and experts users is not appropriate. In terms of 
planning, training was not planned at relevant times to give the most benefit to the users. 




The healthcare sector as a whole represents many industries made up of diverse 
stakeholders representing a wide range of interests. Various stakeholders include 
patients, healthcare providers, regulators, payers and suppliers (including software 
providers). Thus, implementing change to introduce IT-enabled innovation is a 
complex task. Stakeholder engagement findings show it would be useful for hospitals 
to gather a coalition of relevant users to garner buy-in. This coalition could be used to 
decide how to mainstream the new ways of working. Having a shared mission would 
help to keep teams on track with the main objectives of a project. IDD acknowledges 
the need for a shared mission. 
The following areas were strongly identified by interviewees as being necessary 
requirements during the implementation process:  





A number of these areas identified were already uncovered as IDD-Requirements 
earlier in the literature review and in the medical practice case study such as: 
• R4: Foster good communication (Wager et al 2013); 
• R15: Effective training (Noteboom 2012); 
• R32: Employ effective planning (Yock et al 2015); 
• R25: Multidisciplinary teams give more perspectives on an area to innovate 
(Yock et al 2015);  
• R30: Develop a guiding mission (Biodesign 2012). 
The remaining one area, mainstream new ways of working, was added as a requirement 
to IDD:  
• R33 Mainstream new ways of working. 
IDD-V2 was amalgamated with the hospital case to produce IDD-V3.  
 
R33 Mainstream new ways of working. 
New ways of working need to be embedded. For example, in this case having a 
coalition of relevant team members in place was used to decide how to 
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mainstream the new ways of working. The team had a shared mission which 
helped to keep the teams on track with the main objectives of a project and roll 
out the new work process. 
 
 
5.3 IDD-V3  
IDD-Requirement inputs were analysed. This involved uncovering significant themes. 
To make sense of these themes they are synthesised further to form processes and 
strategies in IDD-V3 (Figure 5.1). As there is a lot of content in Figure 5.1 and to aid 
in the readability of IDD-V3 it is broken down into sections (Figures 5.1a, 5.1b and 
5.1c). Arrows in the figures connect relevant sections as sometimes sections need to be 
revisited depending on project outcomes. In IDD-V3 strategies are the instantiation of 
processes or the tasks needed to complete a process. Therefore, processes comprise of 
various strategies.  
 
The literature review examined the NSAI innovation standard (2009) which uses 
perspectives for leaders and practitioners. O’Leary et al (2015) examined primary 
stakeholders and to address their assessment needs use a multi-perspective viewpoint. 
Also, during data collection various stakeholders engaged in this research to allow the 
gathering of the remaining IDD-Requirements. Each had different perspectives and 
























Leaders, Practitioners, Developers, Implementers work throughout IDD in the 
identification, ideation and strategy steps of the model. In IDD-V3, leaders plan 
projects, developers develop projects and implementers implement or deploy projects.  
Identification, ideation and strategy are each comprised of processes. The processes are 
followed typically in order of the flow of information. It must be noted that not all 
projects follow a linear pattern and for unforeseen reasons some processes can take 
longer to complete and may need to be reworked or revisited.  
IDD is an aid to applying innovation strategies to the development of HIS. IDD 
attributes are: 
• Multiple perspectives; 
• Early and on-going user engagement; 
• Change management with project management; 
• Communication to empower with goals and mission; 
• Timely and relevant training; 
• Deployment strategies. 
IDD can be used for HIS projects to bring an awareness of the important strategies that 
can be employed to increase the potential for project success. 
 
 
5.4 Conclusion  
In Stage 3 of this research a hospital case study was carried out to gather further IDD-
Requirements. In Section 5.2.2 one further requirement R33 (mainstream new ways of 
working) for addition to IDD has been discussed. Software should be part of a change 
a new or improved way of working. This requirement along with IDD-V2 were then 








Chapter 6 IDD External Evaluation 
 
6.1 Introduction  
In Stage 4, IDD-V3 was evaluated by interviewing external experts to gather feedback 
on IDD. This feedback was then used to further refine and create the evaluated final 
version of IDD.  
 
6.2 Evaluation of IDD model  
IDD was evaluated with external experts through expert opinion and feedback. 
Fourteen expert participants were recruited externally using the snowballing technique 
(Table 6.1).  
Participant Specialty Years’ Experience 
1 Clinical - Physiotherapist and Lecturer, 
has worked on HIS 
12 
2 Clinical - Lecturer Clinical Therapies, 
has worked on HIS 
15 
3 Clinical - Physiotherapist and Lecturer, 
has worked on HIS 
10 
4 Clinical - General Practitioner and 
Professor, has worked on HIS 
30 
5 Clinical - Lecturer Clinical Therapies, 
has worked on HIS 
13 
6 Clinical – Nurse, currently working on 
HIS 
2 
7 Clinical – Nurse, currently working on 
HIS 
30 
8 Software Engineering Manager, has 
worked on HIS 
15 
9 Software Engineering Manager, has 
worked on HIS 
10+ 
10 Software Architect, has worked on HIS 7 
11 Software Engineer, has worked on HIS 5+ 
12 Software Engineer, has worked on HIS 6 
13 Software Engineer, has worked on HIS  11 
14 Software Architect, has worked on HIS 11 




The expert participants were clinicians, software architects, software engineering 
managers or software engineers, all of who use HIS extensively, as they are working or 
have worked in [hospitals / healthcare industry / health software industry]. Software 
architects are expert in designing HIS. Software Engineering managers deal with 
developing HIS and rolling out the implementation of HIS. As well as treating patients, 
clinical specialists can have management roles and be HIS users. A copy of IDD was 
presented to the experts. The expert participants were all asked the same questions 
(Appendix 3). The reasoning behind the questions were to gather the expert’s opinions 
of innovation in IDD as well as in their own opinion. The results are presented from the 
different stakeholders of IDD.  
 
6.2.1 Feedback from Experts on IDD Model (Identifica-
tion for Leaders)  
Focusing on Step 1 of IDD, Identification, within which each process has a number of 
related strategies, the experts were asked questions such as:  
How do leaders inspire teams in your organisation to be innovative? 
After reviewing IDD, the experts provided feedback (Appendix 4). The feedback was 
analysed and a number of themes emerged. 
 
The following Sections 6.2.1.1 to 6.2.1.10 discusses the more frequent themes 
identified in terms of the expert’s opinion of their impact on IDD. 
 
6.2.1.1 Consultation/Collaboration 
A new strategy consultation/collaboration was added to the initiate (understand) 
process. The experts pointed out the importance of this strategy as managers need to 
consult with relevant staff and often experienced managers respond better when they 
see the problem and challenges exposed. Managers also need to be able to negotiate 
and to define a measure of success or lack of success as this can then be measured. 
“Consultation is crucial it must be connective, for example, have a mutual respect otherwise it 




The importance of a leader was stressed and that maintaining and communicating good 
practice aids success. A leader should be enthusiastic, convincing, experienced and lead 
for the duration of a project. Also change management starts with the leader who must 
be accountable and able to make decisions in order to bring about change. Persistence 
can overcome resistance. “All too often non-IT people are creating software and clinicians 
are project managing it” (Expert opinion Role: Lecturer Clinical Therapies) so IDD can 
help by having processes to guide in areas such as project and change management. 
 
6.2.1.2 Market and Area 
The existing market strategy was expanded and renamed market/area. Experts 
recommended examining the frequency of the problem area. Cost implications are an 
important factor in going forward with a project or not. Leaders should also analyse the 
possibility of streamlining existing processes with innovation. 
“Market and Opportunity. This is a very broad set of areas to account for, and the effort 
required to even grasp a little of the factors is very high. A deep analysis and an equally 
deep understanding of all of them is necessary, so an accurate and expansive study 
phase (mostly around the feasibility of innovation) is necessary”  
     (Expert opinion Role: Software Architect) 
“In order to understand the domain to analyse, the leaders must first analyse the market 
in order to gain the knowledge of the domain and gain information. Then in order to 
better make decisions the leaders must take into account the opportunities, risks and 
rewards. In this way they can the pros and cons of every decision”  
           (Expert opinion Role: Software Engineering Manager)  
 
6.2.1.3 Risks and Rewards 
The existing risk-taking strategy was expanded and renamed risk assess as the phrase 
risk-taking had negative conations for health experts. As well as encouraging risk-
taking leaders must recognise the need to risk assess. “Sometimes giving people a longer 
leash to take risks without penalties of failure, this allows people to try things” (Expert opinion 
Role: Software Engineer). 
“Creativity in an organisation needs to be employed to the benefit of the organisation 
goals. A team leader should recognise the creative individuals in a team, give them 
time to explore their ideas and make sure those ideas are beneficial to the organisation 
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mission and goals. To do so, the leader needs to make the team member aware of the 
goals and of how their innovative ideas fit into those goals. He also needs to make the 
team member aware of the risk involved in embarking in new projects, and in case the 
risk is too high compared to the benefit, he needs to cut the losses”  
            (Expert opinion Role: Software Engineering Manager) 
 
Having quality reviews as well as hiring the right people could reduce some risks. 
“International best practice should be added to risk assessment” (Expert opinion Role: 
General Practitioner and Professor). 
 
Some strategies such as risk-taking had to be renamed as there was a negative 
connotation in healthcare to the word risk, whereas it has positive one in software 
innovation. Therefore, the naming of the strategy Risks and Rewards became Risk 
Assess. This subtle word change has implications in how a process is perceived by 
different people within a project. 
 
6.2.1.4 Communication 
The existing communication and empowerment strategy was seen as a high priority by 
all of the experts. “Have a clear communication strategy” (Expert Opinion Role: Nurse). 
“Use workshops as staff fears can be addressed here and creates a forum for feedback. 
This has in our experience worked well but it takes time to implement so be ridged in 
the time element. Be strategic purposefully choose working groups to see the different 
personality types. Leaders will emerge. This helps with empowerment too. Also, 
problems can emerge, for example, in one group, training was not mandatory at the 
beginning but it became clear that training was needed throughout. This can then be 
addressed to have training all through the project”  
   (Expert opinion Role: Physiotherapist and Lecturer) 
Creating ownership encourages empowerment. “Buy-in is crucial” (Expert opinion Role: 
Nurse). “Encouragement must be recognised as an important element to empowerment” 
(Expert opinion Role: Software Engineering Manager). Within IDD communication is 




6.2.1.5 Multidisciplinary Teams 
The existing multidisciplinary teams and collaboration strategy was also seen as a high 
priority by the experts. “Multidisciplinary teams are common in clinical practice” (Expert 
opinion Role: Lecturer Clinical Therapies). Staff skills need to be taken into account. 
 
Teams need to collaborate, “leaders/managers must be open to the possibility of a new and 
better solution coming from staff” (Expert opinion Role: Physiotherapist and Lecturer).  
 
Resistance to change happens during projects. 
“Early on leaders need to be listening as resistance to change can be logical and rational 
that the leader might not see”  
     (Expert opinion Role: Lecturer Clinical Therapies) 
“Managers must react to dissatisfaction with processes and act not force” (Expert opinion 
Role: Software Engineer). IDD acknowledges that change needs to be managed. 
Multidisciplinary teams are facilitated in IDD through working together in coalition 
with a shared vision and mission.  
 
6.2.1.6 Mission Statement and Vision 
The existing mission and vision strategies have been merged as they were deemed to 
be similar by experts. 
“Both creation of a vision and mission statement make the leaders better describe where 
the team will need to go and define long-term objectives. But in order to give the right 
direction to the team he needs collaboration and communication in order to remove 
every obstacle to the final purpose and empowerment to make all the involved people 
take ownership of their part (Expert opinion Role: Software Engineering Manager). 
I would consider the creation of a vision and a mission statement the same thing: they 
are the representation of the focus”  
(Expert opinion Role: Nurse) 
IDD facilitates having a mission and vision for teams by encouraging teams be 




6.2.1.7 Timescales and Processes  
Timescales were added to IDD as a strategy. “Leaders must recognise that change 
implicates on time. There is a time element to change” (Expert opinion Role: Nurse). 
“Processes must be adaptive and flexible but this depends on goodwill of teams” (Expert 
opinion Role: Physiotherapist and Lecturer). 
“The agile process makes all the team aware of the problems and incentivises everyone 
to give solutions. The process is really important for this”  
(Expert opinion Role: Nurse) 
“Outlining defined process helps the team going in the right direction and has the 
methodology to deal with the daily work; training helps improve the person to gain 
new knowledge and improve the personal skills”  
     (Expert opinion Role: Software Architect) 
“Defining the process is usually not enough for the success of an organisation. The 
process needs to be updated accordingly to the changes the organisation undergoes. 
Governing the process change is an area of consideration a leader needs to take into 
account “(Expert opinion Role: Software Engineering Manager). 
Timescales are important as if estimates of timescales are incorrect it can have cost 
implications on projects. There was an existing strategy in IDD called processes. This 
was expanded to by the experts to include timescales in terms of how processes need 
to be adaptive. 
 
6.2.1.8 Mentorship and Training  
The existing strategy mentorship and the existing process training were confirmed as 
important by experts.  
“Having role models helps as you have a key person on the ground who is the go to 
person (not the leader)” 
(Expert opinion Role: Physiotherapist and Lecturer) 
“Training must be relevant, personalised” (Expert opinion Role: Software Engineering 
Manager). “Set training from feedback of previous training” (Expert opinion Role: Lecturer 
Clinical Therapies). 
“To promote training, leaders need to promote knowledge transfer through 
communication between team members, and encourage the creation of a 
documentation body, to make training easy and repeatable in the future” 
      (Expert Opinion Role: General Practitioner and Professor) 
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The importance of training and mentorship was reiterated by the experts when giving 
feedback on the other areas of IDD and it was recommended to add a further training 
strategy. 
 
6.2.1.9 Review   
The importance of reviews was confirmed by all of the experts. Reviews should take 
place at regular intervals in a project. “Key people should be involved in the review process 
and it should be two way” (Expert opinion Role: Lecturer Clinical Therapies). A number 
of review strategies were added to IDD. 
 
6.2.1.10 Defined Outcomes 
The existing strategy called outcomes were confirmed as important by the experts.  
“Defined outcomes are beneficial to everyone (doctor, patient, health system). Everyone 
wins if used properly”  
      (Expert opinion Role: General Practitioner and Professor) 
“CPD (Continued Professional Development) is useful as an outcome for staff to give 
them the potential to add to their CV and career progression” 
 (Expert opinion Role: Nurse) 
Within IDD expected outcomes should be predefined so that reviews and audits can 
take place and results (positive or negative) can be seen on review. 
 
6.2.2 Feedback from Experts on IDD Model (Ideation for 
Practitioners)  
Focusing on Step 2, Ideation begins with 2 processes Identify and Generate. Each 
process has a number of related strategies. The experts were asked questions such as:  
How do team members generate requirements in your organisation? 
What processes do team members use to develop projects in your organisation? 
After reviewing IDD, the experts provided feedback (Appendix 5). The feedback was 
analysed and a number of themes emerged. 
 
The following Sections 6.2.2.1 to 6.2.2.9 discusses the more frequent themes identified 





The existing immersion strategy was confirmed as important by the experts. IDD 
facilitates immersion to gain a deep understanding of a problem area. 
“Immersion worked very well for us but it has to be done properly. We found that staff 
initially were resistant to new members observing them. We had to call a meeting and 
get the new members to present to the group what their aims were, this allowed staff to 
see that their work was not going to be criticised and interrupt their busy schedules 
during observation. The ultimate goal was that we were all going to try and innovate 
better ways of working that will benefit staff and patients”  
            (Expert opinion Role: Software Engineering Manager) 
 
6.2.2.2 Needs Finding  
The existing strategy called needs finding was confirmed as important by the experts. 
“You have to be aware that sometimes problems exist that will never have a viable solution” 
(Expert opinion Role: Lecturer Clinical Therapies). 
“It must be noted that experts can find it hard sometimes to articulate a problem. I would 
also add that customers can help identify needs by submitting their ideas for 
improvement”  
   (Expert opinion Role: Physiotherapist and Lecturer) 
“The organisation follows the scrum process, so team members periodically groom the 
backlog of issues to be done in order to refine the description and the expected outcome 
of those issues. Also, the team members, guided by a product owner and a scrum master, 
decide which issues will be done in a sprint”  
     (Expert opinion Role: Software Engineering Manager) 
Within IDD observation is one method used to implement the needs finding strategy. This 
allows teams to get close to relevant situations. 
 
6.2.2.3 Needs Screening  
The existing needs screening strategy was confirmed as important by the experts. 
“Before progressing with an identified need we had our clinical audit department carry 
out an audit to look at the current situation before any potential change”  




IDD facilitates needs screening through ranking of needs based on relevant criteria 
devised by teams.  
 
6.2.2.4 Audit  
Audit strategy was added to the Ideation and Strategy areas in IDD as recommended 
by the experts. 
“Team members do not only generate requirements but also artefacts. Creating issues 
when a team member thinks there is a need. The created issues are then refined during 
backlog grooming”  
(Expert opinion Role: Software Architect) 
 
Auditing a part of a project is important to check that the project is going as planned 
and that the outcomes are valid. Audits within IDD will facilitate an inspection of a 
project at a point in time to check if it is on track. 
 
6.2.2.5 Concept Finding  
The existing concept finding strategy was confirmed as important by the experts. “Look 
at existing solutions in similar settings” (Expert opinion Role: Software Architect). 
“Concepts should be driven by patient needs. There should always be at least one 
person on the team who is a patient advocate”  
     (Expert opinion Role: Lecturer Clinical Therapies) 
 
The concept finding strategy within IDD includes acknowledgement for stakeholder 
needs and encourages early engagement. 
 
6.2.2.6 Concept Screening  
The existing concept screening strategy was confirmed as important by the experts. 





Having a structure on how to screen concepts that is workable for teams was confirmed 
as necessary. IDD acknowledges this through concept ranking. 
 
6.2.2.7 Brainstorming  
The existing brainstorming strategy was confirmed as important by the experts. 
“The initial design phase for a new project is always accompanied by a set of initial 
Spikes where we take a defined amount of time to brainstorm the project, find the 
missing holes in the project, propose a solution and brainstorming it with the team 
members. This is an iterative process that can end with other Spikes or the first 
implementation of the project”  
      (Expert opinion Role: Software Engineer) 
 
IDD has a strategy for brainstorming as it is needed for teams to take time to be creative. 
 
6.2.2.8 Prototyping  
The existing prototyping strategy was confirmed as important by the experts. “Useful 
for adapting programs and required adaptations for feasibility and practicality” (Expert 
opinion Role: Software Engineer). IDD encourages prototyping as it is a way of further 
developing potential concepts. 
 
6.2.2.9 Generate Process  
The existing generate process was confirmed as important by the experts. “In the 
generate process commitment to change must be shown as taking shops is usually what we see” 
(Expert opinion Role: Nurse). 
 
IDD encourages teams to stay on track by adhering to the mission which in turn 




6.2.3 Feedback from Experts on IDD Model (Ideation for 
Developers)  
Continuing the focus on Step 2 Ideation contains 3 more processes, Design, Develop 
and Verification and Validation. Each process has a number of related strategies. The 
experts were asked questions such as:  
Can you explain how team members in your organisation verify and validate 
projects? 
After reviewing IDD, the experts provided feedback (Appendix 6). The feedback was 
analysed and a number of themes emerged. 
 
The following Sections 6.2.3.1 to 6.2.3.3 discusses the more frequent themes identified 
in terms of the expert’s opinion of their impact on IDD. 
 
6.2.3.1 Design  
The existing design process and strategy were confirmed as important by the experts. 
Agile practices were also recommended where possible. 
“We use agile development throughout the company, but with variations as needed by 
the different teams preferred approach. The agile approach provides the possibility to 
continuously evaluate design and priorities based on the current conditions”  
  (Expert opinion Role: Software Engineering Manager) 
“Develop; verification and validation are an iterative process, in which a software 
engineer does the development, while a test engineer does the verification and validation. 
The process is repeated until the requirements identified are implemented correctly”  
(Expert opinion Role: Software Engineer) 
 
“I would add an iterative phase in which the requirements in need of clarification are 
discussed between the test engineers, the rest of the team and possibly the product owner"  
     (Expert opinion Role: Software Architect) 
 
With regards to regulations and design planning all the experts confirmed the 
importance of adhering to regulations and standards. “Yes, design should be planned 
especially in health, regulations and standards very important, for example, HIQA standards” 
(Expert opinion Role: Lecturer Clinical Therapies). 
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“If effective planning means the waterfall project management, I don’t think that is still 
a good way to plan a project. Agile methodologies have shown to be much more 
effective”  
            (Expert opinion Role: Software Engineering Manager) 
IDD encourages teams to be aware of the flexibility that agile practices can offer.  
 
6.2.3.2 Review  
The experts recommended a number of review strategies be placed in different areas of 
IDD. “Plan audits and reviews with external people to remove bias and bring transparency 
throughout” (expert opinion Role: General Practitioner and Professor). 
 
Needs analysis should be done and note that this can be different for different groups. 
Key people should be involved in the review process and it should be two way.  
Reporting was also recommended to add with the review strategy. “Report on identified 
outcomes and think about what needs to be reported and is it an improvement” (Expert opinion 
Role: Nurse). 
 
Audit and review strategies were added to relevant areas of IDD. 
 
6.2.3.3 Verification and Validation (V&V) 
The existing V&V strategy was confirmed as important by the experts.  
“New outcomes, reliability must be measured. Consultation with others. Security and 
upgrades should be addressed in V&V. Make sure that the data that is supposed to be 
collected is and that it is correct”  
     (Expert opinion Role: Software Architect) 
V&V is not mandatory in the regulations, however the experts agreed it is necessary. 
This was also seen in the MD industry case study where MedIn had V&V processes in 
place even though the regulations are not explicit on having V&V. IDD encourages 




6.2.4 Feedback from Experts on IDD Model (Strategy)  
Focusing on Step 3, Strategy contains two processes Deploy and Review. Each process 
has a number of related strategies. The experts were asked questions such as:  
What strategies do team members use to deploy projects in your organisation? 
 
After reviewing IDD, the experts provided feedback (Appendix 7). The feedback was 
analysed and a number of themes emerged. 
 
The following Sections 6.2.4.1 to 6.2.4.4 discusses the more frequent themes identified 
in terms of the expert’s opinion of their impact on IDD. 
 
6.2.4.1 User Involvement 
Having a user involvement strategy was deemed necessary by the experts. “Be clear to 
people the benefits and that it will make working life more efficient” (Expert opinion Role: 
Lecturer Clinical Therapies). 
“Highlight advantages of this new system and it helps to have a flag bearer in the team 
to start using it and then they can help with problems”  
   (Expert opinion Role: Physiotherapist and Lecturer) 
 “Balance between force and encouragement to use. Give extra time for people to as-
similate how to use it. Allow for the possibility to make changes as needed to adapt to 
needs. Highlight advantages of this new system Have mentors”  
(Expert opinion Role: Software Engineer) 
User involvement is central. IDD encourages user involvement throughout the model 
from the beginning to the end. 
 
6.2.4.2 Training 
The experts recommended the training strategy be expanded in IDD. “Training and 
education vital for success and rolling progression” (Expert opinion Role: Software 






The experts recommended the audit strategy be expanded in IDD to the main areas 
namely: Identification, Ideation and Strategy.  
“My organisation has teams dedicated to monitoring the health status of the deployed 
projects. In case of issues these teams need to try to react to mitigate the issue or to 
involve developers to try and find a long-term solution”  
     (Expert opinion Role: Software Architect) 
To conduct an audit, input is needed from all relevant stakeholders. IDD encourages 
collaboration through multidisciplinary teams and early engagement with relevant 
stakeholders. This creates buy-in and vested interest in project which in turn makes the 
gathering of inputs easier.  
 
6.2.4.4 Consolidate  
The existing consolidate strategy was confirmed as important by the experts. 
“Consolidation of features, changes and improvements is definitely important and should be 
taken into account at every step” (Expert opinion Role: Software Engineer). IDD 
acknowledges the importance of consolidation to move forward in projects. 
 
6.2.5 Evaluation Impact on IDD Model  
The findings as discussed in the previous sections displayed that after analysis of IDD 
by experts the vast majority of the processes and strategies remain. A number of 
additions and amendments were made. The data analysis revealed emerging themes 
which were discussed. The recommendations from the experts were incorporated into 
development of the final IDD model (Figure 6.1). As there is a lot of content in Figure 
6.1 and to aid in the readability of the final IDD model it is broken down into sections 
(Figures 6.1a, 6.1b and 6.1c). Arrows in the figures connect relevant sections as 
sometimes sections need to be revisited depending on project outcomes.   
 
A number of key points were raised, for example, areas such as risk and communication 
were discussed by many of the experts (Table 6.2). This therefore added relevancy to 
these areas remaining in IDD. The key points were assimilated into the final version of 
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Figure 6.1c: IDD Model Section 3 
 
In summary, the experts confirmed a number of the existing processes and strategies, 
such as brainstorming which was a positive confirmation of IDD. The experts also 
recommended the addition of new strategies that did not exist in IDD such as audit. 
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They also recommended a number of extra practices that can be employed to carry out 
a strategy more successfully. Lastly the model lacked decision points for better 
readability. Review and audit strategies were added to IDD to enable more points for 
informed decisions to be made. 
 
6.3 Conclusion  
In Stage 4 of this research external opinions from health experts facilitated the 
evaluation of IDD-V3. The experts ranged from clinicians to engineers who worked on  
health projects. The experts were presented with a copy of IDD-V3 to gather their 
opinions and feedback. The opinions and feedback confirmed the IDD processes and 
also a number of the related IDD strategies. New strategies were added to IDD such as 
auditing. 
 
The evaluated IDD model can be used for the development of HIS software. The 
processes and strategies are useful as a guide to team members be, they leaders, 
practitioners, developers or implementers. This evaluated version of IDD is presented 












Chapter 7 Description of InnoDesignDeploy (IDD) Model  
 
7.1 Introduction  
This chapter presents the final version of IDD that can be used for innovation, design 
and deployment tasks undertaken when developing HIS. IDD has been refined during 
various Stages of this research. IDD is structured into three levels (Figure 7.1). Level 1 
denotes the three main project steps, identification, ideation and strategy. Level 2 
denotes the key processes within each step. Level 3 denotes the related strategies that 
can be employed to implement each process. IDD is a versatile, comprehensive and 
concise. It can be used: 
• with an existing Software Development Life Cycle (SDLC); 
• or as an entire SDLC to build a HIS. 






Figure 7.1: IDD 
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7.2 Structure of IDD Model 
Within IDD there are 3 steps that contain processes (Figure 7.1). There are processes 
(P1 to P11) to be addressed during a project. Each process has related strategies. 
Processes are made up of strategies to guide teams in the implementation of processes. 
These strategies are guidelines which can be used by teams as an aid when developing 
HIS. 
The structure of IDD involves strategies for team members who perform processes 
(Figure 7.2). The model is broken into three steps, which can be viewed by different 
team members such as Leaders, Practitioners, Developers and Implementers.  IDD uses 
an iterative strategy such as scrum to split the development of the software into fixed 
time sequences of repeated iterations. The key topics used are as follows: 
• A process is an area of work to be done; 
• Strategies are guidance on areas of work used to implement processes; 
• Decisions are used to illustrate various outcomes of processes; 










Figure 7.2: Structure of IDD
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Figure 7.2 shows the Identification step which has processes and strategies applicable 
to begin a software project. Within Identification, the key team member is the leader 
and their role involves performing the processes entitled Understand, Inspire, Support 
and Recognise (Figure 7.3). A leader has four main tasks:  
• To plan and scope a project; 
• To enable team members and maintain a project; 
• To facilitate the realisation of a project; 
• To monitor a project and be proactive to any required changes. 
Depending on the project, a leader can be a project manager, a senior manager, a 
clinician, or a senior software engineer. An organised person is required to scope, 
manage and drive a project by enabling team members to carry out assigned work. 
Teams can comprise of leaders, practitioners, developers and implementors. Leaders 
must collaborate with multiple stakeholders such as end users or clinicians, have the 
ability to be proactive to change, prioritise work and risk as well as encourage team 
members to work effectively. On a project there might be the need to quickly adapt to 
changes on the direction of work in a project or requirements that may be not 
deliverable. In such cases the term fail fast, fail early is used. This means it is better to 
acknowledge something is not working earlier rather than later in a project. This could 
result in the project not continuing or a change in direction of a project. The ability to 
deal with a change in project direction quickly is further confirmed by the successful 
industrial use of Agile practices, which also enables projects to be more flexible to 
changing or evolving needs. Any changes in direction of projects should be reviewed 
to determine if there are lessons to be learnt that can be used in other projects. 
As a project progresses and with feedback from the team in terms of reviews and audits, 
a leader manages iterations, reworks, deployment and if necessary, cancellation of 
projects. The Initiate/Understand process starts IDD. The processes Inspire, Support 
and Recognise are carried out at the start of a project but they are also run in parallel to 
the all the other processes carried out. The reason for this is that the leader must at all 
times manage the project. For example, the leader must always strive to fully 
understand, inspire, support and recognise necessities within the project. The leader is 





Figure 7.3: Leader Perspective within IDD 
 
Within the Ideation step (Figure 7.4), a practitioner generates a concept that adequately 
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Figure 7.4: Practitioner perspective within IDD 
 
 Within a project a practitioner has three main tasks: 
• To identify a need; 
• To validate if a need identified requires innovation; 
• To generate a concept or prototype. 
This requires a person who is creative and prepared to take appropriate risks. This 
person should be able to communicate effectively and also be able to listen when 
required. Like a leader, a practitioner can be a project manager, a clinician, a user or a 
software engineer. The role also requires collaboration with multiple stakeholders such 
as end users or clinicians, the ability to be proactive to change and the ability to 
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prioritise work and risk. The practitioner role is used to identify needs and generate 
concepts. Multidisciplinary teams are recommended to ensure multiple viewpoints to 
aid successful innovation. Practitioners carry out audits to keep on track. Leaders also 
audit the project progress to decide if the project can progress or if more work is needed 
before progression to development.  
Developers develop and test software. A developer (Figure 7.5) can take a concept and 
produce a software design, then develop and test it. The developer has three main tasks: 
• To design software from a concept and develop it into an innovation; 
• To validate an innovation; 





Figure 7.5: Developer Perspective within IDD 
 
This requires a person who can communicate and listen effectively as part of team, can 
deal with changes as they occur and has development skills to quickly deliver software 
and if needed take risks. Developers could be software designers or software testers 
who work with practitioners. Developers carry out audits to keep on track. Leaders also 
audit the project progress to decide if the project can progress or if more work is needed 
before progression to deployment.  
Implementors deploy software. An implementer (Figure 7.6) can deploy a software 
innovation and review its installation. The implementer’s main tasks are: 
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• To deploy a software innovation; 
• To install a software innovation; 
• To review the software installation.  
 
 
Figure 7.6: Implementer Perspective within IDD 
 
It requires a person who can communicate effectively. This person must be able to work 
with different types of stakeholders such as end users to successfully deploy a software 
innovation. Any changes required by users should be conveyed effectively by the 
implementor to other relevant team members. Implementors need be able to work with 
their team members to convey any changes required by end users. Implementors should 
enable end users to successfully use the software innovation that has been developed. 
Implementers could be software designers, software testers and users. Implementers 
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can also be practitioners and developers. Team members having multi-roles in projects 
typically happens where resources are limited, for example, in start-ups. Therefore in 
some cases team members can have multiple perspectives in a project.  
The importance of teams and the various types of roles is acknowledged in IDD in 
terms of teamwork. In software design teamwork is essential. In terms of IDD some 
team members can have different or multiple roles. Some common characteristics 
necessary are good communication skills and the ability to take appropriate risks. There 
is one important point to note, while the assigning of team members to multiple 
different roles does increase knowledge and expertise, this should only be done with 
experienced team members. Multidisciplinary teams are recommended to aid 
successful innovation. The selection, motivation and assignment of tasks to teams are 
important and the leader must manage people, processes and tasks using the relevant  
model strategies, such as providing relevant training and creating a vision for the 
project.  
Time is acknowledged in IDD. The more experienced the team member, the better and 
more accurate the time estimation for the project overall. Additionally, project plans do 
not always go according to plan so continuous iteration is facilitated in IDD using 
review and audit processes. For example, the leader manages any new requirements 
during the development (for example, a scrum) and will not allow the team members 
to take on any new requirements. This protects the team to allow them to concentrate 
on the development task at hand. Another iteration might have to be planned to add 
such new requirements depending on the time the new requirements arrive and the point 
in which the team are in the project. This management of protected time enables teams 
to work more effectively and with less distraction. Projects can run overtime; it is up to 
the leader to make strategic decisions about how to manage such eventualities. For 
example, a leader can prioritise some core features of a project which may have to be 
implemented sooner, and move some lower priority features to later versions. This 
needs to be communicated as early as possible and effectively to users so that they are 
aware of contents of each version. Changes such as this can be managed effectively if 
users are kept up to date as this manages expectations.  
People are at the core of any software development process. As seen in the literature 
review, failures in software can be linked to people factors such as a lack of effective 
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user engagement or a lack of understanding of the different types of stakeholders 
involved. Also, people come to projects with various skills, priorities and levels of 
experience. This can have an impact on how well task duration is estimated to be and 
on the estimation of the difficulty of a task. This needs to be effectively managed for 
both the person’s needs and the project needs, as both can be negatively impacted. IDD 
has various strategies such as using multidisciplinary teams, collaboration and 
immersion in problem areas with relevant stakeholders, to maximise user involvement. 
Having an expert leader is necessary to manage such complex situations as having team 
members working multiple roles. 
 
7.3 IDD Processes 
IDD is comprised of processes. The processes are cyclical and iterative. Each process 
has underlying strategies. Each process will be discussed in terms of significance (what 
is to be done), the relevant strategies (practices to implement) associated with it and the 
expected outcome of the process. Within each process a table is presented which shows 
a sample source of evidence. 
 
7.3.1 Process 1: Initiate/Understand   
The starting point of IDD is the Initiate/Understand process. At the outset projects have 
to be scoped and well defined. This process is relevant to leaders of projects who 
manage projects and facilitate progression to completion. Leaders facilitate innovation 
by creating a conducive environment in which to successfully innovate. The aim of this 
process is to answer four questions. Why, what, who and how as follows (NSAI 2009): 
• Why do we need to do more? 
• What new thing should we do? 
• Who do we need in the team? 
• How are we going to do this? 
Before beginning any innovation, a clear understanding of areas such as the team 
capabilities, the market, the opportunity, the potential risks and the potential rewards is 
needed. This is significant as a clear understanding of these areas allows a leader to 
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prioritise effectively. To aid in the execution of this process there are a number of 
strategies can be employed.  
Strategies to implement the process 
The ability of the leader and the team need to be assessed (See Number 1, Sample 
source of evidence in Figure 7.1). A clear understanding is needed of areas such as the 
team capabilities (skills), the leader’s capability, the market, the opportunity, the 
potential risks and the potential rewards. 
The market that the potential innovation will serve needs to be understood (See Number 
2, Sample source of evidence in Figure 7.1): 
• What regulations are relevant to the market? 
• Is there existing competition? 
• What is the presence and nature of competition in the area to be addressed with 
the potential innovation? 
• What are the number and characteristics of the people in the target market? 
• What is the capacity and willingness to pay of the potential payers? 
 
All of these questions directly affect the viability of pursuing a particular innovation as 
financially they affect the innovator’s ability to commercialise an innovative solution. 
Opportunities such as licencing and patenting should be assessed (See number 3, 
Sample source of evidence in Figure 7.1). Barriers, risks and benefits should be outlined 
(See Number 4, Sample source of evidence in Figure 7.1). Bring as many stakeholders 
together as possible to perform risk analysis and gather the different points of view (See 
Number 5, Sample source of evidence in Figure 7.1). Consultation and collaboration 
can facilitate the formation of coalitions which in turn can empower buy-in. Available 
budget and potential costs should be scoped. These are questions that have to be 
answered to complete the process Understand. The leader identifies the relevant 
stakeholders and begins consultation and collaborations with key stakeholders to 
understand the market potential. A leader cannot inspire people if he or she does not 
understand the needs of the project or the domain.  
Projects should follow appropriate processes such as a time limited iterative strategy 
(See Number 6, Sample source of evidence in Figure 7.1).  
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Number Area Origin of Strategy Example of Relevant 
Quote/Author 
1 Team Capabilities Literature Review 
Medical Practice Case 
Evaluation of IDD 
“Evaluate what you need and 
what you have in a team” 
2 Market/Area Literature Review 
Medical Practice Case 
Evaluation of IDD 
“Don’t be a technology trying 
to find a market” 
3 Opportunity Literature Review 
Medical Practice Case 
Evaluation of IDD 
“Find a valid opportunity” 
4 Risks/Rewards Literature Review 
Medical Practice Case 
Evaluation of IDD 
 “Some opportunities are 
costly to bring to market but 
the rewards are big” 
5 Consultation and 
Collaboration 
Literature Review 
Medical Practice Case 
Evaluation of IDD 
Kuziemsky et al (2019) 
McCaffery et al (2016a) 
6 Review Evaluation of IDD  “Without review then no win 
later” 
Table 7.1 Sample Source of Evidence 
 
Expected outcome  
After completing process Understand, the leader can then review it. On review, the 
leader and the team’s relevant skills and weaknesses are identified. The potential 
market is scoped so as to uncover the relevant opportunity and the related risks. Barriers 
to entry, if any, are identified. Early engagement with stakeholders allows for further 
collaboration later in the project. When a leader feels sufficiently equipped with an 
understanding of the area, he or she can progress to the Inspire process. If, on review, 
there are areas found to be lacking then the Understand process is repeated. Before 
proceeding the objectives must be reviewed to check if they were achieved and if not 
the work needed to complete them must be scoped.  
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7.3.2 Process 2: Inspire  
The process of inspiring teams starts with the team leader who empowers teams to reach 
their potential. How do leaders inspire teams of people? The most common way leaders 
inspire is by effective communication of a common goal to a team. Leaders have to also 
be aware of influences on teams from an organisation, which can be positive or negative 
such as skills and resources. 
A clear understanding of areas such as the team capabilities, the leader’s capability, the 
market, the opportunity, the potential risks and the potential rewards are inputs to this 
Inspire process from the Understand process. If, during this process, it becomes evident 
that the inputs needed are not clearly identified then the process Initiate/Understand 
must be revisited and the change should be planned by the leader.  
Strategic focus is crucial to the success of a project and one way to begin to create focus 
is to define a mission statement. A mission statement along with acceptance criteria is 
an explicit decision on what area(s) to focus on and this focus has, for innovators, 
different risks, challenges, and potential rewards. 
Teams are encouraged to devise a mission statement and acceptance criteria. The 
mission statement and the acceptance criteria are used throughout the project to keep 
the teams centred as to the main aim and goal of the project. The criteria will differ 
from project to project. The criteria to be defined by teams can be identified as must 
have features of an innovation.  
Strategies to implement the process 
Creating a vision sets out a purpose or a common aim for a team (See Number 1, Sample 
source of evidence in Figure 7.2). A mission statement defines the scope and goal for 
the team. An example of a mission statement: 
• To bring to market in 2 years a device (hardware and software) to allow emer-
gency services to access relevant patient information remotely and securely.  
 
Acceptance criteria facilitate decision-making as it sets boundaries for inclusion and 
exclusion (case study Medical Practice, expert opinion and Zenios et al 2010). Each 
project will have different priorities such as time, cost, privacy and security etc. An 
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example of acceptance criteria: 
• The proposed innovation must facilitate secure timely access to patient data. 
 
Multidisciplinary teams, coalitions and collaboration aids innovation by bringing many 
different viewpoints together (See Number 2, Sample source of evidence in Figure 7.2). 
For multidisciplinary teams and collaborations to work the leader must be cognisant of 
the different priorities and opinions that have to work together (such as clinician’s 
professional autonomy where the main priority is patient care over system use). A 
clinician will not use a system that is not easy and quick to use (literature review IDD-
Requirements and case studies medical practice and hospitals). Each team members’ 
responsibilities should be clearly defined as this aids in managing expectations. 
A multidisciplinary approach is important as with teamwork and collaboration there are 
different perspectives and viewpoints. This is the reality of innovation. Therefore, it is 
important that these learnings are taken into consideration in implementing the 
guidelines. Multidisciplinary teams and collaboration are important in process and 
learning evidenced in Blake et al (2010) and Kuziemsky et al (2019). 
Leaders should identify the different stakeholder’s definition of success. The aim 
should be to increase trust with reviews throughout the project of the planned outputs. 
Stakeholders such as clinicians are reluctant to use systems where quality is not assured 
(case study hospitals).   
• Regular meetings with various stakeholders allow them to feel their opinions 
matter to the project. If a stakeholder does not feel their input is recognised, they 
can become disengaged and projects could in turn miss key requirements. 
 
Fostering good communication and empowerment aids creative thinking by building 
trust to listen to all ideas (NSAI 2009, case study Medical Practice, Kotter 2005, 
literature review IDD-Requirements, case study hospitals and expert opinion). 
• The leader should clearly define the responsibilities of the various stakeholders 
(case study Medical Practice and hospitals); 
• Communication must be two way between stakeholders and the leader. Listen-
ing is a crucial part of two-way communication. Good communication aids good 
teamwork (See Number 3, Sample source of evidence in Figure 7.2). Teams 




Team competencies must be managed effectively. If the project budget allows for a 
separate manager for team competencies then the leader can provide this to teams. If 
this is not possible the leader should manage the team competencies. To manage team 
competencies the main focus is on facilitating teams to have sufficient competence to 
carry out their tasks. It empowers teams to feel their needs are important (expert opinion 
and researcher experience in industry). A leader and a team (or in collaboration with a 
competency manager) can identify what training or professional development 
programmes are required. Having a separate competency manager can also reduce the 
work burden on the leader so that they are free to devote more time on other aspects of 
a project. From a cost perspective this does not require a full time position. Education 
and professional development can empower teams, raise moral and reduce apathy (case 
study Medical Practice). 
To facilitate team creativity, divergent and convergence thinking is followed. This is 
called the Osborn-Parnes Creative Problem-Solving Process (CPS). This was 
introduced to the researcher during the medical practice case study and it is 
recommended by expert opinion and the NSAI (2009). The CPS typically follows the 
behaviour of looking far and wide for a lot of inputs (diverging) then distilling that 
information into meaningful chunks that can be understood (converging). The CPS 
process can be used multiple times throughout various parts of IDD as it facilitates and 
complements the innovation process. It allows a team to look at the overall area to get 
a big picture perspective and then narrow down to specific areas. CPS recommends 
diverging and converging at every stage not just when brainstorming/solution finding. 
An example of divergent and convergence thinking is if a team is trying to generate a 
concept to address a need, such as HIS for use in a third world country that has areas 
with poor electrical power. They might diverge and look at how other industries have 
addressed electrical power shortages in third world countries and then converge to look 
at the energy costs of implementing various software functions. 




Number Area Origin of Strategy Relevant Quote/Author 
1 Mission/Vision Literature Review 
Medical Practice Case 
MD Industry Case 
Evaluation of IDD 
NSAI (2009) 
Yock et al (2015)  
2 Multidisciplinary Teams 
and Collaboration 
Literature Review 
Medical Practice Case 
Hospital Case 
Evaluation of IDD 
Blake et al (2010) 
Kuziemsky et al (2019) 
 
3 Communication and 
Empowerment 
Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
 “Have a clear communication 
strategy” 
 
4 Review Evaluation of IDD “Without review then no win 
later” 
Table 7.2 Sample Source of Evidence 
 
Expected outcome  
Teams are brought together from multiple backgrounds by the leader and all members 
communicate effectively. The leader and the team members have a clear set of goals in 
terms of a mission, vision and criteria for defining limits to scope the project. If this is 
not the case the leader must address any shortcomings that emerge on review and this 
might necessitate a repeat of this inspire process before proceeding to the support 
process. 
 
7.3.3 Process 3: Support 
Teams need to be supported in projects. Leaders are the enablers for teams. Leaders 
provide support in the form of processes for guidance on tasks as well as arranging 
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necessary and appropriate training. 
To successfully manage innovation, leaders need effective procedures and tools in place 
to aid teams in their goal. 
Strategies to implement the process 
A clear understanding of the needs of a team is essential. A leader must provide the 
processes/procedures and tools required to facilitate teams (See Number 1, Sample 
source of evidence in Figure 7.3).  
Regulations assert that processes/procedures should be used but do not state which one 
to use (literature review). Some companies have policies is place which state which 
procedures to use (expert opinion). The leader should communicate to the team what 
processes are relevant to the project. The leader should also review chosen processes 
and establish that they are adhered to (literature review IDD-Requirements, case studies 
medical practice, MD company and hospitals). The use of defined processes and 
procedures are useful and needed for regulatory compliance. Relevant regulatory 
requirements identified for compliance of HIS should be reviewed regularly to maintain 
compliance (literature review IDD-Requirements).  
Use a software enabled document management tool to ease the management and 
visibility of documents. The advantage of such tools is that documents are secure and 
workflows can be automated for approvals (case study MD company and expert 
opinion). This aids regulatory compliance also as documents are more readily available. 
This repository for relevant documents must be readily available to teams and it must 
be always up-to-date. 
Tools such as adequate and timely training allows teams to reach their potential (See 
Number 2, Sample source of evidence in Figure 7.3). Reviewing best practices in other 
countries can be useful in deciding the relevant training needs (expert opinion). 
Technology needs to be assessed so that there is effective use of technology (expert 
opinion). Leaders can initiate reviews to be undertaken of available technology options. 
Systems also need to be assessed so that they are interoperable, how do different 
technologies work with and impact, existing systems (literature review IDD-
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Requirements, expert opinion). 
A clear definition of success for the relevant HIS is needed (See Number 3, Sample 
source of evidence in Figure 7.3). The definition can be different for each relevant 
stakeholder so this needs to be defined and reviewed.  
Number Area Origin of Strategy Relevant Quote/Author 
1 Processes Literature Review 
Medical Practice Case 
MD Industry Case 
Evaluation of IDD 
 “The manner in which the 
change process occurred” 
2 Training Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case  
Evaluation of IDD 
 “Training should be relevant 
and timely” 
3 Review Literature Review  
MD Industry Case 
Evaluation of IDD 
 “Key people should be 
involved in the review process 
and it should be two way” 
Table 7.3 Sample Source of Evidence 
 
Expected outcome  
Teams are given guidance on relevant tasks within the project and are supported in 
carrying out the tasks by the provision of processes/procedures, tools and training 
where needed. If this is not the case then a review of the completed processes so far can 
facilitate the project in moving forward. For example, if it emerges that the chosen tools 
are not sufficient the leader and the teams can review the process to gain insight into 




7.3.4 Process 4: Recognise  
Recognition of project risks, the needs of teams as well as the overall project is 
important. This is useful to enable a proactive rather than a reactive approach to 
potential risks. Leaders must recognise the need to empower and encourage teams to 
reach their potential and to be creative. They have to recognise and encourage teams 
while balancing risk such as time and budget constraints.  
Strategies to implement the process 
Risk assessment must include a review of all potentially impacted stakeholders and all 
the relevant issues such as a knowledge of regulatory constraints, patient data privacy 
and security needs. Reviews of potential risks and the creation of plans to address such 
risks should be well documented. Team members responsibilities in addressing 
identified risks should also be documented (See Number 1, Sample source of evidence 
in Figure 7.4). 
Teams must work towards a common outcome. Teams members must know the 
definition of success in relation to the vision so that their activities and decisions are 
more informed (See Number 2, Sample source of evidence in Figure 7.4). The vision 
is different from the mission statement, in that the mission statement is usually more 
specific. 
Innovation does not happen without taking risks and good risk taking should be 
encouraged (See Number 3, Sample source of evidence in Figure 7.4). Note the word 
‘good’ risk taking. This is very important that the teams are shown the difference 
between good and bad risk taking by the leader. This is helped when a team are all 
aware of the vision and mission of the project and that they have goals to reach the 
common endpoint. 





Number Area Origin of Strategy Relevant Quote/Author 
1 Risk Assess Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
 “Sometimes giving people a 
longer leash to take risks 
without penalties of failure, 
this allows people to try 
things” 
2 Outcomes Medical Practice Case 
MD Industry Case 
Hospital Case  
Evaluation of IDD 
”Defined outcomes are 
beneficial to everyone (doctor, 
patient, health system). 
Everyone wins if used 
properly”  
3 Risk-Taking Medical Practice Case 
MD Industry Case 
Hospital Case  
Evaluation of IDD 
 “Encourage staff to think the 
unthinkable” 
 
4 Review Evaluation of IDD  “Without review then no win 
later” 
Table 7.4 Sample Source of Evidence 
 
Expected outcome  
Potential risks are assessed and documented with relevant responsibilities assigned to 
team members. The teams are aware of what a successful outcome is, in terms of the 
project. Team members are facilitated in taking risks to complete the vision of the 
project. An example of risk taking seen during the case study stages of this research 
was where teams were allowed to reduce their time working on projects by spending 
four hours a week on a separate project of interest to them and was significant to the 
project as the team members became more motivated and worked more effectively in 
less time. It was a risk that had a positive outcome. Another example was allowing 
teams to spend time looking at related failed innovations. One team was also able to 
find an innovation that could be reworked and used for a current project.  
When team members take risks to complete the vision of the project then the next stage 
of IDD can be followed which deals with practitioners identifying and generating 
concepts for development. If on review this is not the case, then the process should be 
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repeated to address any identified shortcomings in preventing project progression. 
The leader is involved with reviewing all subsequent processes and depending on the 
expected outcome of each a decision is made as to proceed or not (go/no-go).  
 
7.3.5 Process 5: Identify 
Teams such as practitioners are immersed in the problem area and engage with relevant 
stakeholders such as users. Needs are identified so as to create potential solutions, in 
the form of concepts. To facilitate the creativity required at this crucial stage in 
innovation the CPS divergent and convergence thinking is followed. This involves an 
examination of the broad area for innovation, then narrowing the focus to the core of 
the need (NSAI 2009, Bjögvinsson et al 2012, case study Medical Practice and expert 
opinion). Teams use detailed plans, so that every team member knows what is expected 
and when. Knowing what is expected allows for team members to take responsibility 
and be empowered in their work.  
Strategies to implement the process 
If possible a pilot project can be used to test the viability of a project (case studies MD 
industry and Medical Practice).  
Immersion involves observing stakeholders such as patients and healthcare 
professionals in a range of clinical settings such as outpatient appointments. This puts 
the potential users at the centre of the innovation process. During immersion, 
observations are made on how a variety of stakeholders interact such as clinicians with 
patients. This is an opportunity to identify and document the challenges that are 
encountered (See Number 1, Sample source of evidence in Figure 7.5).  
Sometimes budgets are limited and cannot facilitate full immersion of practitioners. 
Immersion can also be carried out by reducing immersion to, for example, 1 week with 
the addition of stakeholder interviews and industry mapping (NSAI 2009). Immersion 
in a problem area is a way of getting as close as possible to problems and to see first-
hand how such problems impact users. Identifying a need is a core outcome as 
innovation cannot take place if there is not a need that should to be addressed. 
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Immersion facilitates needs finding by the team members who observe healthcare 
situations (See Number 2, Sample source of evidence in Figure 7.5). 
Team members document, refine and screen needs as they gather more information and 
understanding of needs and problems that exist in the area of observation (See Number 
3, Sample source of evidence in Figure 7.5). 
Leaders can organise mentorship for teams. Teams can benefit from mentorship by 
experienced peers (case study Medical Practice). 
Communication is important throughout all the steps in IDD but especially during this 
process as teams are meeting with potential users. Communication needs to be open 
and share information as much as is feasible to reduce uncertainty as much as possible.  
Having a champion for change (case study MD industry, expert opinion) can aid in 
changing behaviours. Champions can offer to help colleagues but also 
acknowledgement of the work of their colleagues must be done too. 
At this stage an audit (See Number 4, Sample source of evidence in Figure 7.5) is 
carried out which is more detailed than a review. It involves relevant stakeholder 












Number Area Origin of Strategy Relevant Quote/Author 
1 Immersion Literature Review 
Medical Practice Case 
Evaluation of IDD 
 “Immersion worked very well 
for us but it has to be done 
properly” 
2 Needs Finding Literature Review 
Medical Practice Case 
Evaluation of IDD 
 “You have to be aware that 
sometimes problems exist that 
will never have a viable 
solution” 
3 Needs Screening Literature Review 
Medical Practice Case 
Evaluation of IDD 
 “Staff must be able to bring 
issues to a manager’s attention 
and there must be an 
atmosphere and environment 
of problem solving to 
highlight relevant needs to 
pursue” 
4 Audit Evaluation of IDD  “Auditing or quality risk 
department should sign off on 
any new changes” 
Table 7.5 Sample Source of Evidence 
 
Expected outcome  
Team members identify relevant needs to progress to the next stage of concept 
generation. If this is not the case then the process needs to be repeated before continuing 
to the next process.  
 
7.3.6 Process 6: Generate 
The generation of innovative ideas is crucial; this process builds on the previous 
processes, which ultimately provide insight to the potential gap to be addressed, and 
the skills and knowhow to achieve this.  
At this stage team members can start to look at potential concepts to address the 




Strategies to implement the process 
Methods to aid concept generation are used such as brainstorming, prototyping, mind 
mapping or Osborn-Parnes Creative Problem-Solving Process (See Number 1, Sample 
source of evidence in Figure 7.6).  
Brainstorming in a space allocated to facilitate creativity (See Number 2, Sample source 
of evidence in Figure 7.6) can produce concepts. Open plan offices are not conducive 
to brainstorming as it can disturb other teams.  
Prototyping with low fidelity tools such as cardboard (See Number 3, Sample source 
of evidence in Figure 7.6). Prototyping is crucial to facilitate users and practitioners to 
gather complete requirements as it allows for feedback from users.  
To validate the feasibility of a concept, a number of factors have to be taken into 
consideration such as the cost of a concept, who will pay for it and the intellectual 
property (IP) landscape. Teams spend time learning about these factors which are 
considered in great detail. This is sometimes called a deep dive in start-up companies  
 
Pitching generated concepts to mentors can aid in refinement of concepts (case study 
Medical Practice). (See Number 4, Sample source of evidence in Figure 7.6).  
 
An audit (See Number 5, Sample source of evidence in Figure 7.6) is carried out 














Number Area Origin of Strategy Relevant Quote/Author 
1 Concept Finding Medical Practice Case 
 
Evaluation of IDD 
 “Finding concepts are 
dependent on the person’s 
knowledge” 
2 Brainstorming Medical Practice Case 
 
Evaluation of IDD 
 “Look for good ideas” 
3 Prototyping Medical Practice Case 
 
Evaluation of IDD 
 “Prototyping is important as it 
help visual learners to know 
this is going to happen” 
4 Concept Screening Medical Practice Case 
 
Evaluation of IDD 
 “Within healthcare what is 
feasible, practical and 
workable” 
5 Audit Evaluation of IDD  “Team members are free to 
propose enhancement” 
Table 7.6 Sample Source of Evidence 
 
Expected outcome  
A potential concept that is ready for development. If that is not the case at this stage 
then iteration can be used to repeat the generate process as required. If that does not 
facilitate a potential concept then the project may repeat the Identify process. If there is 
no potential concept produced then the project should be reviewed. This is termed fail 
fast, fail early. It is better to end a project that is not showing progression earlier rather 
than later. This allows for resources such as time and money to be saved. The team 
could then be free to work on another project in a similar area and not lose the 
competences they have gathered so far. The projects should be reviewed in terms of 
lessons learnt that can be used in other projects. 
 
7.3.7 Process 7: Design  
The design process deals with developing the solution and is carried out by developers 
and should be flexible and open to user involvement in a similar way to the Identify 
process discussed earlier. User involvement is an aid to development and a feedback 
mechanism to stay on track.  
Following the literature review, which included examples of software failures and cost 
overruns where traditional plan-based development were followed such as the V-model 
or the waterfall model, agile practices are recommended here due to its iterative and 
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flexible nature. There is a move towards utilising agile practices more in health projects. 
This acknowledgement of the need for a process that is iterative and includes agile 
practices adds legitimacy to this research. In IDD the development of the software is 
broken down into fixed time sequences of repeated iterations.   
If a project has to use SDLC model, such as the V-model, IDD adds relevant strategies 
that can still be used, such as daily meetings similar to agile daily scrum meetings. 
Strategies to implement the process 
The production of detailed design specifications to include relevant regulatory 
requirements (See Number 1, Sample source of evidence in Figure 7.7). Within the 
design process the following tasks are completed: 
• Produce documentation only that has value and that is required;  
• Define how such documentation is written and controlled;  
• The implementation must be designed with the regulatory requirements consid-
ered for compliance; 
• Tasks such as automated testing, daily builds, daily scrum meetings, retrospec-
tive and reflection strategies, root cause analysis, backlog management and con-
tinuous integration are planned. 
 
A SDLC methodology that suits the project is chosen and where possible it is 
recommended to use agile practices as this provides greater flexibility (expert opinion) 
and has the ability to change direction quickly if needed. A plan is needed to choose 
the most appropriate (See Number 2, Sample source of evidence in Figure 7.7).  
 
Break the proposed design down into small manageable parts or features for 
development. At each iteration in the design of an innovation a quality audit check must 
be carried out. For example, is the innovation adhering to relevant regulations? Will the 
innovation be secure? How is data managed? Can the innovation be used with another 
HIS?  
 
Use Agile practices such as daily scrum meetings for planning. Daily scrum meetings 
are useful for the team members to discuss progress on tasks, problems and risks. Agile 
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scrum planning involves a team member acting as a scrum master to drive and plan 
tasks. Leaders will not allow any new requirements to be added at this stage so as not 
to distract the team. The leader and the team identify which iteration poses the most 
risk to the project and carry out this first.  
 
Use regulation adherence tools so that innovations are regulatory compliant. 
Traceability is important from a regulatory perspective as regulation adherence can be 
tracked with traceability. 
 
An audit is undertaken (See Number 3, Sample source of evidence in Figure 7.7). 
Number Area Origin of Strategy Relevant Quote/Author 




Medical Practice Case 
 




Evaluation of IDD 
“Design around healthcare 
environment, what’s 
available, ease of adaption, 
feasibility and practicality” 
 
2 Plan Literature Review 
 
Evaluation of IDD 
“If effective planning means 
the waterfall project 
management, I don’t think 
that is still a good way to plan 
a project. Agile 
methodologies have shown to 
be much more effective” 
3 Audit Evaluation of IDD “Have an audit trail” 
Table 7.7 Sample Source of Evidence 
 
Expected outcome  
Detailed specifications are created that can be used in the Develop process. If the 
specifications are seen to be incomplete or inadequate then the leader can choose to 
repeat the Design or the Generate processes. 
 
7.3.8 Process 8: Develop 
The Develop process is the implementation of the design. It is similar to the design 
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process as it should be flexible. The ability to develop with as much flexibility as 
possible is required at this stage. Agile practices such as scrum development are again 
recommended (expert opinion). Additionally, at each iteration in the design and 
development of an innovation a quality audit check must be carried out.  
Strategies to implement the process 
Track, Iterate, Release and Report are agile strategies used in other regulated industries, 
such as telecoms, that can be utilised in healthcare also (expert opinion). Track the 
project, iterate when needed, release to test and report progress or issues. Track by 
prioritising and discussing the team's work (See Number 1, Sample source of evidence 
in Figure 7.8). Release and report to the testing process for verification and validation 
(See Number 2, Sample source of evidence in Figure 7.8).  
Time is also an important factor throughout but it is especially crucial at this point also. 
Team members time must again be protected and no new requirements added at this 
stage. This practice of protected time enables teams to work more effectively and with 
less distraction and stress (case study MD company and expert opinion). 
As the earlier Design process broke down the development into manageable parts this 
allows teams to quickly develop software for testing in the next process. 
Configuration management of developed software is important as different customers 
can have various versions of software. Also project teams working on software need 
version control to manage the software project. This can be achieved by using a 
software version control management tool. 
At each iteration in the development of an innovation a quality audit check must be 
carried out (See Number 3, Sample source of evidence in Figure 7.8). For example, is 






Number Area Origin of Strategy Relevant Quote/Author 
1 Track and Iterate Medical Practice Case 
MD Industry Case 
Evaluation of IDD 
“Tracking the development 
helps to keep each team 
member’s focus with his own 
work and without losing the 
final goal” 
2 Release and Report Medical Practice Case 
MD Industry Case 
Evaluation of IDD 
“Releasing and then report 
will then conclude the 
development process from the 
developer point of view” 
3 Audit Evaluation of IDD “Have an audit trail” 
Table 7.8 Sample Source of Evidence 
 
 
Expected outcome  
Software innovation ready for testing in the next process Verification and Validation. 
If that is not the case the design specifications should be examined to determine what 
is preventing progression of the software to the test phase. The project could repeat the 
Develop process or the Design process.  
 
7.3.9 Process 9: Verification and Validation 
Verification and Validation (V&V) involves checking an innovation does what it was 
required to, and functions as planned. Defining team and end user acceptance criteria 
and test cases are useful tools in V&V. End user acceptance criteria can be very 
different to team members acceptance criteria.  
At each iteration a quality audit check must be carried out.  
Strategies to implement the process 
Design of detailed testing specifications (expert opinion) to test the innovation. 
Specifications should test the software does what it is supposed to do while also 
producing the correct result. In keeping with agile practices only relevant and required 
documentation is produced. 
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Team members can have more than one role. In this phase it is advisable not to have 
the same developers that designed an innovation also be the testers. It is better to have 
a different person carry out the V&V process. This removes potential unconscious bias. 
Teams are made up of developers but it is preferable that the developers are specialised 
in testing and not the same developers from the develop process. It can happen, for 
example, in start-up companies where there are small teams and the same developers 
work in the develop process and the V&V process. In such a situation the developer 
should not test their own software but rotate and test another developer’s software. This 
aids in reducing bias. 
Verification through testing of the software innovation (See Number 1, Sample source 
of evidence in Figure 7.9). Verification testing differs from project to project. The aim 
of verification is that the software innovation functions as expected. 
Validation through testing of the software innovation (See Number 2, Sample source 
of evidence in Figure 7.9). Validation testing differs from project to project. The aim 
of validation is that the software innovation maintains the integrity of information (that 
it is correct). 
At each iteration after V&V of the software innovation a quality audit check must be 
carried out (See Number 3, Sample source of evidence in Figure 7.9). The software 
innovation must at all times adhere to relevant regulations, be secure and keep the data 
private.  
 
Include stakeholders (case study Medical Practice). This could be in the form of a 
project status update. Otherwise there is a gap in interaction with stakeholders before 
deployment and this can have a negative impact on morale of stakeholders and buy-in 








Number Area Origin of Strategy Relevant Quote/Author 
1 Verify Innovation MD Industry Case 
Evaluation of IDD 
“The verification of the 
project’s outcomes and the 
fact that they respect the 
requirements is very 
important, as well as 
validating them in real world 
application scenarios” 
2 Validate Innovation MD Industry Case 
Evaluation of IDD 
“Defining a good verification 
and validation process will 
help deliver a good quality 
product that can be easily 
improved in the future” 
3 Audit MD Industry Case 
Evaluation of IDD 
“Have an audit trail” 
Table 7.9 Sample Source of Evidence 
 
 
Expected outcome  
Software innovation verified and validated ready for integration and deployment. The 
software innovation must address criteria. If that is not the case the V&V process could 
be repeated and test specifications should be examined to determine what is preventing 
progression of the software to the Deployment phase. This might necessitate a repeat 
of the Generate, Design or Develop processes.  
As this is an iterative process, when a number of parts are ready for the next stage of 
deployment, then the parts should be integrated into a workable piece of software.  
 
7.3.10 Process 10: Deploy  
Software deployment involves installing a solution, namely a software innovation, as 
ready for use by intended users. Deployment is an important process as all too often 
projects are deployed in a way that does not suit the needs of the end users of the 
innovation. Through case studies it was identified that training provided for end user 
staff was usually scheduled at inappropriate times and not appropriate or relevant to the 
varying skills levels. End users were not involved enough so there was a lack of buy in 
which resulted in negative attitudes. There can be unintended consequences of 
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technology that need to be managed, such as a change in how users carry out their work 
practices. Change management techniques and user involvement are recommended. 
The objective of this phase is that the innovation meets the user needs and that it is 
successfully adopted. 
There are a number of innovations that fail, not because they are not good enough, but 
that the innovation or process is not deployed properly. As with the preceding processes 
putting the user central to the model is key. Without user buy-in most projects and 
processes can fail (expert opinion, case studies and Yock et al 2015). 
Strategies to implement the process 
A detailed plan for deployment that includes inputs from all relevant stakeholders. User 
involvement is critical at this point as an innovation is of no benefit if no one sees its 
use and uses it.  
Engage as early as possible with users to empower them and garner buy-in (See Number 
1, Sample source of evidence in Figure 7.10). This was initiated by the leader at the 
beginning of the project and stakeholder engagement maintained throughout with 
project status updates and meetings.  
Communicate the rationale behind the project or process. Personalise training to the 
needs of the users (novice users and expert users have different training needs). 
• Plan for targets (case study Hospital and literature review IDD-Requirements); 
• Plan training targets such as addressing training needs or gaps to be addressed 
in a timely fashion for users. This allows staff to be more empowered to use the 
innovation and creates a sense of urgency (See Number 2, Sample source of 
evidence in Figure 7.10); 
• Meeting users training needs establishes short-term wins (See Number 3, Sam-
ple source of evidence in Figure 7.10); Schedule training that meets user’s needs 
(See Number 4, Sample source of evidence in Figure 7.10); 
• Not only has training to be completed but it also must be appropriate. For ex-
ample, if some users need to access a HIS innovation in the field, then features 
such as printing should be given lesser priority and showing such users how to 




Consolidation of the new innovation happens when the new innovation is the new way 
of working for the end users. Users see the added benefit of this new way of working. 
End users are supported through after-service customer care to address any issues that 
arise. 
A central repository (case studies) that is accessible to all users and team members is 
useful. This can be used to document issues both positive and negative in a location for 
all to view. This aids buy in as users are part of the process of appraising the software 
innovation.  
Audits of the process allow for a review of the use of the innovation and if there is some 
resistance to this change a plan to empower and facilitate all end users must be 
scheduled. This strategy is made easier if user engagement has been on-going from the 
outset of the project as end users will have more acceptance of the new innovation and 














Number Area Origin of Strategy Relevant Quote/Author 
1 Empowerment and Buy-
In 
Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
“Encouragement must be 
recognised as an important 
element to empowerment” 
2 Establish Urgency Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
“Sense of urgency can be bad 
if it means rush code out” 
3 Short-Terms Wins Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
“Short-term wins can be 
occasionally good but the 
focus should be on having a 
system and process that enable 
long-term wins and 
sustainability” 
4 User Involvement Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
“Be clear to people the 
benefits and that it will make 
working life more efficient” 
5 Audit Literature Review 
Medical Practice Case 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
“A post mortem approach of 
the release of a new project 
will help identify the strong 
points and the weak points that 
appeared during the delivery 
of the project” 





Expected outcome  
Software innovation deployed with users and relevant training and user buy-in is 
observed. If that is not the case then the Deployment process can be repeated. If the 
Deployment process does not work then the leader should evaluate the project in terms 
of repeating the Identify process, to find what is missing from deployment. Having a 
central repository facilitates users to be empowered to improve the software innovation. 
The process of deploying software is an important process as if end users do not use an 
innovation it is of no benefit.  
 
7.3.11 Process 11: Review  
The project should be reviewed in terms of meeting the mission set out at the start of 
the project. Any changes instigated in the Deploy process need to be embedded so that 
the old way of working is replaced (case studies and expert opinion). Using a central 
repository aids in reviewing changes. Review of strategies in the Deployment process, 
in case there needs to be a change in deployment planning. 
Strategies to implement the process 
Regular meetings and updates (case study Medical Practice and expert opinion) keep 
teams focused and allows for teams to see progress of the team individually as well as 
overall. 
Train staff in the new ways of working to consolidate the improvement provided by the 
software (See Numbers 1 and 2, Sample source of evidence in Figure 7.11). A central  
repository can be used to record updates/answers to feedback/issues identified. It must 
be kept current for users to have belief in it and use it. 
If the software is not passing the review stage then the leader must consider options, 
such as stopping or reworking the project. 
Any changes that create new ways of working need to be embedded, audited and 
reviewed so that old ways of working are replaced (See Number 3, Sample source of 
evidence in Figure 7.11). 
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An audit is undertaken (See Number 4, Sample source of evidence in Figure 7.11). 




Evaluation of IDD 
“Consolidation of features, 
changes and improvements is 
definitely important and 
should be taken into account at 
every step” 
2 Institutionalise New 
Approaches 
Literature Review 
MD Industry Case 
Hospital Case 
Evaluation of IDD 
“There is the need to 
constantly analyse the internal 
processes improving the weak 
points and leverage the strong 
ones” 




Evaluation of IDD 
“Yes, it is important in an 
always-improving team to 
consolidate improvements and 
try new approaches and 
review them” 
 
4 Audit Evaluation of IDD “Get input from all 
stakeholders and conduct an 
audit” 
Table 7.11 Sample Source of Evidence 
 
Expected outcome  
Software innovation reviewed and audited with relevant users. Any changes needed to 
be managed and relevant training and user buy-in is maintained. 
If the reviews are positive then this process continues until the innovation is completely 
is deployed. A successful software innovation is one that addresses the needs of the 
users (such as is interoperable with other systems) and is accepted and used by users. 
The output of this phase should be a successful software innovation, if not then either 
rework the project by refining and iterating the innovation, or if the innovation cannot 
proceed then the project could be cancelled. If the project is cancelled then it should be 
reviewed to extrapolate lessons learnt which can be used as input to other innovations.  
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7.4 How to Use IDD 
IDD brings together processes and strategies to empower teams provide relevant and 
usable HIS by gaining a deep understanding of relevant stakeholders so as to be able 
address their needs in innovative ways. IDD follows steps commonly used in existing 
software development models, namely Identification (feasibility), Ideation (design, 
development and testing) and Strategy (maintenance) (Figure 7.1). In each step IDD 
proposes processes (numbered Process 1 to Process 11) which are areas of work to be 
done. Processes are implemented using strategies.  
IDD can be used by team members in projects such as leaders, practitioners, developers 
and implementers. Each team member has different perspectives and different 
processes that impact them directly.  
IDD can be used by team members as a set of guidelines which has a number of SDLC 
processes to support the creation, development and deployment of HIS. As IDD 
contains relevant software development processes it is sufficient as a SDLC for new 
projects. 
In existing projects typically SDLC models, such as the V-model or Agile practices, 
are already used, IDD then becomes an additional set of guidelines. If an organisation 
specifies the use a particular model, IDD adds innovation and user practice strategies 
to their organisation. 
Depending on their roles, team members have different priorities and interpretations, 
for example, of risks. IDD offers a tool to examine software development practices in 
light of how they may or may not facilitate successful innovation. IDD has strategies 
such as immersion that in practical terms might not all be feasible within every project, 
such as budget constraints and time requirements, but it is possible for teams to be able 
to see how they would need to alter their existing practices or be mindful of strategies 
that can aid innovation. It is typical in industry to cherry pick strategies to suit a 
particular project, as no two projects are ever the same. Having guidance as to what is 
recommended at each stage in a project is useful. For novice team members, for 
example, IDD shows how using a more iterative approach aids decisions at various 
points in the model after carrying out reviews or audits. 
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Each step has a number of processes. Processes 2 (Inspire), 3 (Support) and 4 
(Recognise) exist throughout a project in parallel to all the other processes, as these 
processes are needed to manage a project. As not all projects follow a linear pattern, 
some processes can take longer to complete than anticipated, some processes may need 
to be reworked or revisited. Requirements can be missed (Hussain and Mkpojiogu 
2016). An example of a rework is if an important requirement emerges that was missed 
initially, then there is a need to revisit the understand process.  
Leaders initiate IDD and ensure that the correct teams (practitioners, developers and 
implementors), with the correct competencies, are following a relevant and organised 
programme that achieves the goal of innovating HIS. Practitioners work to identify and 
generate a concept for development. Developers create a working piece of software 
from a concept. Implementors deploy software.  
 
7.5 Conclusion 
IDD can be used alone or with existing software development processes. To use IDD it 
is divided into a number of steps which each contain processes. The processes are 
implemented through the employment of various strategies. There are a number of key 
team members, Leaders, Practitioners, Developers, and Implementers. 
 
IDD has the benefit of utilising a set of strategies that have the potential to successfully 
facilitate innovation in projects. The human element is central to this model, and 
engaging with multidisciplinary teams and relevant user involvement as much as 
possible and as early as possible is recommended. People are central to any 







Chapter 8 Conclusion 
 
8.1 Introduction  
This chapter outlines the research questions, the validity of this research, the 
contributions and the recommendations for future work. The following research 
objectives for this thesis were addressed: 
• To define a software innovation model for use in the design, development and 
implementation of health information systems; 
• To develop and evaluate this software innovation model.  
The definition, development and evaluation of the software innovation model (IDD) 
was completed over four stages.  In Stage 1, information was gathered from a literature 
review, which included a discussion on HIS, software development, change and inno-
vation in healthcare. This facilitated the initial model development by gathering a set 
of IDD-Requirements for IDD-V1. In Stages 2 and 3 IDD was then developed further 
after analysing data collected from case studies in medical practice, MD industry and 
hospitals. In Stage 4 IDD was further refined after evaluation by external experts.  
 
Teams are immersed with users early and on-going collaboration is encouraged. 
Projects are scoped by planning what skills are needed in each project; allocating time 
for teams to identify, screen and validate needs to progress. Reviews and audits are 
facilitated throughout to evaluate and aid decision making while also gathering 
feedback to encourage teams to keep to the mission and the vision of a project. An 
iterative strategy is used which is flexible and agile to change. 
 
This chapter examines process used in healthcare, the research questions for this 
research and the validity of this research. It presents the research contribution and then 





8.2. Process Used in Health Innovation 
A number of research questions were used to examine process used in health 
innovation.  
To answer  
RQ1:  How is process used in health innovation? 
A literature review undertaken which examined the history of HIS, HIS innovation and 
change. Some health innovations are required to adhere to relevant standards and to be 
regulatory compliant. Relevant standards and regulations were examined. Relevant 
regulations state that a model should be used but does not stipulate which to use. 
Existing software development process models such as the waterfall or V-model are 
not comprehensive enough as seen by the number of software innovation failures. 
Currently there is no complete integrated model for developing HIS that explicitly 
addresses user-centred practices, innovation and implementation. Processes are used in 
health innovations but innovations still fail. Relevant change management models were 
examined. Factors that influence HIS innovation successes and failures were identified. 
Factors such as stakeholders involvement, change management, communication were 
found to be important in the successful implementation of HIS. These factors were used 
as requirements to be addressed in a SDLC with the effective implementation of 
appropriate processes and strategies. Case studies in medical practice, the MD industry 
and hospitals revealed how processes are used in practice to enable the gathering of 
further requirements.  
 
To answer  
RQ2: How should healthcare software innovations be developed and deployed? 
comprising of  sub-questions How does a medical device company manage software 
development? How do clinical departments within a publicly funded hospital setting 
deploy software? 
To address the RQ2 and the sub-question relating to a MD company, case studies were 
undertaken after completing the literature review. The literature review uncovered a 
number of requirements which were gathered to facilitate the development of IDD-V1. 
To examine how HIS innovation should be developed and deployed, case studies in 
medical practice and in the MD industry were undertaken. There is a gap where a 
model/set of guidelines could build on and complement innovation, stakeholder and 
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change management to aid in the successful deployment of HIS innovations. This 
facilitated the refinement of IDD to produce IDD-V2. Both case studies confirmed a 
number of the existing Requirements found in the literature review. The medical 
practice case study found that mentorship, using multidisciplinary teams to engage with 
users and using a three-Phase approach to developing innovations resulted in successful 
innovations. The MD industry case study found that change management, proactive 
planning, empowerment of staff and having a mission to be important for the 
development of quality software.  
 
To address the RQ2 and the sub-question relating to clinical departments, a case study 
was undertaken within hospitals which, progressed IDD further to IDD-V3. The 
hospital case study identified that software should be part of a change a new or 
improved way of working. Each case study showed that different processes were used 
and provided a greater understanding of the process needs to be used as input to the 
progression of IDD. IDD-V3 was then evaluated by external experts to gain feedback. 
The evaluated IDD model became the final version of IDD which can be used for the 
development of HIS. IDD contains processes and strategies that are useful as a guide 




8.3 Validity of the Research 
To ensure rigour, this research used methodologies which incorporated a number of 
approaches. The research methods chapter (Chapter 3) gave an overview of various 
research methodologies, and described the research design (Figure 8.1). The research 
design used recognised research methods that were suitable to answer the research 
questions while also ensuring the validity of the research approach that was used to 





Figure 8.1: Research Design 
 
To provide confidence a number of methods were used. A multidimensional and mul-
tifaceted approach to undertaking a rigorous research methodology was used to ensure 
all stakeholder perspectives were incorporated at the various stages of IDD definition, 
development and evaluation. 
 
Stakeholder opinions were used to strengthen the credibility of this research. The 
researcher worked closely with stakeholders namely users, administrators, lecturers, 
physiotherapists, nurses, clinicians, project managers, software engineers, software 
architects and software managers. To verify the validity of the data, observations and 
engagement in the health domain was used. Initially, multiple sources of literature were 
used. Industrial practice was integrated through case study research. Interviews were 
also carried out with health experts in the healthcare domain. The methods used 




The final version of IDD was externally evaluated. External expert opinion was used to 
strengthen the transferability of this research. IDD was presented to domain experts, 
who then gave their opinions of  IDD. This provided feedback to further refine IDD.  
 
 
8.4 Research and IDD Contributions 
As well as answering the research questions this research has contributed to the 
software engineering community. At different stages during this research, papers were 
created on the knowledge gained from the research. The papers were peer-reviewed and 
published. The subject matter of the papers included MD industry and the Hospital case 
studies carried out during this research.  
 
IDD was developed based on a literature review, case studies, data analysis and external 
evaluation. Best practices, theories on change and innovation, expert opinion and case 
studies combined. This presents a model, which has added value components such as 
greater emphasis on users, multidisciplinary teams and collaboration. Various users 
such as project managers, developers and implementers can use IDD. It provides 
guidance on how to progress through a HIS project. The main contributions of this 
research are an addition to the body of knowledge as well as IDD. IDD comprises of a 
number of processes and strategies, which should be followed when innovating HIS. 
IDD is versatile and comprehensive: It can be used with or without an existing SDLC. 
 
IDD ensures that the correct staff, with the correct competencies, are following a 
relevant and organised processes that achieve the goal of innovating HIS. Bringing 
together and assessing topics integrated in the literature review which identified 
shortfalls in user-centred practices, innovation practices, deployment/implementation 
(process change) of HIS. IDD addresses:  
• Requirements gathering: Healthcare is highly fragmented this makes gathering 
requirements harder but IDD guides teams to collaborate and network to foster 
better communication by engaging early and sustaining user involvement 
throughout projects to increase the understanding of needs; 
• Multidisciplinary teams bring different perspectives together to further aid in 
understanding needs; Teams can learn and be empowered through the 
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accommodation of multi-disciplinary teams which promotes a culture of 
collaboration amongst all stakeholders. 
• Scoping of projects and team skills. 
• Innovation strategies such as user observation to encourage teams to develop 
innovative HISs;  
• Stakeholders in health are different to other industries, with attributes such as 
clinicians having individual autonomy. Individual autonomy means that a 
clinician can overrule a decision if he/she deems it is not in the best interest of 
the patient. So, HIS data results could be ignored. Also, stakeholders have very 
different motives, some are for profit and some are not, for example, MD 
companies and patients. IDD has user-centred strategies such as immersion to 
gain a full understanding of relevant users. IDD has review strategies that can 
be used to maintain engagement with users throughout projects, this encourages 
and maintains user buy-in and teamwork;  
• Change management strategies as a HIS project brings change that needs to be 
managed; Change management is usually not an explicit part of existing SDLC. 
• Using an iterative strategy. IDD is a practical implementation of how to develop 
HIS software that has an impact on the domain, such as user engagement, col-
laboration and timely personalised training; 
• Specific deployment processes and strategies in acknowledgement of the need 
to manage the rollout of HIS in detail. Training (education) is specific to user 
needs. Reviews are used during deployment to allow for issues to be addressed; 
• Providing guidance, improving training, promoting user centred processes sup-
ports and empowers teams. 
 
8.5 Recommendations for Future Work 
 
There are opportunities for further work on this research: 
• A longitudinal process is one where typically observations are carried out over 
a long period of time, which, provides an understanding of change over time. 
Innovation is a longitudinal process and there maybe stages of it. The literature 
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review undertaken in this thesis is not scoped around being longitudinal but it 
could be in the future.  
• This research could be further extended by carrying out broader MD industry 
case studies with more companies such as small MD start-up companies and 
multinationals. Also, MD companies producing different types of MD devices 
could be examined. This would allow a review of the findings in a broader con-
text.  
• Broader case studies in hospitals nationally and internationally would be of ben-
efit to compare and contrast findings. Also, private and public hospitals could 
be examined. 
• Innovation programmes in other industries could be reviewed for similarities. 
• There was not an opportunity in this research to implement IDD in practice, this 
could be done in the future, possibly as an action research project.  
• IDD recommends fail fast, fail early for non performing projects. Strategies 
could be added to deal with how best to salvage work from cancelled projects. 
Such work might be useful to other projects. 
• This research found that users should be central to projects. Unfortunately, soft-
ware engineers do not always have good people skills to deal with the nuances 
of user requirements. Strategies could be added to IDD to aid in better require-
ment elicitation.  
• This research found that training needs to be personalised to the needs of users. 
How do other regulated industries deal with training requirements? 
• As technology advances and more and more staff work from home. How would 
this affect IDD? 
 
8.6 Conclusion 
IDD is a software innovation model for use in the design, development and 
implementation of HIS. IDD is a model software teams can use for HIS projects. IDD 
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was developed with multiple inputs from a literature review, case studies and 
evaluation. IDD was evaluated by external experts. IDD focuses on processes, tasks 
and strategies used to develop and deploy HIS where innovation strategies and user 
involvement are central. IDD provides a structured approach which defines processes, 





























AAMI (2012) TIR45:2012 Guidance on the use of AGILE practices in the 
development of medical device software 2012, Association for the Advancement of 
Medical Instrumentation. 
 
Abelein, U. and Paech, B., (2015) ‘Understanding the influence of user participation 
and involvement on system success–A systematic mapping study’, Empirical 
Software Engineering, 20(1), pp.28-81. 
 
Abouzahra, M., (2011) ‘Causes of failure in Healthcare IT projects’, In 3rd 
International Conference on Advanced Management Science, Singapore: IACSIT 
Press, Vol. 19, pp. 46-50. 
 
AHRQ The Agency for Healthcare Research and Quality (2012) Designing 
Consumer Health IT: A Guide for Developers and Systems Designers [online] 
available: https://healthit.ahrq.gov/sites/default/files/docs/page/designing-con-
sumer-health-it-a-guide-for-developers-and-systems-designers.pdf [accessed 05 
Nov 2014] 
 
Al Rahbi, D., Khalid, K. and Khan, M., (2017) The effects of leadership styles on 
team motivation. Academy of Strategic Management Journal. 
 
ANSI/AAMI/IEC (2006) 62304:2006 Medical Device Software-Software life cycle 
processes, 2006, Association for the Advancement of Medical Instrumentation. p. 
67. 
 
Antwi, M. and Kale, M., (2014) Change management in healthcare. Ottawa, 
Ontario: The Monieson Centre for Business Research in Healthcare. 
 
Anyieni, A. and Gidion, O., C. (2016) ‘Organisational Change: A Critical Review 





Atkinson R. (1999) Project management: cost, time and quality, two best guesses 
and a phenomenon, it’s time to accept other success criteria, Int J Project Manage, 
17(6):337–42.  
 
Balas, E.A. and Chapman, W.W., (2018) ‘Road Map For Diffusion Of Innovation 
In Health Care’, Health affairs, 37(2), pp. 198-204. 
 
Barry, S., Dalton, R. and Eustace-Cook, J., (2018) Understanding Change in 
Complex Health Systems - A review of the literature on change management in 
health and social care 2007-2017  [online] available: www.hse.ie/changeguide 
[accessed 21 Feb 2019]. 
 
Bath, P. A., (2009) Special Issue Editorial: The changing face of health informatics 
and health information management, Health Informatics Journal, 15, 163-165. 
 
Baxter, G. and Sommerville, I., (2011) “Socio-technical systems: From design 
methods to systems engineering” Interacting with Computers 23(1), 4–17. 
 
Benjamin, R. I., and Levinson, E., (1993) A framework for managing IT-enabled 
change. Sloan Management Review, 34(4), 23-33.  
 
Besant, H., (2016) The journey of brainstorming. Journal of Transformational 
Innovation, 2(1), pp.1-7. 
 
Biodesign (2012) The Future of Health Care [online], available: http://bi-
odesign.stanford.edu/ [accessed 01 Jan 2012] 
 
BioInnovate (2012) BioInnovate Ireland - Innovative Medical Device Training 
[online], available: http://www.bioinnovate.ie/ [accessed 16 Jan 2012] 
Bjögvinsson, E., Ehn, P. and Hillgren, P.A., (2012) Design things and design 




Blake, R.T., Massey, A.P., Bala, H., Cummings, J. and Zotos, A., (2010) Driving 
health IT implementation success: insights from The Christ Hospital. Business 
Horizons, 53(2), pp.131-138. 
Bogner, A., Littig, B. and Menz, W., (2009) Interviewing experts (Research 
Methods Series). Palgrave Macmillan Limited. 
Borrill, C., West, M., Shapiro, D. Rees, A., (2000) “Team working and 
effectiveness in health care”, British Journal of Healthcare Management volume 
6(8), 364-371. 
Braa, K. and Vidgen, R., (1999) Interpretation, intervention, and reduction in the 
organisational laboratory: a framework for in-context information system research, 
in Accounting Management and Information Technologies, 925-47. 
Brown, T. (2019) Change by Design, Revised and Updated: How Design Thinking 
Transforms Organizations and Inspires Innovation, 2nd ed., HarperCollins. 
Buenafe, M.L. (2013) FDA Regulation of Hospital-Developed Technologies 
Hospital Industry Viewpoint [online], available: 
https://www.morganlewis.com/pubs/fda-regulation-of-hospital-developed-tech-
nologies-viewpoint [accessed 01 Dec 2013] 
 
Buntin, M.B., Burke, M.F., Hoaglin, M.C., Blumenthal D, (2011) “The Benefits Of 
Health Information Technology: A Review Of The Recent Literature Shows 
Predominantly Positive Results”, Health affairs 30(3), 464–471. 
Burton, J. (2008) A Software Risk Management Capability Model for Medical 
Device Software, unpublished thesis (Ph.D.), University of Limerick. 
Buttigieg, S. C., Gauci, D., (2015) ‘Health Care Innovation Across Health 
Systems’, in Gurtner, S. and Soyez, K., eds., Challenges and Opportunities in 
Health Care Management, Cham: Springer International Publishing. 
 
Cajander, Å., Grünloh, C. and Köln, T.H., (2019) Electronic Health Records Are 
More Than a Work Tool. 
 
183 
Cameron, E. and Green, M., (2015). Making sense of change management: a 
complete guide to the models, tools and techniques of organisational change. Kogan 
Page Publishers, 4th ed. 
 
Carayon, P., Wooldridge, A., Hose, B.Z., Salwei, M. and Benneyan, J., (2018) 
‘Challenges and opportunities for improving patient safety through human factors 
and systems engineering’, Health Affairs, 37(11), pp.1862-1869. 
 
Carroll, N. (2014). Actor-Network Theory: A Bureaucratic View of Public. Tech-
nological Advancements and the Impact of Actor-Network Theory, Chapter 7, pp. 
115-144, IGI Global, Hershey, PA. 
 
Carroll, N., (2016) Key success factors for smart and connected health software 
solutions. Computer, 49(11), pp.22-28. 
 
Carroll, N, Kuziemsky, C, Richardson, I. (2018) Special issue on software 
engineering for Connected Health: Challenges and research roadmap. J Softw Evol 
Proc. 2018; 30:e1941 
 
Caulfield, B.M. and Donnelly, S.C., (2013) What is connected health and why will 
it change your practice?. QJM: An International Journal of Medicine, 106(8), 
pp.703-707. 
 
Cawley, O., Richardson, I., Wang, X., (2011) Medical Device Software 
Development - A Perspective from a Lean Manufacturing Plant, O’Connor, R. V., 
Rout, T., McCaffery, F., and Dorling, A., ‘Software Process Improvement and 
Capability Determination’, Berlin, Springer, 84 – 96. 
 
Cawley, O., Wang, X., Richardson, I., (2013) Regulated Software Development-
An Onerous Transformation, in Foundations of Health Information Engineering 




Cazzaniga, S., and Fischer, S. (2015) How ICH Uses Organisational Innovations to 
Meet Challenges in Healthcare Management: A Hospital Case Study, In Challenges 
and Opportunities in Health Care Management 355-361, Springer International 
Publishing.  
 
Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, Morton S, Shekelle 
P, (2006) Systematic Review: Impact of Health Information Technology on 
Quality, Efficiency, and Costs of Medical Care, American College of Physicians, 
Annals of Internal Medicine Improving Patient Care, 12-17. 
 
Christensen, C.M., Bohmer, R. and Kenagy, J., (2000) Will disruptive innovations 
cure health care?. Harvard business review, 78(5), pp.102-112. 
 
Cision (2013) CHEO Has Glimpsed the Future; and It is Paperless [online], 
available: https://www.newswire.ca/news-releases/cheo-has-glimpsed-the-future-
and-it-is-paperless-513274661.html [accessed 16 Dec 2019]. 
 
Coiera, E., Ash, J. and Berg, M., (2016) The unintended consequences of health 
information technology revisited. Yearbook of medical informatics, 25(01), 
pp.163-169. 
 
Cooke-Davies, T., (2002) ‘The “real” success factors on projects’, International 
journal of project management, 20(3), pp.185-190. 
 
Cresswell, K. M., Bates, D. W. and Sheikh, A., (2013) “Ten key considerations for 
the successful implementation and adoption of large-scale health information 
technology” J Am Med Inform Assoc, 20, 9-13.  
 
Cresswell, K. and Sheikh, A., (2013) Organisational issues in the implementation 
and adoption of health information technology innovations: an interpretative 




Crotty, Bradley H., Somai, Melek. And Carlile, Narath., (2019) “Adopting Agile 
Principles In Health Care, " Health Affairs Blog, August 15, 2019. [online], 
available: doi: 10.1377/hblog20190813.559504 [accessed 15 Dec 2019]. 
 
Davenport, T.H., (2013) Process innovation: reengineering work through 
information technology, Harvard Business Press. 
 
Dexter, L. A. (2006/1969). Elite and specialized interviewing, with a new 
introduction by Ware, A. and Sánchez-Jankowski, M. (University of Essex, 
Colchester: ECPR Press – ECPR classics, 1st ed., (1969) Evanston: Northwestern 
University Press). 
 
Dewey, J. (1933) How we think, London: D.C. Health & Co. 
 
Donabedian A. (1980). Explorations in Quality Assessment and Monitoring, 
Volume I. The Definition of Quality and Approaches to its Assessment. Ann 
Arbour, MI , Health Administration Press, pp. 1–164. 
 
Donabedian, A (2005) Evaluating the Quality of Medical Care, The Milbank 
Quarterly, 83(4):691-729. 
 
Dzik, W. (2006) New Technology for Transfusion Safety, s.l.: Blackwell 
Publishing Ltd., British Journal of Haematology, Vol. 136, pp. 181-190.  
 
Eckerdal, J.R., (2016) Qualitative research methods: interviewing as a way of 
learning and knowing. Journal of EAHIL, 12(1), pp.36-39. 
Edler, J., Cunningham, P. and Gök, A. eds. (2016) Handbook of innovation policy 
impact, London:Edward Elgar Publishing. 
 
EGFSN Report (2008) “Future Skills Needs of the Irish Medical Devices Sector: 
2007-2013”, Presented to the Irish Ministers for Enterprise, Trade & Employment 




European Commission (2012) Trends and Challenges in Public Sector Innovation 
in Europe [online] available: http://ec.europa.eu/DocsRoom/documents/13181/at-
tachments/1/translations [accessed 04 Nov 2016]  
 
European Commission (2012b) Innovation in Healthcare From Research to Market 
to Health-systems to Patient Main conclusions from 2010, 2011, 2012 conferences 
[online]available:https://ec.europa.eu/research/health/pdf/innovation-in-
healthcare-overview-report_en.pdf [accessed 04 Nov 2016] 
 
EU, Council Directive  (1993) 93/42/EEC of the European Parliament and of the 
Council, Concerning Medical Devices, E. Council, Editor 1993, Official Journal of 
the European Union.  
 
EU, Directive (2007) 2007/47/EC of the European Parliament and of the Council, 
2007, Official Journal of the European Union.  
European Union Council. (2007) EU Directive 2007/47/EC. 
Evered, R., & Louis, M. (1981) Alternative perspectives in the organisational 
sciences: ‘inquiry from the inside’ and ‘inquiry from the outside’. Academy of 
Management Review, 6, (3), 385-396. 
Flood, D., Mc Caffery, F., Casey, V. and Regan, G., (2013) ‘MeD UD–A process 
reference model for usability design in medical devices’, In Human Factors in 
Computing and Informatics 224-239. 
FDA (2009) Code of Federal Regulations 21 CFR Part 820, U.F.a.D. 
Administration, Editor April 2009.  
 
FDA, (2013) General Human Factors Information and Resources [online] available: 
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HumanFacto
rs/ucm124829.htm [accessed 1 June 2013] 
 
Flood, D., Chary, A., Austad, K., Diaz, A.K., García, P., Martinez, B., Canú, W.L. 
and Rohloff, P., (2016), Insights into global health practice from the agile software 
development movement. Global health action, 9(1), p.29836. 
 
187 
Foley, C., Droog, E., Healy, O., McHugh, S., Buckley, C. and Browne, J.P., (2017) 
Understanding perspectives on major system change: a comparative case study of 
public engagement and the implementation of urgent and emergency care system 
reconfiguration. Health Policy, 121(7), pp.800-808. 
 
Forte, G., (1997) ‘Managing Change for Rapid Development’, IEEE Software 
14(6), 114–123.  
 
Geissbuhler, A., (2013) ‘Lessons learned implementing a regional health 
information exchange in Geneva as a pilot for the Swiss national eHealth 
strategy’, International journal of medical informatics, 82(5), 118-124. 
 
Gill, P., Stewart, K., Treasure, E. and Chadwick, B., (2008) Methods of data 
collection in qualitative research: interviews and focus groups. British dental 
journal, 204(6), p.291. 
 
Glassner, B. and Loughlin J., (1987) Drugs in Adolescent Worlds: Burnouts to 
Straights, New York: St Martin’s Press. 
 
Goodison, R., Borycki, E.M. and Kushniruk, A.W., (2019). Use of Agile Project 
Methodology in Health Care IT Implementations: A Scoping Review. In ITCH (pp. 
140-145). 
 
Gottlieb, S. and Makower, J., (2013) A role for entrepreneurs: an observation on 
lowering healthcare costs via technology innovation. American journal of 
preventive medicine, 44(1), pp.S43-S47. 
 
Gray, David, E. (2014) Doing Research In The Real World, 3rd ed., University Of 
Greenwich, UK: Sage Publications. 
 
Grbich, C., (1999) Qualitative Research in Health: An Introduction, CA: Sage 
Publications. 
 




Greenhalgh, T. and Papoutsi, C., (2018) Studying complexity in health services re-
search: desperately seeking an overdue paradigm shift. 
 
Greenhalgh, T., Wherton, J., Papoutsi, C., Lynch, J., Hughes, G., Hinder, S., Fahy, 
N., Procter, R. and Shaw, S., (2017) Beyond adoption: a new framework for theo-
rizing and evaluating nonadoption, abandonment, and challenges to the scale-up, 
spread, and sustainability of health and care technologies. Journal of medical Inter-
net research, 19(11), p.e367. 
 
Hammarberg, K., Kirkman, M. and de Lacey, S., (2016) Qualitative research 
methods: when to use them and how to judge them. Human reproduction, 31(3), 
pp.498-501. 
 
Harvard Business Review (2019) ‘What Banking Can Teach Health Care About 
Handling Customer Data’ [online], available: https://hbr.org/2019/10/what-
banking-can-teach-health-care-about-handling-customer-data [accessed 29 Oct 
2019]. 
 
Harrison, H., Birks, M., Franklin, R. and Mills, J., (2017) January. Case study 
research: Foundations and methodological orientations. In Forum Qualitative 
Sozialforschung/Forum: Qualitative Social Research (Vol. 18, No. 1). 
 
Hayes, J., (2018) The theory and practice of change management. Palgrave. 
 
Hayes, S. and Richardson, I., (2008) Scrum Implementation using Kotter’s Change 
Model, 9th International Conference on Agile Processes and eXtreme Programming 
in Software Engineering, Limerick, Ireland, Lecture Notes in Business Information 
Processing 2008, vol 9, Part 6, 10th-14th June, pp. 161-171. 
 
Heath, M., Appan, R. and Gudigantala, N., (2017) Exploring health information 
exchange (HIE) through collaboration framework: normative guidelines for it 





Henningsen, D.D. and Henningsen, M.L.M., (2018) Does brainstorming promote 
cohesiveness? How the rules of brainstorming mirror symbolic 
convergence. Communication Reports, 31(2), pp.103-114. 
 
Hiatt, J. M. (2006). ADKAR: a model for change in business, government and our 
community. Loveland: Prosci Learning Center. 
 
Hier D, Rothschild A, LeMaistre A, Keeler J. (2004) Differing Faculty and 
Housestaff Acceptance of an Electronic Health Record One-Year After 
Implementation. Pt 2, s.l.: IOS Press, Studies in health technology and informatics, 
Vol. 107, pp. 1300-1303. 
 
Holden, R.J. and Karsh, B.T., (2010) The technology acceptance model: its past 
and its future in health care. Journal of biomedical informatics, 43(1), pp.159-172. 
 
Holloway, I., (2005) Qualitative Research In Health Care, Open University Press. 
Holloway, I., Galvin, K., (2016) Qualitative research in nursing and healthcare, 
John Wiley & Sons. 
 
Hornstein, H.A., (2015) The integration of project management and organizational 
change management is now a necessity. International Journal of Project 
Management, 33(2), pp.291-298. 
 
HSE (2008) IMPROVING OUR SERVICES: A Users’ Guide to Managing Change 
in the Health Service Executive [online] available: http://www.hse.ie/eng/staff/Re-
sources/hrstrategiesreports/Improving_our_Services,_A_Guide_to_Manag-
ing_Change_in_the_the_HSE_-_Oct_2008.pdf [accessed 04 Dec 2016] 
 
HSE (Health Service Executive) (2014) Change Management Resources [online] 





HSE (Health Service Executive) (2014b) ‘eHealth Strategy for Ireland’, available: 
https://www.ehealthireland.ie/Knowledge-Information-Plan/eHealth-Strategy-for-
Ireland.pdf [accessed July 2019]. 
 
Huckvale, K., Wang, C.J., Majeed, A. and Car, J., (2019) Digital health at fifteen: 
more human (more needed). BMC medicine, 17(1), p.62. 
 
Hughes, D.L., Dwivedi, Y.K., Simintiras, A.C. and Rana, N.P., (2015). Success and 
failure of IS/IT projects: A state of the art analysis and future directions. Springer. 
 
Hughes, D.L., Rana, N.P. and Simintiras, A.C., (2017) The changing landscape of 
IS project failure: an examination of the key factors. Journal of Enterprise 
Information Management, 30(1), pp.142-165. 
 
Hussain, A. and Mkpojiogu, E.O., (2016), August. Requirements: Towards an 
understanding on why software projects fail. In AIP Conference Proceedings (Vol. 
1761, No. 1, p. 020046). AIP Publishing LLC. 
Hwang, J. and Christensen, C.M., (2007) “Disruptive Innovation In Health Care 
Delivery: A Framework For Business-Model Innovation” Health Affairs 27(5). 
 
Innovation Task Force Report (2010), Department of the Taoiseach, Dublin, 
Ireland, March 2010, ISBN  9781406424966. 
 
Ireland, Department of Health (2013) e-Health Strategy for Ireland, Dublin: 
Department of Health.  
IEC (2016) IEC 82304-1:2016 health software—part 1: general requirements for 
product safety.  
Jamshed, S., (2014) “Qualitative research method-interviewing and 
observation” Journal of Basic and Clinical Pharmacy, 5(4), 87–88. 
Johnson, J.K., Miller, S.H. and Horowitz, S.D., (2008) Systems-based practice: 
improving the safety and quality of patient care by recognizing and improving the 
 
191 
systems in which we work. In Advances in patient safety: new directions and 
alternative approaches (Vol. 2: culture and Redesign). Agency for Healthcare 
Research and Quality (US). 
Johnson, C. and Reed, H., (2013) Getting to the bottom of HealthCare. gov’s 
flop. New York Times, 24. 
 
Jopling, M., (2019) Using quantitative data. Practical Research Methods in 
Education: An Early Researcher's Critical Guide, p.55. 
 
Kaissi, A., (2012) “Learning From Other Industries Lessons and Challenges for 
Health Care Organisations” The Health Care Manager 31(1), 65–74.  
 
Kalpokaite, N. and Radivojevic, I., (2019) Demystifying Qualitative Data Analysis 
for Novice Qualitative Researchers. The Qualitative Report, 24(13), pp.44-57. 
 
Kannan, V., Basit, M.A., Youngblood, J.E., Bryson, T.D., Toomay, S.M., Fish, J.S. 
and Willett, D.L., (2017) Agile co-development for clinical adoption and adaptation 
of innovative technologies. IEEE Healthcare Innovations and Point of Care 
Technologies (HI-POCT), pp. 56-59. 
 
KAPLAN, B. and HARRIS-SALAMONE, K.D., (2009) Health IT Success and 
Failure: Recommendations from Literature and an AMIA Workshop. J Am Med 
Inform Assoc, 16, pp.291-299. 
 
Karsh, B.T., (2004) “Beyond usability: designing effective technology 
implementation systems to promote patient safety” Qual Saf Health Care 13, 388-
394.  
 
Kellermann, A.L. and Jones, S.S., (2013) ‘What it will take to achieve the as-yet-
unfulfilled promises of health information technology’, Health Affairs, 32(1), 63-
68. 
 
Khan, M.E. and Manderson, L. (1992) Focus Groups in Tropical Diseases 
 
192 
Research, in Liamputtong, P., Ezzy, D. Qualitative Research Methods, p. 76. 
Kijsanayotin, B., Pannarunothai, S.,and Speedie, S. M., (2009) “Factors influencing 
health information technology adoption in Thailand's community health centers: 
Applying the UTAUT model” International Journal of Medical Informatics, 78, 6, 
404 – 416. 
Kitto, S.C., Chesters, J. and Grbich, C., (2008) Quality in qualitative 
research. Medical journal of Australia, 188(4), p.243. 
 
Körner, M., Wirtz, M.A., Bengel, J. and Göritz, A.S., (2015) Relationship of 
organisational culture, teamwork and job satisfaction in interprofessional 
teams. BMC health services research, 15(1), p.243. 
 
Kotter, J., (2005) Leading Change: Why Transformation Efforts Fail, Harvard 
Business School Press, Boston. 
 
Kuziemsky, C.E., (2015) Review of social and organizational issues in health in-
formation technology. Healthcare informatics research, 21(3), pp.152-160. 
 
Kuziemsky, C.E. and Lau, F., (2010) ‘A four stage approach for ontology-based 
health information system design’, Artificial Intelligence in Medicine, 50(3), 
pp.133-148. 
 
Kuziemsky, C.E., Randell, R. and Borycki, E.M., (2016) Understanding unintended 
consequences and health information technology. Yearbook of medical 
informatics, 25(01), pp.53-60. 
 
Kuziemsky, C.E., Abraham, J. and Reddy, M.C., (2019) Characterizing 
Collaborative Workflow and Health Information Technology. In Cognitive 
Informatics (pp. 81-102). Springer, Cham. 
 
Lamé, G., Yannou, B. and Cluzel, F., (2018) Usage-driven problem design for 
radical innovation in healthcare. 
 
193 
Lau, F., Kuziemsky, C., Price, M., Gardner, J. (2010) “A review on systematic 
reviews of health information system studies ” Journal of the American Medical 
Informatics Association 17(6), 637-645. 
 
Lenz R, Blaser R, Blaser M, Heger O, Biber C, Baumlein M, Schnabel M. (2007) 
IT Support for clinical pathways - Lessons learned, s.l. : Elsevier Ireland Ltd., April 
2007, International Journal of Medical Informatics 76s, pp. 397-402. 
 
Lewin, K. (1947). Frontiers in Group Dynamics: Concept, Method and Reality in 
Social Science; Social Equilibria and Social Change. Human Relations, June, 1: 36. 
 
Lincoln, Y.S. and Guba, E.G., (1985). E. Naturalistic Enquiry, Beverly Hills, CA: 
Sage Publications. 
Lo, B., Zhang, T., Leung, K., Mehta, R., Kuziemsky, C., Booth, R.G., Chyjek, A., 
Rossetti, S.C., McLean, D., Borycki, E. and McLay, D., (2020) Identifying best 
approaches for engaging patients and family members in health informatics initia-
tives: a case study of the Group Priority Sort technique. Research Involvement and 
Engagement, 6, pp.1-9. 
Lorenzi, N.M. and Riley, R.T., (2000) ‘Managing change’, Journal of the American 
Medical Informatics Association, 7(2), 116-124. 
Ludwick, D.A. and Doucette, J., (2009) Adopting electronic medical records in pri-
mary care: lessons learned from health information systems implementation expe-
rience in seven countries. International journal of medical informatics, 78(1), 
pp.22-31. 
MacNeil, M., Koch, M., Kuspinar, A., Juzwishin, D., Lehoux, P. and Stolee, P., 
(2019) Enabling health technology innovation in Canada: Barriers and facilitators 
in policy and regulatory processes. Health Policy, 123(2), pp.203-214. 
 
Magrabi, F., Ammenwerth, E., Hyppönen, H., de Keizer, N., Nykänen, P., Rigby, 
M., Scott, P., Talmon, J. and Georgiou, A., (2016) Improving Evaluation to Address 
 
194 
the Unintended Consequences of Health Information Technology. Yearbook of 
medical informatics, 25(01), pp.61-69. 
 
Malerba Franco (2006) The Oxford Handbook of Innovation Sectoral Systems: 
How and Why Innovation Differs across Sectors Edited by Jan Fagerberg and 
David C. Mowery 
 
Malterud, Kirsti (2019) Qualitative metasynthesis : a research method for medicine 
and health sciences . London: Routledge, Taylor & Francis Group. 
 
McCaffery, F., Casey, V., Sivakumar, M.S., Coleman, G., Donnelly, P., Burton, J., 
(2012) Medical Device Software Traceability, Software and Systems Traceability, 
Ed. Zisman A., Cleland-Huang J. and Gotel, O., Springer Verlag Publishers, pp 321 
– 340. 
 
McCaffery, F., Lepmets, M., Trektere, K., Ozcantop, O. and Pikkarainen, M., 
(2016a). Agile medical device software development: introducing agile practices 
into MDevSPICE®. International Journal on Advances in Life Sciences, 8(1 & 2), 
pp.133-142. 
 
McCaffery, F., Trektere, K. and Ozcan-Top, O., (2016b), Agile–Is it Suitable for 
Medical Device Software Development?. In International Conference on Software 
Process Improvement and Capability Determination (pp. 417-422). Springer, 
Cham. 
 
McHugh, M.D. and Ma, C., (2013) ‘Hospital nursing and 30-day readmissions 
among Medicare patients with heart failure, acute myocardial infarction, and 
pneumonia’. Medical care, 51(1), 52. 
 
McHugh M., McCaffery F., Coady G., (2015) “Adopting Agile Practices when 
Developing Medical Device Software”, Journal of Computer Engineering & 




McHugh, Martin., Cawley, Oisin., Mccaffcry, Fergal., Richardson, Ita., Xiaofeng 
Wang, (2013) ‘An agile V-model for medical device software development to 
overcome the challenges with plan-driven software development lifecycles’, in 
2013 5th International Workshop on Software Engineering in Health Care (SEHC). 
[Online]. May 2013 IEEE. pp. 12–19. 
 
MEDDEV 2.1/6 (2012) Guidelines on the qualification and classification of 
standalone software used in healthcare within the regulatory framework of medical 
devices, European Commission. 
 
Merriam, S.B. and Grenier, R.S., (2019) Qualitative research in practice: Examples 
for discussion and analysis. John Wiley & Sons. 
 
Meyer, J. and Eslambolchilar, P., (2017), October. Research challenges of emerging 
technologies supporting life-long health and wellbeing. In Proceedings of the 2nd 
International Workshop on Multimedia for Personal Health and Health Care (pp. 
27-34). ACM. 
 
Miles, M.B., Huberman, A.M. (1994) Qualitative Data Analysis, 2nd ed., CA: Sage 
Publications. 
 
Miles, M. B., Huberman, A.M., Saldana, J. (2014) Qualitative data analysis: A 
methods sourcebook (3rd.). Los Angeles: Sage Publications. 
 
Munassar, N. M. A., Govardhan A., (2010) “A Comparison Between Five Models 
Of Software Engineering”, IJCSI International Journal of Computer Science Issues 
7, 94-101.  
 
Myers, M. D. (1997) Qualitative Research in Information Systems, MIS Quarterly 
(21:2), June 1997, pp. 241-242. 
 
National Research Council, (2001) Preparing for an aging world: The case for 




Nelson, R. and Staggers, N., (2016) Health Informatics-E-Book: An 
Interprofessional Approach. Elsevier Health Sciences. 
 
NSAI (2013) Innovation Management, CEN/TS 16555-1:2013, Dublin. 
 
Noller, R. B., Parnes, S. J., Biondi, A. M. (1976) Creative action book. New York: 
Scribners. 
Noteboom C, Bastola D, Qureshi S. (2012) Cycles of electronic health records 
adaptation by physicians: How do the positive and negative experiences with the 
EHR system affect physician EHR adaption process? s.l.: IEEE Computer Society. 
45th Hawian  International Conference on System Sciences. p. 2685. 
 
NSAI (2009) Guide to Good Practice in Innovation and Product Development 
Processes, NWA 1, Dublin: National Standards Authority of Ireland.  
 
O’Cionnaith, F. (2010) ‘HSE pay system costing €6m a year’, Irish Examiner 
[online], 3 Sept 2010, available: 
https://www.irishexaminer.com/ireland/health/hse-pay-system-costing-euro6m-a-
year-129774.html [accessed Jan 2014] 
 
O'Leary, P., Carroll, N., Clarke, P., Richardson, I., (2015) “Untangling the 
Complexity of Connected Health Evaluations”, IEEE International Conference on 
Healthcare Informatics, pp. 272-281. 
 
O’Sullivan, D. and Dooley, L., (2010) Collaborative innovation for the 
management of information technology resources. Professional Advancements and 
Management Trends in the IT Sector, p.207. 
 
Omachonu, V.K. and Einspruch, N.G., (2010) Innovation in healthcare delivery 
systems: a conceptual framework. The Innovation Journal: The Public Sector 
Innovation Journal, 15(1), pp.1-20. 
 
Orlikowski, W.J. & Baroudi, J.J. (1991) Studying Information Technology in 
 
197 
Organisations: Research Approaches and Assumptions, Information Systems 
Research (2), pp. 1-28. 
Queirós, A., Faria, D. and Almeida, F., (2017) Strengths and limitations of qualita-
tive and quantitative research methods. European Journal of Education Studies. 
Ray, P.P., Amaral, J.F. and Hinoul, P., (2017) Innovation best practices in the 
medical device industry. Techniques in vascular and interventional 
radiology, 20(2), pp.90-93. 
 
Ray, J.M., Ratwani, R.M., Sinsky, C.A., Frankel, R.M., Friedberg, M.W., Powsner, 
S.M., Rosenthal, D.I., Wachter, R.M. and Melnick, E.R., (2019) Six habits of highly 
successful health information technology: powerful strategies for design and 
implementation. Journal of the American Medical Informatics Association, 26(10), 
pp.1109-1114. 
 
Reid, L., Lotter, M., Burton, J., Richardson, I. (2012) Designing and Implementing 
a Hospital Quality Assurance Program, Software, IEEE , vol.29, no.3, pp.37,44, 
May-June.  
 
Richardson, I. (1999) Improving the Software Process in Small Indigenous 
Software Development Companies using a model based on Quality Function 
Deployment, unpublished thesis (Ph.D.), University of Limerick. 
 
Richardson I. (2015) Connected Health: People, Technology and Processes, Lero-
TR-2015-03, Lero Technical Report Series. University of Limerick. 
 
Richardson, I., Casey, V., Burton, J. and McCaffery, F., (2010) ‘Global software 
engineering: A software process approach’. In Collaborative Software Engineer-
ing, 35-56. 
 
Richardson, I., Reid, L. and O’Leary, P., (2016) Healthcare systems quality: 
development and use. In 2016 IEEE/ACM International Workshop on Software 




Robson, C. (2002) Real World Research: A Resource for Social Scientists and Prac-
titioner-Researchers, 2nd ed., UK: Blackwell Publishing. 
 
Runeson, P. and Höst, M., (2009) Guidelines for conducting and reporting case 
study research in software engineering. Empirical software engineering, 14(2), 
p.131. 
 
Saks M. and Allsop, J., (2019) Introduction to Researching Health. Researching 
Health: Qualitative, Quantitative and Mixed Methods. 
 
Seal, C. (2000) The Quality of Qualitative Research, SAGE Publications Ltd, ISBN 
0-7619-5597-6 
Seers, K. (2012)  ‘Qualitative data analysis’, Evidence Based Nursing, 15 (1), 2.  
Shroff, V., Reid, L., Hashmi, S., Mulligan, G., Sheehy, D., Xiang, K., Richardson, 
I., (2011) ‘Development of a Software Quality Plan for Hospitals: An Irish 
Perspective’, International Conference on Health Informatics HEALTHINF, Rome, 
Italy. 
Sligo, J., Gauld, R., Roberts, V. and Villa, L., (2017) ‘A literature review for large-
scale health information system project planning, implementation and evaluation’, 
International journal of medical informatics, 97, pp.86-97. 
Spence, J.W. (2005) There has to be a better way! [software development] in 
AGILE Conference, July 24 - July 29, 2005. Denver, CO, United states: Inst. of 
Elec. and Elec. Eng. Computer Society, 272-278. 
 
The New Oxford Dictionary of English (1998) Oxford: Oxford University Press. 
 
Szydlowski S, Smith C. (2009) Perspectives From Nurse Leaders and Chief 
Information Officers on Health Information Technology Implementation, 1, s.l.: 




Tavassoli, S. and Karlsson, C., (2015) Persistence of various types of innovation 
analysed and explained. Research Policy, 44(10), pp.1887-1901. 
TechInnovate (2017) TechInnovate [online], available: http:// www. 
techinnovate.org/ [accessed 16 Mar 2017]. 
Teixeira, M.B. (2019) Design Controls for the Medical Device Industry, 3rd ed., 
Boca Raton Fl: CRC Press. 
Tobey, B., (2019) ‘Are Healthcare Providers Slow To Embrace Digital 
Technologies?’, available: https://www.hitstech.net/blog/are-healthcare-providers-
slow-to-embrace-digital-technologies/ [accessed May 2020]. 
 
Tohidi, H., Jabbari, M.M., (2012) ‘Different Stages of Innovation Process’, 
Procedia Technology 1, 574 – 578. 
Turner, P., Kushniruk, A. and Nohr, C., (2017) Are We There Yet? Human Factors 
Knowledge and Health Information Technology–the Challenges of Implementation 
and Impact. Yearbook of medical informatics, 26(01), pp.84-91. 
UNESCO Institute for Statistics, (2005) Oslow Manual, The Measurement of 
Scientific and Technological Activities, 3rd Edition, p.34. 
 
Unger, C. and Celentano, M., (2016). AGILE SYSTEMS IN HEALTHCARE: 
Report from the Inaugural Medical Device Agile Systems Development 
Workshop. INSIGHT, 19(2), pp.66-68. 
 
Van Gemert-Pijnen JE, Nijland N, Van Limburg M, Ossebaard HC, Kelders SM, 
Eysenbach G, Seydel ER (2011) “A Holistic Framework to Improve the Uptake and 
Impact of eHealth Technologies”, J Med Internet Res Vol. 13, No. 4 e111. 
 
Vincent, C. J., Niezen, G., O’Kane, A. A., Stawarz, K. (2015). ‘Can Standards and 
Regulations Keep Up With Health Technology?’, Journal of Medical Internet 




Wager, K.A., Lee, F.W. and Glaser, J.P., (2013) Health Care Information Systems: 
A Practical Approach for Health Care Management, 3rd Ed. CA: Wiley. 
 
West, M.A., Borrill C.S., Dawson J.F., Brodbeck, F., Shapiro, D.A., Haward B., 
(2003) “Leadership clarity and team innovation in health care”, The Leadership 
Quarterly 14, 393–410.  
 
World Health Organization, (2019) WHO guideline: recommendations on digital 
interventions for health system strengthening: web supplement 2: summary of 
findings and GRADE tables (No. WHO/RHR/19.7). World Health Organization. 
 
Yin, R. K. (2013). Case study research: Design and methods. Sage publications. 
 
Zenios, S., Makower, J. and Yock, P.G. (2010) Biodesign: The Process of 
Innovating Medical Technologies, 1st ed., New York: Cambridge University Press. 
 
Yock, P.G. and Zenios, S. and Makower, J. and Brinton, T.J. and Kumar, U.N. and 
Watkins, F.T.J. and Denend, L. and Kurihara, C.Q. and Krummel, T.M. (2015) 
Biodesign : The Process of Innovating Medical Technologies, 2nd ed., New York: 
















































Excerpt from Wager et al (2013): 
 
Decade Health Care Environment State of Information 
Technology  
Use of Health Care 
Information Systems 
1960s Enactment of Medicare and 
Medicaid Cost-based reimbursement 
‘‘Building’’ mode. Focus on 
















maintained in-house  
Shared systems 
available to smaller 
hospitals. Centralized 
data processing 
1970s Still time of growth Medicare and 
Medicaid expenditures rising. Late 
in decade, recognition of need to 
contain health care costs 


















1980s Medicare introduces prospective 
payment system for hospitals  
Medicaid and private insurers follow 
suit  








power to desktop; 
revolutionizes how 
companies process 
data and do business  




Expansion of clinical 
information systems 








1990s Medicare changes physician 
reimbursement to a resource-based 
relative value scale (RBRVS) Health 
care reform efforts of Clinton era 
(HIPAA)  
Growth of managed care and 
integrated delivery systems Institute 
of Medicine (IOM) calls for 
computer-based patient record 
(CPR) adoption 
Unveiling of the 





each other, market 
services, conduct 
business 
Growth of Internet 
has profound effect 





more widely available 
and affordable  
Enterprise-wide 
systems Increased 
interest in clinical 
application  
Relatively small 





2000s IOM report on patient safety and 
medical errors  
Both President Bush and President 
Obama call for electronic health 
record (EHR) adoption HIPAA 
privacy and security regulations in 
effect  
Leapfrog Group Medicare 
Modernization Act Transparency on 
quality and price; consumer 
empowerment  
Funding for health information 
technology (HIT) initiatives  
Reimbursement practices changing 
to include telehealth 
Personalized medicine 









phones) Bar coding 
















invest in information 
systems that promote 
safety (for example, 
CPOE, medication 
administration, e-
prescribing, and other 
decision-support 
systems) Personal 
health record (offered 
by insurers, Google, 




2010+ Meaningful use of HER 
Medicare and Medcaid EHR 
Incentive Programs in effect 
Affordable Care Act goes into effect 
New models of care and payment 
reform (such as accountable care 
organisations and bundled payment) 
IOM Report on Patient Safety and 
Health IT  
Implementation of ICD-10 
Personalized medicine 
iPads and hand-held 





Web 2.0 and social 
media used in 
innovative ways in 
health care 
Home monitoring 
devices and Web aps 
Hugh databases 
compiled by health 
information exchange 
(HIE) 
Expansion in the 
adoption and 
meaningful use of 
HER systems  
Certification of EHR 
systems 
State-supported HIEs 
Home as the new 
medical home-growth 
in telehealth 









I, the undersigned, declare that I am willing to take part in research for the project 
entitled “Software quality in various industries”.   
 
• I declare that I have been fully briefed on the nature of this study and my role 
in it and have been given the opportunity to ask questions before agreeing to 
participate.  
• The nature of my participation has been explained to me and I have full 
knowledge of how the information collected will be used. 
• I fully understand that there is no obligation on me to participate in this study 
• I fully understand that I am free to withdraw my participation at any time 
without having to explain or give a reason 




______________________________________         __________________________ 





1. The proposed research aims to compare and contrast the use of software (infor-
mation systems) in various industries. A questionnaire will be used to gather 
information from participants from different industries. 
2. The questionnaire will take one hour to complete. 
3. The questionnaire will be given to the participant to complete with the 
researcher at a location of their choice.  
4. No risks or benefits envisaged to participants. 
5. Participants have the right to anonymity therefore no names will be recorded on 
the questionnaires. 
6. Each participant has the right not to answer questions and withdraw at any time. 
Also each participant has the right to contact Chair of the Science & 
Engineering Research Ethics Committee if they have any concerns about 
participating in the research. 
7. Contact information:  
 
Researcher: Marie Travers  
    Email: Marie.Travers@ul.ie 
Supervisor: Dr Ita Richardson 
   Email: Ita.Richardson@ul.ie 
Chair of Science & Engineering Research Ethics Committee: Thomas Waldmann 
   Email: Thomas.waldmann@ul.ie   







QUESTIONNAIRE FOR MEDICAL DEVICE INDUSTRY AND HOSPITALS: 
 
What are the current IT systems in place in your department?  
 
Give examples of how new IT systems or processes were implemented?  
 
Specifically how was change was managed? Give examples 
 
Kotter’s (2005) Change management model recommends 8 steps to follow to manage 
change. Kotter’s step 7 Consolidate Improvements and Produce More Change 
recommends that management or change advocates should become more involved in 
the process thus ensuring continuation of changes. Kotter’s step 8 Institutionalise New 
Approaches recommends that for success change has to be implemented so that it is 
now part of the organisations culture.  
Is this true in your experience in regards to moving or changing to new IT 
systems/processes? Give examples 
 
Were there unexpected problems or issues that affected such project changes? 
Give examples 
 
What is your opinion of the new IT system/process implemented? 
 
What could or should have been done differently? Give examples 
 




Kotter, J.: Leading Change: Why Transformation Efforts Fail. Harvard Business School 










Dear  proposed participant, 
My name is Marie Travers and I am currently undertaking a PhD at the University of 
Limerick under the supervision of Prof. Ita Richardson. The title of my proposed 
research is Software Process in Health. The purpose of this project is to validate 
guidelines I have identified for the development of health information systems.  
To validate these guidelines each participant is required to fill in a questionnaire.  
The questionnaire will take less than one hour to complete.  
The questionnaire will be given to the participant to complete at a location of their 
choice.  
No risks or benefits envisaged to participants. 
Participants have the right to anonymity therefore no names will be recorded on the 
questionnaires. 
Each participant has the right not to answer questions and withdraw at any time.  
If you have further questions regarding this research please feel free to get in touch with 
either myself or my supervisor using the email addresses listed below. 
If you have concerns about this study and wish to contact someone independent, you 
may contact: The Chair, Faculty of Science & Engineering Research Ethics Committee, 






Marie Travers,  
marie.travers@ul.ie 
Prof. Ita Richardson, Lero,  










I, the undersigned, declare that I am willing to take part in research for the project 
entitled “Software process in health”.   
 
• I declare that I have been fully briefed on the nature of this study and my role 
in it and have been given the opportunity to ask questions before agreeing to 
participate.  
• The nature of my participation has been explained to me and I have full 
knowledge of how the information collected will be used. 
• I fully understand that there is no obligation on me to participate in this study 
• I fully understand that I am free to withdraw my participation at any time 
without having to explain or give a reason 




______________________________________         __________________________ 











My name is Marie Travers and I am a PhD student at the University of Limerick 
researching how to provide a valid framework/set of guidelines for software developers 
when they are developing software information systems to be used in health. My UL 
ethics approval board number is  
Ref: ___________. 
 
I would be hopeful of getting your opinion on my proposed framework.  I have attached 
a consent form and information sheet for you to review. There is no obligation to take 
part. 
  
If you decide to participate it would involve less than 1 hour of your time to complete 
a questionnaire. Your name will not be used in any publications. If you decide you want 





















QUESTIONNAIRE FOR EVALUATION 
 
Processes and strategies facilitate the provision of guidelines for use by teams when 
developing software.  Health software has to also adhere to relevant regulations. This 
questionnaire is used to gather your opinion of such processes and strategies proposed 
to aid in the development of software that is used in various industries but specifically 
healthcare.  
There are a number of processes or strategies that a team leader can employ to 
effectively manage a project that requires innovation. Four key processes have been 
identified: Understand, Inspire, Support and Recognise.  
What strategies do leaders employ to understand the domain to be innovated in your 
organisation?  
Key areas of consideration identified as key for leaders to understand are: the market; 
the opportunity; the risks and the rewards. Please explain your opinion of this 
statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
How do leaders inspire teams in your organisation to be innovative? 
Key areas of consideration identified as key for leaders to inspire are, the creation of a 
vision; mission statement; multidisciplinary teams; collaboration; communication and 
empowerment. Please explain your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
Can you explain how leaders in your organisation support teams to be innovative? 
Key areas of consideration identified as key for support are, defined processes and 
training. Please explain your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
Can you explain how leaders in your organisation recognise the need to empower and 
encourage teams to reach their potential and to be creative? 
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Key areas of consideration identified as key to recognise needs are, defined outcomes; 
foster risk-taking. Please explain your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
There are a number of processes and strategies that team members (practitioners, 
developers) can employ to effectively select and scope an area to innovate. Two key 
processes have been identified: Identify and Generate.  
 
What strategies do team members’ use to Identify areas of need to be developed for 
projects in your organisation? 
Key areas of consideration identified as key for team members to identify needs are, 
Immersion in the problem area, needs finding, and refinement of needs. Please explain 
your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
How do team members generate requirements in your organisation? 
 
Key areas of consideration identified as key to generate requirements are, concept 
finding, refinement of chosen concepts, brainstorming, and prototyping. Please explain 
your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
There are a number of processes and strategies that team members (practitioners, 
developers) can employ to effectively develop a project that requires innovation. Three 
key processes have been identified: Design, Develop and Verification and Validation.  
 
What strategies do team members use to design projects in your organisation? 
Key areas of consideration identified as key to develop a project is, to specify the design 
while considering relevant regulations and effective planning. Please explain your 
opinion of this statement? 
Are there areas you would add?  
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Are there areas you would remove?  
 
What processes do team members use to develop projects in your organisation? 
Key areas of consideration identified as key are, to track the development, iterate as 
needed, release and report. Please explain your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove? 
 
Can you explain how team members in your organisation verify and validate projects? 
Key areas of consideration identified as key are, to have appropriate verification 
processes and relevant validation processes. Please explain your opinion of this 
statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
There are a number of processes and strategies that team members can employ to 
effectively deploy a project that requires innovation. Two key processes have been 
identified: Deploy and Review. 
 
What strategies do team members use to deploy projects in your organisation? 
Key areas of consideration identified as key are, to empower users, encourage buy-in 
from users, to establish a sense of urgency and to plan for and create short-term wins. 
Please explain your opinion of this statement? 
Are there areas you would add?  
Are there areas you would remove?  
 
What processes do team members use to review deployed projects in your organisation?  
Key areas of consideration identified as key are, to consolidate improvements and to 
institutionalise new approaches. Please explain your opinion of this statement? 
Are there areas you would add?  





Feedback from experts on IDD model (Leader’s Perspective)  
Themes Tasks identified by experts  
Consultation Managers should consult with relevant staff. 
Often experienced managers respond better when they see the problem and 
challenges exposed. 
Add an evaluation task, for example, what do we measure success or lack 
of success as? 
Negotiation is sometimes needed. 
Consultation is crucial it must be connective, for example, have a mutual 
respect otherwise it becomes dysfunctional.  
Leaders must show ability to make changes while running the business: they 
show that nothing is static, introduce new areas of interest, business 
development, expansion, and keep that visible at all times to all levels. 
Leaders engage the customer using the following channels: 
• Community portal, where customers can discuss new 
proposed features and propose their own 
• Customer meetings, where customers can try the new 
releases and give feedback 
• User conferences, where users and organisation leaders 





Examine the frequency of the problem 
What is the significance of the challenge? 
Review the totality of evidence? 
How are things done at the moment that could be done better? 
What is the USP (Unique Selling Point)? 
What is done internationally? 
Cost implications are a major factor in going forward with a project? 
Analysis of the current domain based on usage, customer expectation and 
forecast of future usage.  
Leaders talk to customers and study the market for opportunities. They also 
think on how it is possible to innovate and streamline existing processes 
with innovation. 
Leaders keep close contact with Product Management (the customer side of 
things) and monitor the industry technological challenges. 
Market and Opportunity. This is a very broad set of areas to account for, and 
the effort required to even grasp a little of the factors is very high. A deep 
analysis and an equally deep understanding of all of them is necessary, so 
an accurate and expansive study phase (mostly around the feasibility of 
innovation) is necessary and should spend time across all of them. 
Leaders are aware of what the problems are and the solutions that the 
industry provides/can provide 
In my organisation the innovation is driven by the customer requests and 
needs. However I see more pro activity lately welcoming innovation 
proposals from the bottom   
My leaders always try to take all the needed information to understand the 
domain of work in a way to tackle all the unknowns as soon as possible and 
try to solve impediments that could delay the final goal. 
In order to understand the domain to analyse the leaders must first analyse 
the market in order to gain the knowledge of the domain and gain 
information. Then in order to better make decisions the leaders must take 
into account the opportunities, risks and rewards. In this way they can the 
pros and cons of every decision. 
Research for sure, sometimes you need to do it yourself or 
manipulate/change existing solution. 





Somewhat like a SWOT analysis. 
Hiring the right people also might contribute. 
Is this problem big enough to invest time in as time is valuable. 
Need to be free of failure. 
Rewards are good, managers should show how this will help in the end.  
Provide case examples of successful innovations. 
Remind staff of rewards do not force. 
Sometimes giving people a longer leash to take risks without penalties of 
failure, this allows people to try things. 
In health software rewards are very apparent. For example, moving from 
paper records. 
To allow people to be creative, failure isn’t penalised. 
Bring exposure to success stories that can inspire teams to see the potential 
rewards. 
KOL (Key Opinion Leaders) are very important in healthcare, which are 
people that are held up as an example. If possible, bring such people in to 
talk to teams about their experiences with success so that teams can be 
motivated to see the rewards. 
The market for the current demand. Does the current product satisfy that? 
What will the market look for in 10 years?  
The leaders have to understand the market and the opportunities that are 
available, but also, they need to take into consideration if the rewards are 
worth the risks in doing such innovations. 
Creativity in an organisation needs to be employed to the benefit of the 
organisation goals. A team leader should recognise the creative individuals 
in a team, give them time to explore their ideas and make sure those ideas 
are beneficial to the organisation mission and goals. To do so, the leader 
needs to make the team member aware of the goals and of how their 
innovative ideas fit into those goals. He also needs to make the team member 
aware of the risk involved in embarking in new projects, and in case the risk 
is too high compared to the benefit, he needs to cut the losses. 
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Communication Communication must be effective, for example, two-way. 
Communication is a two-way process. 
Use workshops as staff fears can be addressed here and creates a forum for 
feedback. This has in our experience worked well but it takes time to 
implement so be ridged in the time element. 
Be strategic purposefully choose working groups to see the different 
personality types. Leaders will emerge. This helps with empowerment too. 
Also problems can emerge, for example, in one group, training was not 
mandatory at the beginning but it became clear that training was needed 
throughout. This can then be addressed to have training all through the 
project. 
Have a clear communication strategy. 
My leaders always try to make each member a part of the decision process 
and anyway involved in order to have clear goals and make each person own 
their part. They promote collaboration to better use the skills of everyone 
and the communication between team members and other teams. 
The leaders always keep the teammates up to date with the latest 
technologies; make them improve their knowledge and their skills. 
Multidisciplinary 
teams 
Have a mix of teams. 
Engagement with relevant stakeholders. 
Multidisciplinary teams are common in clinical practice. 
Look at the skills mix of the staff. 
Flexibility Staff are very busy so they cannot be overwhelmed and it cannot take too 
much time. 
Resistance Most people fit into 1 of 3 groups: Nervous, Strong and In-between. Identify 
these dynamics. 
Managers must react to dissatisfaction with processes and act not force 
Use relevant personality types to drive project. 
Fear leads to resistance. 
Leaders on wards create tension use working groups instead. 
Early on leaders need to be listening as resistance to change can be logical 





The mission statement must be comprehensive, evidence-based and user-
informed. 
It has to show the ultimate goal. 
This is not of value if staff don’t work together.  
I would consider the creation of a vision and a mission statement the same 
thing: they are the representation of the focus. 
Both creation of a vision and mission statement make the leaders better 
describe where the team will need to go and define long-term objectives. 
But in order to give the right direction to the team he needs collaboration 
and communication in order to remove every obstacle to the final purpose 
and empowerment to make all the involved people take ownership of their 
part. 
I think that the creation of a vision and the mission statement might be the 
same thing. In fact the vision should be the mission of the organisation. 
I would merge creation of a vision and mission statement. 
Rename some 
wording 
Change the strategy word for market to specialist area. 
Wording could be changed. 
 
220 
Empowerment You need to create ownership. 
Ownership of tasks required. 
Bring the project to staff and moving forward include staff. 
Buy-in is crucial. 
Encourage involvement. Acceptance of each role. 
Managers need to be role models. 
Engagement is key. 
Encouragement is must be recognised as an important element to 
empowerment. 
Working groups aid empowerment of staff. 
Involve staff in decisions and realising this creates ownership. 
Value the input of the team and audit results. 
Be open to hearing problems and work together to try and address them. 
Leaders empower teams to be service owners and to find out the best 
solutions/innovations for their team. They also might have an R&D practice 
that looks for newer technologies and processes and help teams up taking 
them. 
Teams needs to be empowered in taking risks and thinking like a start-up 
company, where it’s all about innovation. Teams must also collaborate to 
avoid duplicates and going into opposite directions on key technical 
decisions. 
Using service ownership and agile methodologies. 
I believe those are mostly all the necessary characteristics to a successful 
endeavour. There is the need to feel part of the same effort and to share the 
responsibility for that effort to succeed under the banner of a guide that must 
represent and share the same. 
A happier employee works better. My company provides training and a 
comfortable environment.  
Encourage team members to learn about the domain and the architecture. 
Give team members time to explore their ideas. 
As for inspiration also here we use talks, meet ups, hackathons and 
sometimes conferences. 
Giving responsibility and rewards. 
Ethics Is ethical approval needed, this must always be checked and it could be 
different in other hospitals. 
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Vision We use this in clinical practice. 
We call this the philosophy of the organisation. 
Vision is worthless if teams are not working together. 
Innovation is rewarded promoting those who deliver innovative solutions. 
Occasions to showcase innovative solutions inside the enterprise are 
organised (e.g. hackathons, conferences, etc.). The vision is shared with the 
teams in meetings. 
Encourage team members in understanding how their ideas can fit in the 
organisation vision. 
Timescales  Timescales are needs for staff. 
In our organisation allocating of time is crucial, for example, freeing up staff 
from clinical setting. 
Free up time for teams. 
Time allocation for staff. 
Time is an issue; leaders must recognise that change implicates on time. 
Change doesn’t happen overnight. 
There is a time element to change. 
Collaboration Leaders/managers must be open to the possibility of a new and better 
solution coming from staff.  
Openness to new ideas is very important. 
It cannot be a top down approach and must be from a workload perspective. 
Have a problem solving mentality. 
No all problems are negative, collaborate to identify a solution. 
Mentorship  Staff can learn by doing and have a mentor. 
Mentorship is important as when little problems come up, they can be 
addressed in his way.  
Use role models (act as). 
Having role models helps as you have a key person on the ground who is 
the go to person (not the leader).  Support has to come within the team not 
from the top. 
Have a mentorship/buddy system. 
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Training  Do training in a practical setting. 
Training must be relevant, personalised. 
Use of technology for training, for example, YouTube videos. 
Mutual respect needed. 
Set training from feedback of previous training. 
Motivate people, look at evidence of training working and if it does not work 
well do something about it. 
Not just training and processes but being an active member of the tech 
community.  
Training is very useful in learning new technologies. 
To promote training, leaders need to promote knowledge transfer through 
communication between team members, and encourage the creation of a 
documentation body, to make training easy and repeatable in the future. 
I agree especially with training, not going blind down the way is a good start 
when you want to innovate. 
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Defined process  Processes must be adaptive and flexible but this depends on goodwill of 
teams. 
Teams must get the bigger picture to see the use of defined processes. 
Have clear deliverables. 
Provision of resources (time, space, funding, infrastructure etc). 
Have team leads and mentorship. Then set deliverable. 
Have actions on objectives. 
Healthcare is complex and competitive we found that innovation diffusors 
were a failure. Working groups work much better.  
Set structures, minutes, findings and training. 
Don’t have deadlines too far ahead. 
Be ridged with what has to be achieved but not how.  
Inviting team members to come up with new solutions, challenging them to 
scale in order to support the business. Joining meet ups, training sessions 
and conferences. Be an active member of tech community, possibly being 
even a speaker.  
R&D dedicated team. Service Ownership teams. Training on new 
technologies/best practices. Allow people to attend meet ups/conferences. 
Think like a start-up company. 
Defined processes are needed to be able setup owners and responsibilities 
for the innovation, but this is not enough by itself as a company must not 
end up being caged by existing processes but should always be able to 
innovate also there. 
Managers are encouraged to take new projects and ideas seriously, and 
invest resources in exploring new patterns and approaches to issues. Their 
main goal is to support their team members into contributing better ideas 
and better ways of accomplishing results. Time can be dedicated to 
exploring areas of improvement identified by the team by all the members. 
I believe that a defined process is much less important than training and 
meeting opportunities: this should be the focus and receive most of effort 
both from the management (to offer) and the team members (to take 
advantage of). In learning there are the best possibilities for innovation. 
Defined Processes do not seem critical to me, they could actually end up 
making everything more rigid and reduce the possibilities of finding 
something interesting to evolve around. 
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The agile process makes all the team aware of the problems and incentivises 
everyone to give solutions.  The process is really important for this 
Outlining defined process helps teams going in the right direction and have 
the methodology to deal with the daily work; training helps improve the 
person to gain new knowledge and improve the personal skills 
Defining the process is usually not enough for the success of an 
organisation. The process needs to be updated accordingly to the changes 
the organisation undergoes. Governing the process change is an area of 





Defined outcomes for me follows on from defined processes. 
This is a mechanism to address challenges and leaders need to be open to 
input and open to change. 
Recognise that leaders needs to be open and staff have to get a better idea 
of the value of every member of the team. 
This is the ultimate goal but can change if needs change. 
Have formal PDRs (Professional Development Reviews). 
Have regular team meetings. 
Defined outcomes are beneficial to everyone (doctor, patient, health 
system). Everyone wins if used properly. 
Note that clinicians can have a narrow vision. 
Outcomes can include incentives to staff such as publishing posters and 
audit potential. 
Busy staff think is this just extra work so more clarification needed for them 
such as the successful outcome. 
CPD (Continued Professional Development) is useful as an outcome for 
staff to give them the potential to add to their CV and career progression. 
More than defined outcomes (which I would consider hopeful outcomes) 
the risk to be taken is part of the necessary wisdom. And yet, also the correct 
assessment and balancing needs to be part of the exercise: reckless risking 
is not useful.  
Defined outcome, should be more of vision outcome. 
Give defined outcome helps, don’t lose track of the final goals; and without 
taking risks there will not be real gain. 
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Foster risk taking  Encourage staff to think the unthinkable. 
Think outside the box. 
Have open forums. 
Risk taking in healthcare has negative connotations I presume that means 
problem solving. 
Have a recognition of need so as to carry out a risk assessment and risk 
factors. 
Multidisciplinary teams that have collaboration and competition leads to 
creativity ultimately taking risks to be innovative. 
Foster risk taking is a different definition in healthcare to business. 
Foster risk taking is not generally perceived as a positive attribute in 
healthcare. Risk is associated with an adverse outcome. It is considered high 
stakes.  
Risk taking must recognise the input of all stakeholders. 
To encourage risk taking go to an experienced person and collaborate with 
them. 
Encouraging the team to join conferences, experiment with prototypes, 
brainstorming new options in a blame free environment.  
My leaders tend to put teams in position to work a step out of their own 
comfort zone; always in the area where the person can take advantage of his 
own skills but a step outside where he can improve his own personal skills. 
Outcomes are useful, but taking risk even more, non-comfortable situations 
stimulate evolution and growth. 
Risk assessment  Limit adverse risks by carrying out risk assessment. 
Have external reviews. 
Look at international best practices. 
International best practice should be added to risk assessment. 
Have quality reviews. 
Risk-taking should be encouraged as it is the way to innovate and disrupt 
what’s there.   
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Review  Needs analysis should be done and note that this can be different for 
different groups. 
Key people should be involved in the review process and it should be two 
way. 
Without review then no win later. 
Learn from 
previous projects 
We reviewed our previous failed attempts so we learnt to be ridged, tight on 
time and flexible with staff. 
User satisfaction  Current customer satisfaction. Feedback from customers on what to improve  
Inspire process  The creation of a vision; mission statement; multidisciplinary teams; 
collaboration; communication and empowerment. Please explain your 
opinion of this statement?  
Agreed. The above are fundamental levers to enable and nurture a 
functioning team.  




An enthusiastic team, interested in their job, naturally come with new ideas 
and suggestions on how to improve. If the product (s) stay stale is generally 
a sign that the team is not engaged.  
The people in the various teams are generally able to work with the tools 
that they find more congenial and can select the best practices they believe 
will be more effective, this generally allows for the creativity and selection 













Feedback from experts on IDD model (Practitioners perspective)  
 
Themes Tasks identified by experts  
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Immersion For immersion to work collaboration and consultation is important. 
To find a need you have to be involved deeply in the area. 
Be aware that staff have to deal with problems/needs all the time so there is 
an element of frustration sometimes.  
Immersion is good but it has to be handled properly. If it is not then it can 
create barriers and issues involving stakeholders. For example, not a lot of 
enablers, no joined up thinking, blockages in the system. 
Immersion worked very well for us but it has to be done properly. We found 
that staff initially were resistant to new members observing them. We had to 
call a meeting and get the new members to present to the group what their 
aims were, this allowed staff to see that their work was not going to be 
criticised and interrupt their busy schedules during observation. The ultimate 
goal was that we were all going to try and innovate better ways of working 
that will benefit staff and patients.  
Immersion had to be treated in an innovative way as there was fear of this 
new way of working so having an KOL on our side helped. Also we had to 
deal with insurance issues before allowing observations to start.  
Immersion can be costly. Money is not the issue it’s how you spend it. 
Contextualise the problem (identify the burden). 
Immersion can be tricky, for example, there can be an ethical issue in 
bringing in external people where there can be vulnerable people. 
You have to have a plan for sensitive information.  
Full prolonged immersion is riskier as seeing everything has implications for 
patients. 
Immersion can overcome the problems of trying to define problems to 
external people. 
Risk assess potential issues to patients and families of access in immersion. 
Understanding the problem space is fundamental to evaluate under- 
developed areas.  
Product Owners will drive the identification process from a 
business/customer point of view, adding new features/improvements to the 
backlog of items of the team. 
This is an accurate statement considering there is first a need to understand 
the issues and then try to find innovative ways to solve them. 
A team member works daily in an area of competence improving more and 
more the confidence of it. Retrospective (agile ceremony). 
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As a team the experience fill an important role where it can be use as history 
memory about the past and build the fundamentals in order to track the weak 
areas of a project and improve the missing features. 
Working in an agile environment, first of all we need information and 
experience in order to tackle the possible impediments for a project. As a 
team each member can find the needs and the missing holes; then the 
refinement of needs is at the base of agile development where we define an 
initial idea that can be improved with the voice of everyone. 
I agree especially with the immersion in the problem area, if you don’t know 
the problem you can’t identify the needs. Still the findings have to be 
reviewed with someone to confirm they are team needs. 
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Needs Finding Identify what is known about the problem, how could a proposed innovation 
meet the gap in that space. 
You have to be aware that sometimes problems exist that will never have a 
viable solution. 
To find a need the pathways of communication must be more open. 
Collaboration and an open ear to problems, aids in finding needs. 
It must be noted that experts can find it hard sometimes to articulate a 
problem. 
Finding a need should be very nailed down as sometimes you can’t fully 
work out the benefits and there might be unexplained/unexpected outcomes. 
Lateral thinking is needed here. 
Analysing the current projects, using metrics and static indicators. 
Experienced team members understand risks and possible future scenarios to 
be addressed.  
I would also add that customers can help identify needs by submitting their 
ideas for improvement. 
The most important findings come from the analysis of the current issues and 
the tools we have to resolve them. New requirements from product 
management also generally spark new ideas and considerations that drive 
more potential innovation. 
The organisation follows the scrum process, so team members periodically 
groom the backlog of issues to be done in order to refine the description and 
the expected outcome of those issues. Also, the team members, guided by a 
product owner and a scrum master, decide which issues will be done in a 
sprint. 
Needs Screening Staff must be able to bring issues to a manager’s attention and there must be 
an atmosphere and environment of problem solving to highlight relevant 
needs to pursue. 
Before progressing with an identified need we had our clinical audit 




Audit  Auditing or quality risk department should sign off on any new changes. 
Following the scrum process each team member is expected to work to be 
up to speed to what’s the team mission and to understand how the code the 
team maintains works. Team members are free to propose enhancement. To 
do so they can open an issue, that is then examined and refined during 
backlog grooming. The team analyses and refines existing issues during the 
backlog grooming. 
Team members do not only generate requirements but also artefacts. 
Creating issues when a team member thinks there is a need does the process. 
The created issues are then refined during backlog grooming. 
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Concept finding Concepts should be driven by patient needs. There should always be at least 
one person on the team who is a patient advocate. 
Look at existing solutions in similar settings. 
Everything should be derived by patient needs and wants and improved 
patient outcomes. 
Have key stakeholders, for example, end users involved in finding concepts. 
Finding concepts are dependent on the person’s knowledge. 
What do we want the system to do and what functionality does the system 
need to have? What are the limitations of the current system? Engage with 
the users to answer these questions. 
Analysing the problem space. Forecasting business risks. The means can be 
different: via initial short meetings; observing product behaviour in 
production to then spin up Spikes and further analysis.  
They are coming from product strategy, listening to customers and/or 
partners and from product management. Some technical requirements are 
also coming from development too. 
The most important part is the concept finding, brainstorming with the 
different stakeholders (internal/external users, other teams) and then the joint 
work of product management and development should go towards producing 
a prototype. 
Analysing “the ask” for the project and finding if we already have all the 
means able to complete the project and eventually define impediments as 
soon as possible. If we are not able in an early stage to define all the needs, 
we then eventually start building an initial prototype to define other 
impediments. The first analyse will produce the concept finding, that can be 
refined with an iterative process. Wherever the first analysis is not enough, 
start the prototyping will better uncover possible impediments. 
Concept finding and brainstorming are probably the same concept. 
Refinement is done during the backlog grooming. Prototyping is done only 






Within healthcare what is feasible, practical and workable. 
Depending from the needs team member create JIRAs with them in it. JIRA 
is software used in agile to plan, track and release software. 
I think that the “Generate” process needs to be further refined. I would 
consider the generate process as the phase in which design artefacts are 
produced. So I would add the “refine” and “document” activities for this 
process. 
Brainstorming Use feedback and two way communication so that the users have information 
to mitigate fear and users are involved in coming up its potential solutions. 
The users see what is the win for me? What can this potential do for me? 
Look for good ideas. 
Brainstorming must generate a result or a provisional outcome. 
The initial design phase for new project is always accompanied by a set of 
initial Spikes where we take a defined amount of time to brainstorm the 
project, find the missing holes in the project, propose a solution and 
brainstorming it with the team members. This is an iterative process that can 
end with other Spikes or the first implementation of the project. 
I agree especially with brainstorming, best ideas come always out from 
combined brains. 
Prototyping  Useful for adapting programs and required adaptations for feasibility and 
practicality. 
Piloting and refinement this needs to be cyclical. 
Feedback important here. 
Prototyping is important as it help visual learners to know this is going to 
happen. 
I would keep the prototyping stage as a separate late stage where the main 
requirements are already well understood and established, but there still 
something to explore about the technologies and practices around how to 
solve the issue itself. 




Generate process  Overall the generate process is dependent on team experience, for example, 
pilot studies can be problematic if inexperienced people involved as they are 
not ready for rollout and put off implementation. 
In the generate process commitment to change must be shown as taking 
shops is usually what we see. 
We have a dedicated team organised to functionally understand issues and 
collect requirements in the Product Managers. They work in integration with 
the team to make those requirements consistent with the best practices and 



























Feedback from experts on IDD model (Developer perspective)  
 
Themes Tasks identified by experts  
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Design  Design around healthcare environment, what’s available, ease of adaption, 
feasibility and practicality. 
Design is influenced by time, space, cost effectiveness and staff ability. 
Individualised requirements should be fit for purpose. 
MDTs (Multidisciplinary teams) useful for the speciation of a design. 
For outsourced teams we provide the design specification to dedicated 
departments. We link in with the department with regular communication.  
For in-house development we use MDTs and again there is regular 
communication, team meetings, terms of reference, targets set. We draft a 
sample design, set feedback and refine. 
Ethical issues must be considered in the design. 
Initial Spikes that can include research on the market and possible solutions. 
Discussions with the team and / or more experienced peers. Prototyping, 
further discussions and definition of actual design implementation.  
Developers will identify technology gaps needed to be filled to fulfil those 
needs and improve the delivery, quality and speed of the artefacts. 
Usually there are Architects who design the projects from a technical 
perspective based on the requirements gathered by the business. 
The choice of what design strategy to apply depends on the issue at hand, 
mostly, but also on the general architecture of the system they have to 
integrate with. The resulting structure maintainability also plays a role in the 
decisions. 
The design process is the moment where ideally a proposed solution will be 
its outcome.  
Key areas of consideration identified, as key to develop a project is to specify 
the design while considering relevant regulations and effective planning. 
Please explain your opinion of this statement? It’s a beautiful statement, still 
external key areas that affect the whole process has to be considered like 
time, resources and politics.  
Beta versions released with bugs. In health people won’t use it. 
In conjunction with developers do required adaptations. 
Working groups review and make sure required changes completed and if 
revisions are needed. Cycle between the working groups and the developers. 
If looking at technology the individualised aspect is very important, for 
example, adaptations for people at home. 
Training should be interspersed between the developed revisions. 
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We use agile. Depending on team members, TDD (Test Driven 
Development), implementation by breaking up features in smaller units, 
code review and pair programming.  
Key areas of consideration identified as key are to track the development, 
iterate as needed, release and report. Please explain your opinion of this 
statement? Agreed. Tracking the development as team, status updates and 
feedback when needed.  
We use the Agile Scrum methodology: projects are broken down into smaller 
pieces (stories) that are done in 2-weeks sprints. Every sprint there’s a sprint 
review where the work is reviewed and demoed to stakeholders, We use 
JIRA to track stories, bug, and high level features. 
We use agile development throughout the company, but with variations as 
needed by the different teams preferred approach. The agile approach 
provides the possibility to continuously evaluate design and priorities based 
on the current conditions. 
The tracking is essential, and should always be carried out using a dedicated 
tool that allows all participants to log and show their considerations and 
efforts. As part of the release process, it should be possible to monitor 
continuously the usage of the delivered projects and tune it accordingly over 
time. 
The development phase is usually defined in a 2 weeks’ time window, where 
we focus on delivering a key set of features or part of them. Each developer 
works in smaller part of the feature commit small parts as soon as possible. 
Code is review by other peers or senior team members. We try to avoid long 
periods without committing as this implies possible problems when merging 
with the main code base. Each small part is then QAed in order to guarantee 
always a high and efficient level of code. Each feature is then verified in 
functionality at the end of the delivery. 
Tracking the development helps to keep each team member focus with his 
own work and without losing the final goal; an agile environment has as 
fundamental the iterative process to refine the work or the ideas. Releasing 
and then report will then conclude the development process from the 
developer point of view. 
Develop, verification and validation are an iterative process, in which a 
software engineer does the development, while a test engineer does the 
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verification and validation. The process is repeated until the requirements 
identified are implemented correctly. 
Key areas of consideration identified, as key to develop a project is to specify 
the design while considering relevant regulations and effective planning. 
Please explain your opinion of this statement? I agree with this statement. 
While specifying or refining the design, if issues are found with regulations 
or planning, the scrum master and the product owner work with the developer 
and the team to overcome the issue. If this is not possible, another design 
phase is kicked off or the issue is shelved, waiting for the issues to be 
overcome. 
Key areas of consideration identified as key are to track the development, 
iterate as needed, release and report. Please explain your opinion of this 
statement? We follow exactly the same areas of consideration. 
Development is driven by customer requirements, so we improve firstly the 
customer experience.  
I would add an iterative phase in which the requirements in need of 
clarification are discussed between the test engineers, the rest of the team 
and possibly the product owner. 
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Regulations Yes design should be planned especially in health, regulations and standards 
very important, for example, HIQA standards. 
Design planning Have structure for people in design. 
We are mindful of potential data protection issues. 
Plan audits and reviews with external people to remove bias and bring 
transparency throughout. 
Data protection, moving of data, sending data and anomamising of data must 
be considered. 
Ongoing consultation, input from users and consult as you go on. 
If effective planning means the waterfall project management, I don’t think 
that is still a good way to plan a project. Agile methodologies have shown to 
be much more effective. 
I too think that clarity of the design is necessary since the earliest possible 
stage to allow for a good end result, and the design stage should be favoured 
in time and effort. 
If the task to develop is complex, there are spikes on which the projects are 
investigated and designed  
Design is normally done before starting the implementation. It is refined by 
who is implementing. 
YES: make the users part of the long-term design initiatives and the 
development of the system. 
Review  Add another process called review or have it as a strategy. 
I’d add constant feedback from stakeholders.  
Review. Processes should be more and more refined having metrics (Ex how 
many bugs weren’t found in the verification process? Is the number 
increasing? If yes why?) 
Report Report on identified outcomes and think about what needs to be reported and 
is it an improvement. 
I would account for the need of “clarification” of some requirements. 
Add time, resources and politics. 
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V&V New outcomes, reliability must be measured. Consultation with others. 
Security and upgrades should be addressed in V&V. 
Make sure that the data that is supposed to be collected is and that it is 
correct. 
Check the content and the face validity. 
Via code review, QA testing, and demoing the product.  
Add feedback from the stakeholders.  
Evaluate unintended outcomes and talk to staff. 
Have due regard for identified outcomes. What am I measuring this outcome 
against? 
Look to verify as we envisaged. 
Verification is done by QA team members that follow the story 
confirmations and do the functional testing. Automation testing coverage 
provides regression testing. Demoes to stakeholders provide validation on 
the work done. 
There are two approaches mostly: automated testing developed around the 
basic functionalities, and well established Quality Assurance teams melted 
with the development team that keeps track of the projects and features to be 
released from the earliest stages and understands the functional domains. 
These people will validate and test the various projects against the 
requirements they are to satisfy and help identify shortcomings. 
The verification of the project’s outcomes and the fact that they respect the 
requirements is very important, as well as validating them in real world 
application scenarios. 
I would not very much distinguish between verification and validation. 
We have QA mates that have to functionally validate and verify the work. 
They check the requirements in the JIRA and see if they are met 
After every biweekly feature release, QA is going to verify each part 
singularly and the whole feature as per requirements. Then the stakeholders 
will validate and verify the final product (PM or other teams). 
Defining a good verification and validation process will help deliver a good 
quality of the product that can be easily improved in the future. Make sure it 




Developers write unit tests for the software. Test Engineers write system 
tests and verify that the implemented software conforms to the identified 
requirements. 
Peer review and QA acceptance. 






Feedback from experts on IDD model (Implementer perspective)  
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Deploy with user 
involvement 
Balance between force and encouragement to use, you need a bit of both. 
Give extra time for people and extra allowances for administration time to 
assimilate how to use it. 
Lack of time so block off time for staff to get used to it. 
Allow possibility to make changes as needed to adapt to needs. 
Highlight advantages of this new system and it helps to have a flag bearer 
in the team to start using it and then they can help with problems. 
Have mentors. Invest in 1 or 2 users successfully using it. 
Problem solve with working groups. Be rigid with ultimate goal but flexible 
in getting there. 
Deadlines and dates are important as clinical work will take precedence and 
importance. 
Be clear to people the benefits and that it will make working life more 
efficient. 
Support service by having a contact person identified within the 
organisation.  
Have a defined “phase-in” period. 
Collaboration and communication needed here. 
Agree deadlines. 
Be adaptable to changing knowledge or future needs. 
Gather user feedback. 
Have regular updates to make sure it is “fit for purpose”. 
Get regular feedback and updates. 
Currently the deployment is not owned by the organisation I’m part of. For 
projects currently ongoing, the team will have such ownership. The key is 
to have a better understanding of the mechanics involved in production 
environments.  
Each team commit changes to a repository, a build plan executes 
automation tests and if the changes pass them, an artefact is generated and 
automatically deployed in a shared area, where the deployment team picks 
it up and deploy to the production environment. 
Sense of urgency can be bad if it means rush code out or fix things in a 
hurry. Short-term wins can be occasionally good but the focus should be on 
having a system and process that enable long-term wins and sustainability. 
The deployment is increasingly automated through a building and testing 
pipeline that runs the features through integration with the rest of the system 
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and then makes them available in the runtime production product after a 
series of manual steps that have to be carried out with the supervision of the 
teams involved. 
This does not seem like the right set of key criteria: I would not make it key 
to work on the sense of urgency and short term wins since they might lead 
to long term costly issues in the relationship with the users and the system 
itself. 
YES remove: to establish a sense of urgency and to plan for and create 
short-term wins 
We have a build engineering team on which we discuss deployment 
strategies with.  
Every week the main code line is branched in a release candidate version 
that (if there are no problems) will be deployed in customer environment 
the following week. We have plenty of different environments in order to 
test at different levels each project. 
Defining short term delivery points help work with the good amount of 
pressure in order to deliver small parts of the whole project every time, do 
an incremental test phase and avoid a big bang impact during releasing time. 
My team does not deal with deployment. The organisation comprises teams 
who deal with that. 
Agile development style encourages the short-term wins with the iterations. 
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Training Training would need to be at an appropriate time and that can be different 
for different people. 
Training and education vital for success and rolling progression. 
Technical support is needed. 
 Repeat training days. If people on holidays or new team members have 
initial burst of training. 
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Audit Change the process word Review to Audit. 
Consolidation should be in the roll out. 
Get input from all stakeholders and conduct an audit. 
This process of review must involve users and communication must be two 
way. 
In my experience the review is always a post review but it should be 
throughout an area to gather opinions. Review throughout. A user comment 
section would be useful (either paper or login or a blog). The comment 
section has to be confidential. There might be some venting on the comment 
section but you can ignore this. 
The review has to be for all concerned. Whoever involved should be 
included and you need feedback. 
Get rid of the old system otherwise you’ll have 2 ways of working. 
Have an audit trail. 
Your strategies are missing an area, for example, you are assuming that it’s 
successful and effective. 
Monitoring production data, like logs and metrics. Constant review and 
discussion of the product behaviour in production.  
We have a code review process before deploying the code to make sure that 
the code is of good quality and follows the best practices. We also have a 
formal sprint review after each sprint where the project is demoed to the 
stakeholders. 
We tend to collect data about the usage of the features and the access to the 
new functionalities delivered to the user in order to assess their reception 
and then stay in touch with the support people that keep a close tie with the 
users and their reactions. 
Consolidation of features, changes and improvements is definitely 
important and should be taken into account at every step. 
We usually review deployed projects at various stages, like every delivery 
of biweekly work and after a 6 months release plan. People involved are the 
developers and QA of the team plus all the relevant teams close to the 
project. 
A post mortem approach of the release of a new project will help identify 




My organisation has teams dedicated to monitoring the health status of the 
deployed projects. In case of issues these teams need to try to react to 
mitigate the issue or to involve developers to try and find a long-term 
solution. 
I would also add that monitoring the health status of deployments is part of 
the implementer team’s responsibility. 
Through monitoring the customers and via customers feedback. 
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Remove strategies Remove Establish a sense of urgency and to plan for and create short-term 
wins 
Key areas of consideration identified as key are to empower users, 
encourage buy-in from users, to establish a sense of urgency and to plan for 
and create short-term wins. Please explain your opinion of this statement? 
I don’t think that encouraging buy-in is a task to be fulfilled by the 
implementation team. The implementation team comes in when customers 
have made up their mind. That task is rather accomplished by a team of sale 
specialists. I agree with the rest of the statement. 





Yes, it is important in an always-improving team to consolidate 
improvements and try new approaches and review them. 
There is the need to constantly analyse the internal processes improving the 
weak points and leverage the strong ones. 
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